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ABSTRACT OF DISSERTATION 
ROLE OF HAIRY-RELATED (HER) GENES DURING VERTEBRATE RETINAL DEVELOPMENT AND 
REGENERATION 
 Development and regeneration of the vertebrate eye are the result of complex interactions of 
regulatory networks and spatiotemporally controlled gene expression events. During embryonic retinal 
development, the coordination of cell signaling and transcriptional regulation allows for a relatively 
homogenous sheet of neuroepithelial cells to proliferate and differentiate in-to a multilayered, light 
sensitive retinal tissue. Following injury, the retinas of many cold-blooded vertebrates, such as the 
zebrafish, undergo a proliferative response that results not only in new retinal cells of the correct type in 
the correct location, but also functional integration of these cells and restoration of vision. In order for 
embryonic retinal neurogenesis to proceed correctly, systems must be in place that restrict subsets of 
progenitor cells from differentiation. Pools of actively proliferating retinal progenitor cells are 
maintained to fill the needs of developmental processes and normal growth of the retina. In addition, 
subsets of radial glia in the retina retain the ability to de-differentiate into proliferating progenitor cells 
to meet the demands of the regenerating retina. All of these processes rely on the tight coordination of 
extrinsic and intrinsic cues, as well as regulation of gene expression by transcription factors. Although a 
considerable amount of work has been conducted to identify key regulators of retinal de velopment and 
regeneration, many gene regulatory networks which include both master signaling pathways as well as 
individual transcription factors remain poorly characterized. 
 Some of these factors implicated in retinal development and regeneration are me mbers of the 
Hairy/Enhancer of Split (Hes) superfamily of genes, including the Hairy-related (Her) factors Her4 and 
Her9. Her transcription factors are basic-helix-loop-helix-orange (bHLH-O) transcription factors that bind 
to palindromic E- and N-box canonical sequences in the promoters of target genes. Her factors have 
been previously shown to play roles in a diverse array of developmental and neurogenic processes, 
including neural tube closure, floor plate development, somitogenesis, and development of various 
components of the central nervous system as well as the cranial sensory placodes. The roles of her4 and 
her9 in retinogenesis, however, remain undefined. To determine the possible roles of her4 and her9 
factors in the retina, I characterized the expression patterns of these factors during developmental 
retinal neurogenesis and/or regeneration, examined loss of function phenotypes, and identified 
signaling pathways that modulate expression of these factors. 
Chapter 1 of this dissertation provides an overview of vertebrate retina and retinal 
development, the known functions of her4 in other tissues, and the Notch-Delta signaling pathway. 
Chapter 2 provides evidence that her4 is a primary effector of the Notch pathway during retinal 
development, and examines the role of her4 expressing cells during regeneration of the mature 
zebrafish retina within the context of both chronic and acute photoreceptor damage paradigms. In 
addition, generation and validation of the transgenic her4:Kaede zebrafish which was used to identify 
the lineage of her4-expressing cells is described. Characterization of her9 during retinal development, 
identification of the retinoic acid signaling pathway as a regulator of her9 expression in the retina, and 
the role her9 plays during retinal vasculogenesis are discussed in Chapter 3. Chapter 4 discusses the 
generation of her9 knock-out zebrafish lines using clustered regularly interspaced short palindromic 
repeats (CRISPR)/Cas9 technology and characterization of mutant phenotypes in mosai c her9 mutant F0 
fish. In addition, in Chapter 4 I also discuss the screening processes used to identify and characterize 
genetic lesions in the her9 allele and establish various lines that stably transmit deleterious her9 alleles 
in the germline, and provide preliminary data of the her9 mutant phenotype. Finally, in Chapter 5 I 
discuss conclusions from the data generated from this dissertation, additional studies that would 
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expand upon this work, and the implications of these results on the broader understanding of retinal 
development and regeneration. 
My dissertation incorporates reverse genetic analysis in zebrafish, biochemical analysis, 
transgenesis, and various molecular approaches to help better understand the roles of her4 and her9 
during retinal neurogenesis. Moreover, these studies may also contribute to a better understanding of 
retinal development, and disease pathogenesis. It is my hope that this work could also ultimately 
contribute, even if in some small way, to the goal of enabling human patie nts who have suffered from 
vision loss a means by which a damaged retina could be regenerated and functional vision restored. 
 
 
KEYWORDS: Retina, Development, Regeneration, Vasculogenesis, Notch-Delta, Retinoic Acid, her4, her9, 
Zebrafish, CRISPR/Cas9 
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CHAPTER 1: Vision, retinal development, and bHLH-O transcription factors 
KEYWORDS: Vision, retinal development, Notch-Delta signaling, Her4 
1.1 Introduction 
A primary function of all living organisms is the ability to perceive and act upon environmental 
cues and information in an effort to collect resources, avoid predation, and in many cases, reproduce. 
One of the most heavily relied upon means by which vertebrates survey their world is through vision, 
which can be described as the process by which an organism collects, organizes, and interprets quanta 
of electromagnetic radiation emanating from the environment (Lamb et al., 2007). Vision, or the ability 
to “see”, is a critically important biological process in nearly every aspect of our lives. In addition, 
retaining the capacity to detect visual information from the environment has proven to be so 
evolutionarily advantageous, that analogous traits that allow for various forms of light-sensing have 
arisen independently multiple times in every biological domain (Nilsson, 1996). 
Functional vision in vertebrates requires the coordinated efforts of multiple complex tissues, 
including both neural and non-neural tissues derived from different embryonic origins, as well as 
establishment and refinement of connections between the numerous cell types found in the retina and 
brain. There is a multitude of individual genetic, cellular, and tissue level events that must take place in 
near spatiotemporal precision during initial embryonic eye development for proper v ision to occur. In 
addition, there are numerous eye pathologies that can occur after the visual system has already been 
established that can lead to various types of vision loss. Due to these factors, the National Eye Institute 
estimates that over 1 in 10 Americans currently suffer from inadequate vision or eye disease, at an 
estimated cost of over $68 billion per year. Because the United States, like other first world nations, is 
experiencing the results of an increasingly large aging population, visual pathologies such as Age-related 
Macular Degeneration (AMD), diabetic retinopathies, and slow onset Retinitis Pigmentosa (RP) are 
becoming much more common and are likely to exacerbate these numbers. Although in this modern era 
9 
 
it is certainly possible to live a long and fulfilling life that doesn’t include functional vision, retaining 
and/or acquiring the ability to see can profoundly affect the quality of life of those afflicted with vision 
loss. 
The retina is the photosensitive neural tissue that lines the inner part of the back of the eye and 
is an outgrowth of the vertebrate brain, making it the outermost portion of the central nervous system 
(CNS). Although the various retinal cell types as well as the overarching structural themes are very 
similar in cold- and warm-blooded vertebrates, warm-blooded mammals lack the ability to regenerate 
neurons of the CNS (Fischer and Bongini, 2010). Whereas both acute and chronic damage to the 
mammalian retina is generally permanent, the damaged zebrafish retina undergoes a robust 
regenerative response (Vihtelic and Hyde, 2000, Morris and Fadool, 2005, Goldman, 2014, Gorsuch and 
Hyde, 2014). Although there have been recent advances in cell transplantation therapies as well as gene 
therapies designed to stimulate some degree of regeneration in the mammalian retina, restoration of 
vision in human patients remains a distant goal. In order to properly implement a biological therapy that 
restores vision, one promising avenue of research is to uncover exactly what molecular and cellular 
mechanisms enable a cold-blooded vertebrate such as the zebrafish to have the remarkable ability to 
fully regenerate damaged retinal tissue. 
This chapter will provide an overview of the visual system and retinal development, including 
relevant signaling pathways and transcription factors that are essential for proper retinal neurogenesis. 
Additionally, we will discuss the utility of the zebrafish as an appropriate model organism for these 
studies, and review the known functions of basic-helix-loop-helix-orange (bHLH-O) proteins, including 
the Hairy-related 4 (her4) transcription factor. Throughout this text, we will follow established 
nomenclature, designating human genes in all capital letters, rodent genes with the first letter 
capitalized, and lower case letters for all other vertebrates; italic letters indicate genes, whereas non-
italicized names refer to proteins. 
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1.2 Vertebrate retinal development 
1.2.1 Retinal cell types, functions, and connections 
 The vertebrate retina is a highly conserved and specialized extension of the central nervous 
system (CNS) that enables vision by allowing photons of light to be captured and transduced into 
electrical signals that output to and are interpreted by the brain (Figure 1.1). The neural retina is a 
complex multi-layered tissue that consists of three nuclear layers; the Outer Nuclear Layer (ONL), Inner 
Nuclear Layer (INL), and Ganglion Cell Layer (GCL). In addition, there are two synaptic layers that enable 
electrical and chemical signal transmittance of visual information between the cell layers to occur. The 
processes of cells in the ONL and INL synapse in the outer plexiform layer (OPL), and in the in ner 
plexiform layer (IPL), the processes of INL neurons synapse with ganglion cells (Fadool and Dowling, 
2008).  
There are six major classes of retinal neurons, each containing multiple subtypes, and one 
intrinsic glial cell type (Stenkamp, 2007, Fadool and Dowling, 2008). The two general classes of 
photoreceptor cells (PRCs), the light receiving cells responsible for phototransduction which are found in 
the ONL, are the rods and cones. Rods are exquisitely sensitive to light, allow for the detection of as little 
as one quanta of photons, and are responsible for scotopic vision.  Rod PRCs, however, are not able to 
discriminate spectral information. Cones allow for color vision in photopic conditions. They require 
significantly more light to induce a signal transduction cascade than rods, but enable high visual acuity 
and operate at significantly faster response times (Joselevitch and Kamermans, 2009). Multiple cone 
subtypes that are spectrally tuned to respond to different wavelengths of  light have been identified. This 
wavelength sensitivity and specificity is the result of expression of  several variants of the opsin visual 
pigment in the different cone PRC types. The different cone cell types each containing a different opsin 
enables an organism to differentiate between wavelengths of light and is the basis of color vision. The 
soma of rod and cone PRCs (basal side of the PRCs) reside in the ONL, but it is the outer segments of the 
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PRCs (apical side of the PRCs) that are responsible for initial photon detection. The photoreceptor outer 
segments are modified sensory cilia composed of numerous lipid bilayer disks or folds (in rods and cones 
respectively) that contain the photosensitive opsin transmembrane proteins. These long outer segments 
are embedded into and closely associate with the retinal pigmented epithelium (RPE), a part or the non-
neural retina that is responsible for absorption of scattered light, phagocytosis and turnover of  shed 
outer segment tips, ion buffering, transport, secretion, and recycling and storage of 11-cis retinal, the 
chromophore bound to opsins that undergoes a conformational change upon photon capture (Strauss, 
1995, Navid et al., 2006). The PRC terminals project into the OPL, where they form synapses with the 
interneurons located in the apical part of the INL. 
There are three types of interneurons in the retina that are located in the INL: horizontal, 
bipolar, and amacrine cells. These cells are responsible for organizing, refining, and transmitting signals 
that originated from the photoreceptor cells to the ganglion cells in the GCL. In addition, the nuclei of 
the only intrinsic retinal glial cell, the Müller glia, is found in the INL. The cell bodies of horizontal 
interconnecting neurons can be found on the apical side of the INL, and bipolar cell soma can be found 
throughout the INL. The horizontal cells synapse with the processes of multiple photoreceptors in the 
OPL as well as processes from bipolar cells. There are 3 horizontal cell subtypes, and 13 bipolar cell 
subtypes that have been identified in the primate retina (Kolb et al., 1992, Euler et al., 2014). At the 
basal side of the INL, the cell bodies of more than 25 subtypes of amacrine cells can be found (Wassle et 
al., 2009). The amacrine cells further refine output from the bipolar cells, and interconnect with both 
the bipolar cell processes and the ganglion cells in the IPL. The ganglion cell bodies are found in the GCL, 
and their axons bundle together to form the optic nerve which serves as the terminal output of visual 
signals from the retina to the brain (Sanes and Masland, 2015). 
12 
 
 
Figure 1.1: Schematic of the vertebrate retina. The vertebrate retina is composed of three nuclear 
layers and two plexiform layers: the Outer Nuclear Layer (ONL) which contains the cell bodies for rod 
and cone photoreceptors, the Inner Nuclear Layer (INL) which contains the cell bodies of horizontal, 
bipolar, and amacrine interconnecting neurons, and the Ganglion Cell Layer (GCL) which contains 
ganglion cells whose axons form the optic nerve. The Outer Plexiform Layer (OPL) contains synapses of 
photoreceptors, horizontal cells, and bipolar cells, and the Inner Plexiform Layer (IPL) contains synapses 
of amacrine, bipolar, and ganglion cells. The Müller glia cells are the only intrinsic retinal glial cell and 
expand the entire thickness of the neural retina. The Retinal pigment epithelium (RPE) envelops the 
photoreceptor outer segments, and the choroid contains blood vessels that nourish the retina. Adapted 
from webvision.com. 
 
Müller glia are the intrinsic radial glial cells of the retina. Although their cell bodies are found in 
the INL, Müller glia processes extend throughout the full thickness of the retina, from the inner limiting 
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membrane in the basal retina to the PRC outer segments and RPE. The Müller glia act as support cel ls for 
the retinal neurons by phagocytosing cellular debris, regulating concentrations of neurotransmitters, 
ions, and signaling factors, have neuroprotective properties, and serve as a scaffold that provides 
structural support to all of the neurons throughout all of the retinal layers (Reichenbach et al., 1989, 
Newman and Reichenbach, 1996, Garcia and Vecino, 2003, Bringmann et al., 2006) . In addition, the 
Müller cells in the mature retina of many cold-blooded vertebrates as well as embryonic avian retinas 
can serve as a source of retinal stem cells that contribute to regeneration of the damaged retina (Fischer 
and Reh, 2001, Fischer and Reh, 2003, Garcia and Vecino, 2003, Bernardos et al., 2007, Fischer and 
Bongini, 2010, Lenkowski and Raymond, 2014). 
1.2.2 Development of the vertebrate retina 
 Initial embryonic development of the vertebrate retina has been intensely studied, in part 
because it can serve as an experimentally tractable proxy for understanding the development in of other 
parts of the CNS including the brain. Here, we focus primarily on development of the zebrafish retina, 
which serves as an excellent example of the general paradigm of retinal development in all  vertebrates 
because the overall order of cell signaling, proliferation, cell cycle exit, and differentiation are highly 
conserved within the subphyla. The zebrafish retina has the same superstructure, lamination, 
morphology, cell types and function as the human eye (size and regenerative capacity notwithstanding). 
1.2.2.1 Order of zebrafish retinal cell differentiation 
Development of the zebrafish retina proceeds in an ordered and predictable spatiotemporal 
pattern. By 11 hours post fertilization (hpf), the primordial eye field of the zebrafish is identifiable as an 
evagination from the anterior neural keel. Development proceeds rapidly; at 24 hpf the presumptive 
retina exists as a single, pseudostratified neuroepithelial layer of proliferating cells (Malicki, 1999, 
Schmitt and Dowling, 1999, Stenkamp, 2007). Cell cycle exit and differentiation of the first born cell type 
occurs first in the ventral patch of the inner retina then proceeds towards the outer retina, an d 
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neurogenesis within each respective nuclear layer occurs asynchronously. In the developing zebrafish 
retina, differentiation of retinal cell types in their respective layer is mostly complete before cells in the 
next nuclear layer start to differentiate (Figure 1.2A). In addition, whenever differentiation first begins 
in the ventral portion of the retina within a respective nuclear layer, neurogenesis occurs in a fan -
shaped wave and proceeds through the ventro-nasal to the dorsal and the ventro-temporal regions of 
the retina (Figure 1.2B) (Stenkamp, 2007). Starting at 28 hpf, the first cells to differentiate are the 
ganglion cells. This is followed by differentiation of cells that make up the INL (amacrine and horizontal 
cells) from 36-48 hpf, with bipolar cell differentiation starting around 60 hpf (Schmitt and Dowling, 1999, 
Connaughton, 2011). Cone PRCs develop from 48-60 hpf. Rod PRCs follow a developmental program 
that is different from cones. Rods develop from a defined lineage of retinal progenitor cells, and their 
neurogenesis is protracted and delayed relative to cone photoreceptors (Raymond, 1985, Raymond and 
Rivlin, 1987, Morris and Fadool, 2005, Morris et al., 2008a). Müller cells are the last retinal cells to 
differentiate. Although they are the principle glial cell type in the retina, they differentiate from the 
same pools of progenitor cells that give rise to the retinal neurons (Turner and Cepko, 1987, Bernardos 
et al., 2005, Jadhav et al., 2009). 
After initial embryonic retinal neurogenesis in the zebrafish, there remains a specialized domain 
within the retina that contains continuously proliferating stem cells and retinal progenitor cells to meet 
the demands of a continuously growing retina. Because the zebrafish displays indeterminate growth, the 
eye gets larger throughout the life of the animal. As a result, the retina must expand, and new neurons 
and glia must be incorporated into the growing retinal tissue to maintain visual acuity. The source of  
these new retinal cells is the ciliary marginal zone (CMZ), a specialized area at the far periphery of the  
neural retina where populations of retinal stem cells are maintained that give rise to both new retinal 
cells as well as RPE cells (Raymond et al., 2006, Stenkamp, 2007, Reinhardt et al., 2015).  
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Figure 1.2: The order of differentiation of retinal cell types in vertebrates is highly conserved . A) 
Differentiation of subsets of zebrafish RPCs to GCs begins around 24 hpf and is largely completed by 36 
hpf, prior to the onset of AC and HC differentiation at 36 hpf. The other INL neuron type (BPCs) begin to 
differentiate around 60 hpf. In the ONL, cone PRCs start to differentiate at 48 hpf, and rod PRCs start to 
appear at 55 hpf. Müller glia, that last retinal cell type to develop, start to differentiate in the INL around 
60 hpf. B) Saggital view of (outward facing zebrafish eye) diagram depicting sequential, fan-shaped 
waves of differentiation of RPCs into retinal  neurons starting at the ventral patch. The cells of the GCL 
are generated from 24-36 hpf, INL neurons (besides BPCs) are generated from 36-48 hpf, and ONL 
neurons start to differentiate from 48-60 hpf. 
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1.2.2.2 Regulation of proliferation of retinal progenitor cells during development 
 The relatively homogeneous population of proliferating, pseudo-stratified neuroepithelial cells 
of the primordial eye that form the retina are derived from the inner layer of the optic cup. These 
progenitor cells are maintained in the cell cycle until the appropriate extrinsic and intrinsic cues push 
subsets of retinal progenitor cells (RPCs) within a respective nuclear layer towards cell cycle exit and 
differentiation. The RPCs balance proliferation and cell cycle exit with expression of fate determinant 
genes to ensure the correct number and proportion of each neuron type as well as Müller glia are 
generated (Jusuf et al., 2011, Ng Chi Kei et al., 2016). Proliferation of RPCs is highly regulated, and 
keeping RPCs in the cell cycle depends upon upregulation of proliferative signals from the Notch-Delta 
pathway which results in increased expression of downstream effectors that repress typically pro-neural 
and pro-differentiation factor expression (Dvoriantchikova et al., 2015, Taylor et al., 2015). In addition, 
expression of intrinsic cell cycle progression factors such as cyclinD1, repression of cell-autonomously 
acting factors such as p27Kip1 and p57Kip2, as well as extrinsic cues from factors such as transforming 
growth factor alpha (TGFα), fibroblast growth factor (FGF), vascular endothelial growth factor (VEGF), 
Wnt/Frizzled and epidermal growth factor (EGF) are all required to keep a RPC in the cell cycle (Lillien 
and Cepko, 1992, Van Raay and Vetter, 2004, Hashimoto et al., 2006). 
1.2.2.3 Cell cycle exit and retinal cell specification during development 
Neurogenesis in the developing zebrafish retina occurs in several waves of differentiation of 
post mitotic progenitor cells. These neurogenic waves are highly conserved, and arise from many of the 
same mechanisms and expression of orthologous factors observed in the morphogenetic wave during 
Drosophila retinogenesis (Neumann and Nuesslein-Volhard, 2000, Kay et al., 2005). The neurogenic 
waves utilize hedgehog (hh) signaling via the vertebrate homolog sonic hedgehog (shh) with minor 
contributions from tiggy winkle hedgehog (twhh) as well as indian hedgehog (ihh). During the initial 
differentiation of RPCs, extrinsic cues stimulate expression of intrinsic factors that regulate retinal 
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neurogenesis. The key transcription regulators that are expressed as a result of extrinsic cues belong 
predominantly to three major classes: the homeobox-containing factors, members of the basic helix-
loop-helix (bHLH) motif containing family of transcription factors, and nuclear hormone receptors 
(Vetter and Brown, 2001, Dyer, 2003, Stevens et al., 2011, Suzuki et al., 2013) . 
 A transition zone that defines which cells will differentiate into the retina and RPE versus the 
optic stalk is created by expression of pax6 and pax2 respectively, and is generated and maintained by 
midline hh signals (Macdonald et al., 1995). In the early eye primordia, the homeodomain containing 
transcription factor pax6 is expressed in all retinal precursor cells, and this expression persists through 
the early stages of retinal neurogenesis when pax6 is downregulated in all retinal cell types except 
ganglion and amacrine cells (Hitchcock et al., 1996, Nornes et al., 1998). There are retinal homeobox 
(rax or rx) genes expressed during zebrafish eye development. Rx1 and rx2 are expressed in the anterior 
neuroepithelium and become restricted to retinal progenitor cells where expression persists until they 
are downregulated as neurogenesis proceeds and are then re-expressed in cone PRCs and subsets of INL 
neurons. Rx3 is also expressed in anterior neuroepithelial cells but only appears in a few INL cells later in 
development, and is the only rx gene shown to be required for eye development in zebrafish (Chuang et 
al., 1999, Loosli et al., 2003). 
The bHLH genes that are expressed during retinogenesis are pro-neural; their expression in RPCs 
promotes the adoption of a neuronal fate. The first neurogenic wave is initiated by hh signaling in a 
small portion of precursor cells adjacent to the optic stalk and the pax6/pax2 expression boundary in 
the ventronasal quadrant of the retina (Stenkamp et al., 2000). Differentiation of ganglion cells is 
initiated by upregulating expression of the bHLH transcription factor ath5/atoh7 in conjunction with 
expression of the POU-domain homeobox transcription factor pou4f (DeCarvalho et al., 2004, Kay et al., 
2005). 
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The second wave of hh signaling initiates differentiation of amacrine, horizontal, and bipolar 
cells in the INL and arises independently of hh signaling from the GCL and is not dependent upon 
expression of ath5 from the ganglion cells (Shkumatava et al., 2004). RPCs in the INL retain the plasticity 
to produce the three types of neurons found in the INL, and the type of neuron generated depends 
upon the relative levels of various transcription factors that are expressed in INL RPCs.  Here, expression 
of foxn4 promotes RPC differentiation towards the amacrine and horizontal cell fate and is negatively 
regulated by vsx2 (Li et al., 2004, Vitorino et al., 2009). In addition, continued expression of vsx2 as well 
as expression of foxn4, pax6, and neuroD in RPCs in the INL result in amacrine cell fate determination. To 
specify subtypes of amacrine cells, expression of the bHLH transcription factors bhlhb5 and garhl2 
specify GABAergic or glycinergic amacrine cell fates respectively (Duquette et al., 2010, Jusuf et al., 
2012). Expression of prox1 is required for horizontal cell specification in INL RPCs that express vsvx2, 
foxn4, low levels of pax6, and not neuroD (Dyer, 2003). Bipolar cell specification requires vsvx2 and 
ascl1a expression (Stenkamp, 2007). 
The last retinal neurons formed are the PRCs in the ONL. During embryonic retinal development, 
both rod and cone PRCs are derived from a common progenitor cell pool , but in the mature retina, rod 
PRCs are derived from a separate lineage than cones (Morris and Fadool, 2005). The RPCs that give rise 
to PRCs express the required transcription factors otx2, crx, neuroD, ascl1a, and the retinoid receptors 
rar and rxr (Stenkamp, 2011, Suzuki et al., 2013, Wang et al., 2014). Expression of otx2 causes 
transactivation of crx, which in turn acts with rorβ to induce expression of pro-rod genes such as nrl and 
nr2e3 which leads to suppression of cone-specific genes biasing the RPC towards the rod PRC fate (Jia et 
al., 2009, Wang et al., 2014). Crx-expressing cells that do not receive the necessary signals to drive them 
towards a rod PRC fate and do not express pro-rod factors will express cone-specific factors and 
differentiate into the various cone subtypes instead. Specification of the four cone subtypes found in 
zebrafish relies upon expression levels of the thyroid hormone receptor trβ2 as well as various retinoid X 
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receptor (rxr) genes and various retinoic acid receptor related orphan receptor (ror) genes during 
terminal symmetric divisions of precursor cells (Suzuki et al., 2013). Patterning of the cone mosaic in the 
tangential plane of the ONL relies upon cell-cell and cell-surface interactions by Notch-Delta mediated 
signaling (Bernardos et al., 2005). 
The only intrinsic glial cell in the retina, and the last type of retinal cell to differentiate are the 
radial Müller glia. Activated Notch-Delta signaling typically favors the maintenance of proliferating stem 
and progenitor cells as well as glial cell differentiation while precluding differentiation to neuronal cells. 
(Livesey and Cepko, 2001). During development, the RPCs that retain relatively higher levels of Notch 
activity differentiate into Müller glia. Transgenic zebrafish embryos that globally express constitutively 
active Notch signaling experience a repression of neuron differentiation and increased Müller glia 
populations in the retina (Scheer et al., 2001). 
The tightly regulated and highly coordinated processes of prol iferation, specification, migration, 
differentiation, and synaptogenesis are necessary for proper retinal development to occur. In addition, 
multiple series of cell-specific apoptotic cell death further refine each retinal layer, although the amount 
of apoptosis in the developing zebrafish retina is minimal when compared to mammals (Biehlmaier et 
al., 2001). After the initial embryonic development and establishment of the retina, there are also a 
variety of processes that regulate maturation, maintenance, and cell homeostasis in the neural retina as 
well as the RPE. Misregulation of or failure to complete any of these functions could lead to cell -type 
specific or global retinal cell degeneration and multiple types of retinal degenerative diseases that 
ultimately result in disruption or complete loss of visual function. 
 
1.3 The Notch-Delta signaling pathway during retinal development 
1.3.1 Notch-Delta signal transduction 
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 The Notch-Delta signaling pathway is highly conserved juxtacrine signaling system present in 
most multicellular organisms that establishes embryo polarity, coordinates cell clocks during 
somitogenesis, and regulates lateral inhibition, proliferation, and gliogenesis (Furukawa et al., 2000, 
Scheer et al., 2001). In addition, components of the Notch pathway are upregulated in the retina 
following injury (Kassen et al., 2007, Ghai et al., 2010). The Notch signaling pathway is a master 
regulator during neurogenesis, because it influences expression of transcription factors at or near the 
very top of entire gene regulatory networks. Activation of Notch signaling influences expression of 
thousands of genes at various downstream regulatory levels, and modulates numerous other 
intracellular and extracellular signaling events. 
During canonical Notch-Delta signaling, initially all cells within an equivalence group will express 
both the Delta ligand and the Notch receptor. However, once lateral inhibition starts to take place, a 
signaling cell will begin to express a larger proportion of a ligand of the DSL (Delta/Serrate/LAG-2) class 
of single-pass transmembrane proteins (the vertebrate orthologs include multiple Delta, Delta-like, and 
Jagged ligands) than its neighboring cells. Typically, the signaling cell will be the most differentiated cell 
in a pool of equipotent progenitors that will eventually give rise to a specific tissue type or large 
structure. Since all of the cells within an equivalence group are expressing both the ligand and the 
receptor, and because proximal cells in the group are continuously signaling and re -expressing 
components of the Notch pathway, the system is always in flux until the most differentiated cells start 
to express predominantly the Delta ligand. The signal-receiving cell expresses the single-pass 
transmembrane Notch receptor (of which there are multiple paralogs in vertebrates). The neighboring 
cells (which also still express limited numbers of the Delta ligands) now contain a relatively higher 
number of Notch receptors embedded in the plasma membrane, and as a result will receive a higher 
dose of Notch activation (Bray, 2006). 
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Both the Delta ligand and the Notch receptor contain a large extracellular domain, as well as a 
small transmembrane and intracellular domain. There are numerous epidermal growth factor like (EGF-
like) repeats in the long extracellular domain of the protein. The EGF-like repeats (typically 36-42 on the 
Notch receptors, and 25-30 on the Delta ligands) consist of 40 amino acid residues per repeat, and their 
structure is defined by six conserved cysteine residues that form three conserved disulfide bonds per 
EGF-like repeat (Kopczynski et al., 1990, Nye and Kopan, 1995). Furthermore, the EGF-like repeats of the 
extracellular domain can be further modified by the addition of various sugar groups by fringe genes 
which influence the binding affinity of the Notch receptor to either Delta or Jagged ligands (Shao et al., 
2002, Taylor et al., 2014). 
When a signaling cell expressing a Delta-like ligand comes into direct physical contact with a 
signal-receiving cell expressing a Notch receptor, a series of proteolytic cleavage events liberates the 
Notch intracellular domain (NICD) from the cell membrane and the soluble NICD ( which contains two 
flanking nuclear localization sequences) diffuses freely through the cytoplasm where it is trafficked into 
the nucleus (Lai, 2004). ADAM-family metalloproteases initiate cleavage at the S2 site at the 
extracellular side of the transmembrane domain, releasing the majority of the extracellular domain to 
the Delta ligand which then undergoes endocytosis and re-processing by the signaling cell. A second 
proteolytic cleavage event at the S3 site on the intracellular side of the transmembrane domain of Notch 
is mediated by γ-secretase, freeing the NICD from the membrane into the cytosol. In the nucleus, the 
NICD interacts with various members of the CBF1/Su(H)/Lag1 (CSL) family of prote ins and the resulting 
NICD/CSL complex acts as a transcriptional activator by binding to Suppressor of Hairless (Su(H)) sites on 
the promoters of target genes (Lai, 2004, Bray, 2006, Nelson et al., 2007). Targets of Notch signaling 
include members of the hairy/enhancer of split (hes) and hairy-related (her) gene families (Fischer and 
Gessler, 2007). 
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Notch activity in the retina has been shown to be necessary for maintenance of pools of stem 
and progenitor cells and mediates lateral inhibition of neuron differentiation and synchronizes 
differentiation of RPCs (Nelson et al., 2007). Notch signaling plays a role in repressing the specification of 
earlier born cell types to maintain the necessary RPC pool size so that later born retinal cells can 
differentiate, and is one mechanism of selecting photoreceptor subtypes and Müller glia (Scheer et al., 
2001, Bernardos et al., 2005, Dvoriantchikova et al., 2015). 
1.3.2 Notch-Delta signaling during interkinetic nuclear migration in the developing retina and in retinal 
stem cell niches in the mature retina 
 Although it is a juxtacrine signaling pathway and therefore doesn’t rely upon secreted signals,  
the effects of Notch mediated signaling are surprisingly dosage dependent. The dosage of Notch 
signaling that an individual proliferating RPC or differentiating progenitor will receive depends upon 
migration of the nucleus within a defined apical-basal boundary in a process called interkinetic nuclear 
migration (Buchman and Tsai, 2008). Throughout the nervous system, nuclear migration is prominent 
during both proliferative and post-mitotic phases of development. During embryonic retinal 
development, proliferating progenitor cells have processes that extend the width of the neural retina. 
The cell body and nucleus are on the apical side of the neuroepithelium closest to the RPE upon entry 
into G1 phase. Progression of G1 phase proceeds as the cell nuclei move toward the basal side of the 
retinal neuroepithelium. They pass through G1 and enter S-phase near the end of this migration near 
the lens. Upon completion of the basal migration, the cell nuclei migrate back to the apical side during 
G2, where they enter M-phase at the apical boundary. Notch expression in these cells and subsequent 
Notch activity increase nearer the apical side of the neuroepithelium, and Delta ligands are expressed in 
a gradient with the opposite orientation (Baye and Link, 2008). Upon completion of mitosis, the 
daughter cells repeat this entire process. This nuclear migration of RPCs and differentiating precursors 
leads to regulation of retinal neurogenesis of the various retinal cell types by altering exposure to Notch 
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signals through the apical-basal Notch gradient while at the same time individual cells are moving 
through different competence states in a time dependent manner (Clark et al., 2012, Aggarwal et al., 
2016). 
 The circumferential germinal zone (CGZ), also referred to as the ciliary marginal zone (CMZ) is 
found at the margin where the neural retina and RPE meet the iris epithelium. It consists of stem cells 
and retinal progenitor cells and has long been considered a remnant of the embryonic retina due to the 
proliferative nature of the cells found here (Johns, 1977). Recent studies, however, have shown that 
although at the genetic level there are many of the same regulatory networks and transcription factors 
are expressed in both the embryonic retina and the CMZ, cells in the ciliary margin have many 
distinctive features from those of the RPCs in the developing retina (Wehman et al., 2005). In the teleost 
retina, it is the CMZ that provides new RPCs as the retina grows, and these RPCs have the capability to 
contribute to every retinal cell type during retinal growth except for rod PRCs. Notch-Delta signaling 
persists in the CMZ of the teleost retina throughout the life of the animal (Zupanc and Sirbulescu, 2011). 
In addition, it has been shown that functional Notch-Delta signaling is required for not only for normal 
retinal growth and neurogenesis, but also for stimulating proliferation in the CMZ following retinal 
damage (Uribe et al., 2012, Fischer et al., 2013). In the CMZ, many of the downstream effectors of the 
Notch-Delta signaling pathway are persistently expressed, and act to keep stem cells and RPCs in the cell 
cycle in the peripheral most areas of the retina (Raymond et al., 2006). 
 Another retinal stem cell niche found in the teleost retina that is heavily dependent upon the 
Notch-Delta signaling pathway is associated with the cell bodies of Müller glia in the INL (Raymond et al., 
2006, Lenkowski and Raymond, 2014). In the uninjured zebrafish retina, rod precursor cells are derived 
from slowly proliferating progenitors in the INL associated with subsets of Müller glia. Notch-Delta 
signaling is required for the postmitotic retinal progenitor cells that differentiate into Müller glia during 
initial embryonic development to maintain a glial cell fate (Nelson et al., 2011). In the mature retina, 
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there are subsets of slowly proliferating Müller glia in which Notch-Delta signaling is still active, and 
these cells give rise to the rod PRC lineage (which will be discussed in detail in chapter 2). In addition, 
the Müller cells in the zebrafish retina are capable of de-differentiating, proliferating, and generating 
RPCs that will give rise to all retinal cell types following injury (Thummel et al., 2008). 
 
1.4 Zebrafish as a model organism  
 The zebrafish, Danio rerio, is a small freshwater teleost fish native to the streams of the 
southeastern Himalayan region and belongs to the minnow family. In addition to being a popular fish for 
aquarists, the zebrafish has also been used extensively in scientific studies (Li et al., 2013). The zebrafish 
presents an excellent model system for studying a wide variety of biological processes, including 
development and regeneration of the vertebrate retina. 
 As a model organism, the zebrafish possesses many desirable characteristics. It has remarkably 
high fecundity for a vertebrate; a typical cross between a single mating pair can generate well over a 
hundred viable offspring. Due to the large number of embryos per clutch, experiments can be designed 
and performed with results that yield high statistical power. In addition, the zebrafish exhibits external 
fertilization and development, and the fertilized embryos remain optically transparent until onset of 
pigmentation (which can be blocked chemically or avoided altogether through use of albino mutant 
strains), thus permitting direct observation of the developing embryos without the requirement of 
sophisticated imaging techniques. Development of the embryos occurs rapidly, with the first cell division 
taking place as early as 0.5 hours post fertilization (hpf), and successive cell divisions taking place 
roughly every half hour. As quickly as 24 hpf the embryo is already immediately identifiable as a small 
vertebrate; it has a recognizable head, tail, eyes, recognizable somites, a beating heart, as well as a yolk 
sack that provides nourishment until the larval stage. By 72 hpf, embryonic development is largely 
completed, and most of the major organs and essential tissues have already been established and are 
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functional (Kimmel et al., 1995). At this point, the embryos respond to touch stimuli and each individual 
embryo has already exited the protective chorion through lateral swiveling of the tail. In addition, 
visually evoked responses can be measured and quantified at 5 dpf through relatively high throughput 
methods such as visualization of the optokinetic response which can be easily observed through various 
low tech devices (Mueller and Neuhauss, 2010). By 5 days post fertilization, the zebrafish larvae is 
actively swimming, hunting/scavenging, and avoiding predation. The zebrafish larvae begin 
metamorphosis from 10-14 days post fertilization (dpf), at which point they start to refine fin epithelial 
tissues, start scale formation, and show early signs of sexual dimorphism and sexual maturation. With 
optimal growth conditions, the zebrafish can achieve sexual maturity as quickly as 6 weeks post 
fertilization (Hsiao and Tsai, 2003). 
1.4.1 Zebrafish as a genetic and molecular vertebrate model 
 Although it is a relatively new model organism within the field of embryology and 
developmental biology when compared to classically studied animals (various species of Drosophila, 
Gallus, and Mus genera), the zebrafish quickly came to the forefront of study within the field due to the 
relative ease of genetic manipulation within this vertebrate model and the advent of modern molecular 
techniques. 
 The zebrafish has a fully sequenced and nearly fully annotated genome which is currently on the 
10th iteration of the reference assembly (Howe et al., 2013). The zebrafish has well developed genetic 
resources, and many mutant and transgenic lines are available to the research community.  The zebrafish 
has been a go-to model organism for forward genetic screens in vertebrates due to the large clutch size, 
fast generation time, and ease of mutagenesis through application of either N-ethyl-N-nitrosourea (ENU) 
or ethyl methansulfonate (EMS) alkylating agents to sperm. In addition, knockdown (via morpholino 
mediated RNA splicing or translation interference) as well as misexpression of selected genes via mRNA 
or plasmid injection are common methods of studying the effects of specific genes in zebraf ish 
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(Nasevicius and Ekker, 2000). Besides gene knockdown, genomic knockout techniques have also recently 
become available in the zebrafish, thus greatly expanding the types of reverse genetic approaches to 
that can be employed. Both transcription activator-like effector nuclease (TALEN) and clustered 
regularly-interspaced short palindromic repeats with Cas9 nuclease (CRISPR/Cas9) have been 
successfully used to generate targeted mutations and site-specific knock-in lines (Hisano et al., 2015, 
Varshney et al., 2015, Prykhozhij et al., 2016). 
 Another advantageous aspect of zebrafish as a vertebrate model organism that is permitted by 
their small size and high fecundity as well as being an aquatic species is their use in quantitative, high-
throughput drug screens and drug discovery applications. A zebrafish embryo easily survives in a very 
small volume of fluid, enabling small quantities of potentially expensive compounds to be added to the 
media to determine efficacy and dosage requirements in a developing vertebrate with relatively little 
expense (Miscevic et al., 2012). Although it is comparatively more labor intensive and expensive to use 
zebrafish for chemical screens rather than cultured cells, it has been repeatedly been documented that 
traditional high-through-put drug screening methods such cell-based assays are often unreliable 
because of limited physiological relevance and do not yield nearly as much useful information as 
organismal level studies (Ryan et al., 2016). In addition, the use of zebrafish in drug screens permits 
direct observation of the effects of compounds within the context of the biological networks in which 
they act (Wist et al., 2009). Numerous biological processes have been studied and potential therapeutic 
compounds for diseases ranging from cancer, cardiac disease, depression, and even hair loss and have 
been evaluated using zebrafish (Miscevic et al., 2012, Zulkhernain et al., 2014, Stawicki et al., 2015, 
Fonseka et al., 2016). 
 
1.5 Hairy-Related 4 
1.5.1 Overview of basic-Helix-Loop-Helix-Orange (bHLH-O) transcription factors 
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 Hairy-related (her) genes (also referred to as hairy and enhancer of split related) are the highly 
evolutionarily conserved zebrafish counterparts of the Hairy and Enhancer-of-split type genes in 
Drosophila, and of the Hes/Hey genes in mammals, all of which are members of the basic-Helix-Loop-
Helix-Orange (bHLH-O) class of DNA binding proteins (Muller et al., 1996). Genes in the bHLH-O family 
are ancient eukaryotic transcription factors that can only be found in metazoans. They have undergone 
numerous duplication events throughout metazoan evolution which has resulted in not only a large 
number of these types of genes per species, but also extensive subfuncti onalization and differential 
expression even within the same tissue (Davis and Turner, 2001, Zhou et al., 2012). There are four 
general types of bHLH-O proteins found throughout the animal kingdom: Stra13, Hey, E(spl), and Hairy 
(which include Hes and Her), all of which have very similar residue sequences and protein structure 
(Davis and Turner, 2001). 
Members of the bHLH-O family, including the zebrafish Hairy-related 4 (Her4), are 
transcriptional regulators known to play critical roles in many physiological processes including cellular 
differentiation, cell cycle arrest, apoptosis, self-renewal ability, and have also been extensively studied 
for their roles in metastasis, antagonizing drug-induced apoptosis, and crosstalk with carcinogenic 
signaling pathways (Liu et al., 2015). The bHLH-O genes act as downstream effectors of various signaling 
pathways, but are most commonly associated with being effectors Notch-Delta signaling and mediating 
cross-talk between Notch and other signaling pathways (Delidakis et al., 2014). 
The first bHLH-O gene to be identified (E(spl)) was a spontaneous dominant mutation in 
irradiated Drosophila that enhanced the small eye phenotype caused by a recessive allele of Notch 
(Welshons, 1956). After numerous other bHLH-O genes were identified, it was recognized that the loss 
of function of these genes commonly resulted in hyperplasia of the embryonic nervous system at the 
expense of larval epidermis, caused by misspecification of most ectodermal cells as neural precursors 
(what is termed a “neurogenic” phenotype) (Knust et al., 1987, Knust and Campos-Ortega, 1989, Knust 
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et al., 1992). These observations lead to the early conclusions that bHLH-O genes primarily mediated 
lateral inhibition downstream of the Notch pathway, although it was soon discovered that they have a 
much more diverse role in regulation of gene function. 
During development, bHLH-O genes have been shown to be critically important in regulating a 
variety of processes including the segmentation clock, somitogenesis, neural tube development, floor 
plate development, CNS development, primary neuron, hypochord development, and are transiently 
expressed in most developing tissues (Takke et al., 1999, Sun et al., 2007). In addition, they have been 
shown to play similar roles in the regeneration of CNS tissues (Zupanc and Sirbulescu, 2011). 
1.5.2 Structure and function of the bHLH-O transcription factor, her4 
 Her4 is the zebrafish ortholog of the mammalian HES5 (Hortopan and Baraban, 2011), a basic-
Helix-Loop-Helix transcriptional repressor directly regulated by the Notch-Delta signaling pathway in 
mouse (Kageyama and Ohtsuka, 1999). The DNA-binding basic domain (b) of her4 binds to palindromic 
E-box (CANNTG) and N-box (CACNAG) sequences on the promoters of target genes (Massari and Murre, 
2000). Adjacent to the basic domain are two amphipathic α-helices separated by a loop (HLH) that serve 
as a dimerization domain as well as an interface for additional protein-protein interactions (Massari and 
Murre, 2000). Following the HLH region is the orange domain (O). It is composed of two additional α -
helical structures that serve as a site for additional protein interactions and can act as a transcriptional 
repressor when fused to a DNA-binding domain (Dawson et al., 1995, Fischer and Gessler, 2007). The C-
terminal end of Her4 contains the characteristic WRPW (Trp-Arg-Pro-Trp tetrapeptide) motif of bHLH-O 
transcription factors, and is required for strong transcriptional repression (Fisher et al., 1996). The 
WRPW motif recruits various transducin-like enhancer of split (tle) co-repressors (orthologs of Groucho 
in Drosophila) as well as histone deacetylases, and once bound to the WRPW tetrapeptide, greatly 
increase the transcriptional repressive properties of Her proteins (Fischer and Gessler, 2007). 
1.5.3 Mechanisms of Her mediated gene regulation 
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 The targets and mode of Her mediated regulation are varied. Expression of different bHLH-O 
genes in different combinations (and in different tissues) can result in a vastly different transcriptional 
profile through various mechanisms (Gazave et al., 2014). Numerous genes contain E-box (CANNTG) and 
N-box (CACNAG) sequences in their promoter regions as well as throughout the gene in which the bHLH 
domains of various Her dimerization partners bind. Active repression is dependent upon binding of the 
Her to DNA is dependent upon homo- or heterodimerization of Her transcription factors, but not 
dependent upon interaction with a different heterodimerization partner with the Orange domain of Her 
(Kageyama et al., 2007). Once bound to an E- or N-box, the Orange domain can repress transcription 
directly by blocking access of other transcription factors to an adjacent DNA target sequence. In 
addition, the Orange domain interacts with numerous other proteins to form heterodimers which in 
turn can both repress or activate transcription (Dawson et al., 1995). In addition, when Her transcription 
factors are bound to DNA, the WRPW motif will recruit tle co-repressors or histone deacetylases which 
results in repression of a target gene or of multiple genes within a given loci (Fisher et al., 1996). 
When not bound to the DNA, Her still has the capability to passively regulate gene expression. 
The bHLH and Orange domains of Her still readily interact with binding partners (usually pro-neural 
bHLH transcription factors), sequestering them from the DNA binding sites of their own target genes 
through steric hindrance. The WRPW motif, in addition to recruiting repressors, acts as a 
polyubiquitylation signal (Kang et al., 2005). When not bound to DNA, either free in solution or 
dimerized with a binding partner, Her proteins are rapidly polyubiquitylated and quickly undergo 
proteosomal lysis. The Her proteins themselves have very short half-lives and a high turnover rate (~20 
minutes), but the heterodimerization partner may be quickly titrated out if it does not have an equally 
high turnover rate itself (Hirata et al., 2002, Coglievina et al., 2010). 
1.5.4 The zebrafish hairy/enhancer of split gene superfamily 
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 The zebrafish genome contains 26 members of the hairy/enhancer of split gene superfamily of 
bHLH-O transcriptional repressors. These include 3 of the hairy/enhancer of split (hes) class, 4 of the 
hes-related with YRPW motif (hey) class, and 19 of the hairy-related (her) class bHLH-O genes (Table 
1.1). These three classes of hairy-type genes are structurally very similar to each other at the protein 
level when compared to each other, and many have redundant functions and expression patterns across 
the three groups (Figure 1.3). The peptide sequences in the major domains contain few polymorphisms 
between the three hairy-type classes. There are, however, numerous polymorphisms (both in residue 
and sequence length) in inter-domain regions of the proteins. At the nucleotide sequence level, there 
are numerous polymorphisms throughout the entire gene, although less so in conserved domains. 
Intron regions vary widely in number, sequence, and length between classes. In addition, the only 
common promoter elements to be found (and only among the Notch-responsive genes) are consensus 
Su(H) binding sites which are necessary for NICD/CSL complex binding. 
Various members in the three hairy-type classes have been shown to be regulated not only by 
Notch-Delta signaling, but also by Hh, VegF, Nodal, FGF, and retinoic acid signaling (Holzschuh et al., 
2005, Latimer et al., 2005, Morrow et al., 2009, Radosevic et al., 2011) (Table 1.1). Hairy-related genes 
tend to be self-regulating due to having numerous E- and N-box sequences within their respective 
promoters that lead to feedback loops which result in cyclic gene expression. Her genes are also key 
interconnecting factors that allow for crosstalk between multiple signaling pathways (Hue et al., 2012). 
Another level of regulatory complexity is added when considering that these transcription factors are 
co-expressed or differentially expressed within the same tissues in various spatiotemporal patterns. This 
is due to heterodimers (with respect to bHLH-O proteins dimerizing via the bHLH domain) having 
different binding affinities for the E- and N- box sequences in target promoters than homodimers or 
other permutations of heterodimers involving the numerous Her transcription factors (Davis and Turner, 
2001). It must also be noted that because the zebrafish contains such a large compliment of her genes 
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(in part due to a whole genome duplication in the teleost lineage), there is much functional redundancy. 
As with many other genes in the zebrafish, occasionally only very mild (or no observable) phenotypes 
can be observed when knocking down or knocking out single her genes that are expressed in the same 
spatiotemporal pattern as other her genes within the same developing tissue. 
 
Figure 1.3: The zebrafish bHLH-O proteins. The zebrafish genome contains 3 classes of bHLH-O 
transcription factors; 3 Hairy (Hes), 4 Hairy/Enhancer of Split-Related with YRPW motif (Hey), and 19 
Hairy/Enhancer of Split-Related (Her). The DNA-binding basic domain (b) of her4 binds to palindromic E-
box (CANNTG) and N-box (CACNAG) DNA sequences. The HLH domain is composed of two amphipathic 
α-helices (H) separated by a loop (L) that serve as a dimerization domain as well as an interface for 
additional protein-protein interactions. The Orange domain (O) is composed of two additional α-helical 
structures that bind to DNA to inhibit binding of pro-neural bHLH genes and also serves as a site for 
additional protein interaction. The WRPW tetrapeptide motif (in Hes and Her proteins) and YXXW motif 
(in Hey proteins) associates with co-repressors and HDACs which lead to strong repression of target 
genes. 
 
1.6 Rationale, hypotheses, and specific aims 
 Previous studies have shown that bHLH-O genes play diverse roles in many physiological 
processes including cellular differentiation, cell proliferation, cell cycle arrest, oscillation clock cycling, 
and crosstalk between signaling pathways. In addition, bHLH-O genes are transiently expressed in most 
tissues during embryonic development. Many members of the bHLH-O family have been shown to be 
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downstream effectors of the Notch-Delta signaling pathway and typically repress expression of pro-
neural genes and keep stem and progenitor cells in the cell cycle. There are, however, multiple bHLH-O 
genes that are negatively regulated by Notch, or are downstream of other signaling pathways 
altogether. To add to the complexity of understanding the gene regulatory networks that individual 
bHLH-O genes are involved with, expression of a single bHLH-O transcription factor can be regulated by 
different signaling pathways depending on what tissue it is expressed in. The hairy/enhancer of split-
related 4 and 9 (her4 and her9) bHLH-O transcription factors have been found to be upregulated in the 
mature zebrafish retina following rod PRC degeneration, but the roles that these genes play in the retina 
have remained largely unexplored. The main questions addressed in this dissertation are: What are the 
gene regulatory networks that control expression of her4 and her9 in the retina? What are the roles of 
her4 and her9 during retinal development? What are the roles of these genes during regeneration of the 
zebrafish retina? Reverse genetic analysis, biochemical analysis, transgenesis, and various molecular 
approaches have been used to address these questions in this study.  
 The aims of this dissertation were to determine the regulatory networks that control her4 and 
her9 expression in the retina and to determine their functions during retinal neurogenesis.  The initial 
hypothesis was that her4 and her9 play a role in retinal neurogenesis, specifically by maintaining pools 
of proliferating stem and progenitor cells downstream of the Notch-Delta signaling pathway. Presented 
here is evidence that her4 is a primary effector of Notch-Delta signaling during retinal development, and 
that her4-expressing cells in the INL of the mature retina give rise to the rod PRC lineage. Separately, we 
have shown that her9 expression in the developing retina is regulated by retinoic acid signaling, and that 
her9 plays a role in the development of the retinal vasculature. This work will be organized into the 
following aims: 
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Specific Aims: 
I. Determine if her4 is downstream of the Notch-Delta signaling pathway. 
a. Assess expression her4 following manipulation of Notch-Delta signaling. 
II. Characterize the effects of her4 misexpression in the developing retina at the molecular and 
cellular level. 
a. Using morpholino mediated knockdown and mRNA overexpression, determine the 
function of her4 during embryonic retinal development. 
i. Comparison of her4 morphant with genetic and pharmacological based 
knockdown of the Notch pathway. 
ii. Comparison of her4 morphant and control retinas using immunohistochemistry 
for cell identity, morphology, and arrangement. 
III. Determine the contribution of her4-expressing cells in the mature zebrafish retina. 
a. Characterize her4 expression in the adult retina. 
b. Generate a transgenic line of zebrafish that expresses a photoconvertible fluorescent 
reporter driven by the her4 promoter. 
c. Track the lineage of her4-expressing cells in the INL of a retina experiencing constitutive 
rod degeneration and regeneration. 
d. Track the lineage of her4-expressing cells in the CMZ. 
e. Characterize expression of her4 in the retina following acute light damage. 
IV. Determine if her9 is regulated by retinoic acid signaling. 
a. Assess expression of her9 following manipulation of retinoic acid signaling. 
b. Determine if retinoic acid signaling plays a role in retinal vasculogenesis.  
V. Characterize the effects of her9 misexpression in the developing retina and retinal 
vasculature network. 
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a. Using morpholino mediated knockdown and mRNA overexpression, determine the 
function of her9 during development of the retinal vasculature. 
VI. Generate her9 knockout lines using CRISPR/Cas9 genome editing technology. 
a. Characterize genome lesions and find germline transmitted her9 mutant alleles. 
b. Characterize the her9 mutant phenotype. 
 
Aims I, II, and III are included in Chapter 2. 
Aims IV, and V are included in Chapter 3. 
Aim VI is included in Chapter 4. 
 
Chapter 1 Tables 
Table 1.1: The zebrafish bHLH-O superfamily of transcription factors 
Gene Regulatory 
Pathway(s) 
Human 
Ortholog 
Reference 
hes2.1 (hairy/enhancer of split 2.1) Notch HES2 (Zhou et al., 2012) 
hes2.2 (hairy/enhancer of split 2.2) Notch HES2 (Zhou et al., 2012) 
hes6 (hairy/enhancer of split 6) FGF HES6 (Kawamura et al., 
2005) 
hey1 (hairy/enhancer of split-related with 
YRPW motif 1) 
Notch HEY1 (Fischer et al., 2004) 
hey2 (hairy/enhancer of split-related with 
YRPW motif 2) 
Hh, VegF HEY2 (Rowlinson and Gering, 
2010) 
heyl (hairy/enhancer of split-related with 
YRPW motif-like) 
Notch HEYL (Zhou et al., 2015) 
hey4 (hairy/enhancer of split-related with 
YRPW motif 4) (a.k.a. helt) 
unknown HELT (Peukert et al., 2011) 
her1 (hairy/enhancer of split-related 1) Notch HES7 (Takke and Campos-
Ortega, 1999) 
her2 (hairy/enhancer of split-related 2) Notch HES5 (Cheng et al., 2015) 
her3 (hairy/enhancer of split-related 3) Negatively 
regulated by Notch 
HES3 (Hans et al., 2004) 
her4.1 (hairy/enhancer of split-related 
4.1) 
Notch HES5 (Takke et al., 1999) 
her4.2 (hairy/enhancer of split-related 
4.2) 
Notch HES5 (Takke et al., 1999) 
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her4.3 (hairy/enhancer of split-related 
4.3) 
Notch HES5 (Takke et al., 1999) 
her4.4 (hairy/enhancer of split-related 
4.4) 
Notch HES5 (Takke et al., 1999) 
her4.5 (hairy/enhancer of split-related 
4.5) 
Notch HES5 (Takke et al., 1999) 
her5 (hairy/enhancer of split-related 5) FGF, negatively 
regulated by Notch 
HES7 (Dyer et al., 2014) 
her6 (hairy/enhancer of split-related 6) Notch HES1 (Pasini et al., 2004) 
her7 (hairy/enhancer of split-related 7) Notch HES7 (Oates et al., 2005) 
her8a (hairy/enhancer of split-related 8a) Notch HES6 (Chung et al., 2011) 
her8.2 (hairy/enhancer of split-related 
8.2) 
Unknown HES6 (Wang et al., 2009) 
her9 (hairy/enhancer of split-related 9) Nodal, BMP, RA HES1, 
HES4 
(Bae et al., 2005, 
Latimer et al., 2005, 
Radosevic et al., 2011) 
her11 (hairy/enhancer of split-related 11) Negatively 
regulated by Notch 
HES7 (Sieger et al., 2004) 
her12 (hairy/enhancer of split-related 12) Notch HES5 (Shankaran et al., 2007) 
her13 (hairy/enhancer of split-related 13) Notch HES7 (Dias et al., 2012) 
her15.1 (hairy/enhancer of split-related 
15.1) 
Notch HES5 (Shankaran et al., 2007) 
her15.2 (hairy/enhancer of split-related 
15.2) 
Notch HES5 (Shankaran et al., 2007) 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Stephen G. Wilson 2016 
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Chapter 2: Tracking the fate of her4 expressing cells in the regenerating retina using 
her4:Kaede zebrafish 
Stephen G. Wilsona, Wen Wena, Lakshmi Pillai-Kastooria, and Ann C. Morrisa* 
a Department of Biology, University of Kentucky, Lexington, KY 40506-0225 
 
Key words: Her4; Hes5; Müller glia; Regeneration; Retina; Stem cells; Zebrafish 
Adapted from: Experimental Eye Research. Volume 145 (doi: 10.1016/j.exer.2015.11.002) 
Wilson SG, Wen W, Pillai-Kastoori L, Morris AC. Tracking the fate of her4 expressing cells in the 
regenerating retina using her4:Kaede zebrafish, Pages 75-87, April 2016, With permission from Elsevier. 
N.B. For this dissertation, figure numbers, headings, and text were modified to match dissertation style.  
Characterization of her4 during embryonic retinal development (Sections 2.3.1-2.3.2, and Figures 2.1-2.6 
and 2.S1-2.S2) were added. Supplemental Figure 2.S7 was added. 
 
2.1 Abstract 
 The Basic-Helix-Loop-Helix-Orange (bHLH-O) transcription factor Hairy-related 4 (her4) is a 
downstream effector of Notch-Delta signaling that represses expression of typically pro-neural genes in 
proliferative domains of the central nervous system. Notch-Delta signaling in the retina has been shown 
to increase in response to injury and influences neuroprotective properties of Müller glia. In contrast to 
mammals, teleost fish are able to regenerate retinal neurons in response to injury. In zebrafish, her4 is 
upregulated in the regenerating neural retina in response to both acute and chronic photoreceptor 
damage, but the contribution of her4 expressing cells to neurogenesis following acute or chronic retinal 
damage has remained unexplored. Here we investigate the role of her4 in the regenerating retina in a 
background of chronic, rod-specific degeneration as well as following acute light damage .We 
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demonstrate that her4 is expressed in the persistently neurogenic ciliary marginal zone (CMZ), as well as 
in small subsets of slowly proliferating Müller glia in the inner nuclear layer (INL) of the central retina. 
We generated a transgenic line of zebrafish that expresses the photoconvertible Kaede reporter driven 
by a her4 promoter and validated that expression of the transgene faithfully recapitulates endogenous 
her4 expression. Lineage tracing analysis revealed that her4-expressing cells in the INL contribute to the 
rod lineage, and her4 expressing cells in the CMZ are capable of generating any retinal cell type except 
rod photoreceptors. Our results indicate that her4 is involved in a replenishing pathway that maintains 
populations of stem cells in the central retina, and that the magnitude of the her4-associated 
proliferative response mirrors the extent of retinal damage. 
 
Highlights: 
 We provide evidence that her4 is a primary effector of Notch-Delta signaling during embryonic 
retinal development. 
 We characterize the expression of her4 in the regenerating zebrafish retina i n response to 
chronic and acute photoreceptor degeneration. 
 We describe a novel transgenic her4:Kaede reporter line for tracing the lineage of her4-
expressing cells. 
 We demonstrate that her4-expressing cells in the inner nuclear layer of the retina contribute to 
the rod photoreceptor lineage. 
 We show that the magnitude of her4 expression during regeneration correlates with the extent 
of damage to the retina. 
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2.1 Introduction 
 The vertebrate retina is a highly conserved and specialized extension of the ce ntral nervous 
system that enables vision by transducing photons of light into an electrical signal. It is a complex, multi-
layered tissue that consists of three nuclear layers: the outer nuclear layer (ONL), inner nuclear layer 
(INL), and ganglion cell layer (GCL). In addition, there are two plexiform layers where synaptic 
transmission between retinal neurons occurs (Fadool and Dowling, 2008). There are six major classes of 
retinal neurons and one intrinsic glial cell type (Stenkamp, 2007, Fadool and Dowling, 2008). The two 
general classes of photoreceptor cells in the retina are the rods and cones. Rods are exquisitely sensitive 
to light, allow for detection of as little as one quanta of photons, and are responsible for scotopic vision. 
Cones allow for color vision in photopic conditions.  Mutations in several photoreceptor specific genes 
cause chronic damage to the retina, ultimately leading to blinding retinopathic diseases such as retinitis 
pigmentosa (RP) (Hartong et al., 2006, Morris, 2011). In addition, photoreceptor cells are sensitive to 
both chronic and acute damage from natural ionizing radiation such as ultraviolet light or simply from 
exposure to intense white light (Abler et al., 1996). 
 Although the various retinal cell types as well as the overarching laminar organization are similar 
in cold- and warm-blooded vertebrates, mammals lack the ability to regenerate neurons of the CNS 
(Fischer and Bongini, 2010). Whereas both acute and chronic damage to the mammalian retina is 
generally permanent, the damaged zebrafish retina undergoes a robust regenerative response (Vihtelic 
and Hyde, 2000, Morris et al., 2005, Goldman, 2014, Gorsuch and Hyde, 2014) . Following injury, Müller 
glia in the central regions of the zebrafish retina de-differentiate and proliferate to produce neural 
progenitor cells that migrate to the correct location, differentiate into the correct cell type, and 
functionally integrate into the existing tissue. In contrast, in response to injury or chronic degeneration, 
the mammalian retina undergoes gliosis, scarring, and various degrees of vision loss (Raymond and 
Hitchcock, 1997, Fischer and Reh, 2001, Fischer and Reh, 2003, Fischer and Bongini, 2010, Nelson and 
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Hyde, 2012). In the undamaged, but continuously growing zebrafish retina, new retinal neurons arise 
from proliferating stem cells in the ciliary marginal zone (CMZ) in the peripheral retina (Raymond et al., 
2006). Progenitors in the CMZ, however, are not thought to produce rod photoreceptors. Rod 
photoreceptors are generated from a discrete population of rod progenitor cells located in the ONL, 
which are themselves seeded from more slowly dividing stem cells associated with radial Müller glia in 
the INL (Johns and Fernald, 1981, Johns, 1982, Raymond and Rivlin, 1987, Otteson et al., 2001, Raymond 
et al., 2006, Morris et al., 2008a, Morris et al., 2008b). 
 It has been observed that the zebrafish retina is capable of matching its re generative response 
to the amount of damage detected. For example, the XOPS:mCFP transgenic line of zebrafish exhibits 
selective degeneration of rod photoreceptor cells without any secondary effects on other retinal 
neurons (Morris et al., 2005). In contrast to acute damage models, in this background of chronic, rod-
specific degeneration and regeneration, there is no reactive gliosis and the number of proliferating 
Müller glia cells in the INL appears to be unchanged. Rather, rod regeneration in this model is mediated 
solely by an increase in the number of proliferating rod progenitor cells in the ONL (Morris et al., 2005). 
A microarray analysis of mRNA from adult wild-type and XOPS:mCFP retinas identified several 
transcription factors with increased expression in response to the chronic rod damage and regeneration. 
The present study focuses on one of those transcription factors: Her4, an effector of Notch-Delta 
signaling (Takke et al., 1999, Morris et al., 2011). 
 The Notch-Delta pathway is a highly conserved juxtacrine signaling system that regulates lateral 
inhibition, proliferation, and gliogenesis (Furukawa et al., 2000, Scheer et al., 2001), and components of 
the Notch pathway are upregulated in the retina following injury (Kassen et al., 2007, Ghai et al., 2010). 
When a signaling cell expressing a Delta-like ligand comes into physical contact with a signal-receiving 
cell expressing a Notch receptor, a series of proteolytic cleavage events liberates the Notch intracellular 
domain (NICD) from the cell membrane. The soluble NICD then diffuses through the cytoplasm and 
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binds to Suppressor of hairless (Su(H)) sites where it interacts with the CBF1/Su(H)/Lag1 (CSL) family of 
proteins and activates transcription of target genes (Campos-Ortega, 1995, Lai, 2004). Notch activity in 
the retina has been shown to be necessary for maintenance of pools of stem cells and progenitor cells 
and mediates lateral inhibition during neural differentiation (Nelson et al., 2007). During retinal 
development, Notch-Delta signaling functions to prevent the premature depletion of progenitor cells 
before all of the retinal neurons and glial cells have differentiated in their correct proportions (Bao and 
Cepko, 1997, Bernardos et al., 2005, Nelson et al., 2007). In the regenerating retina, the Müller glia are 
directed by various extrinsic signals, including Notch-Delta signaling, to dedifferentiate and re-enter the 
cell cycle, acquiring progenitor-like phenotypes (Gorsuch and Hyde, 2014, Lenkowski and Raymond, 
2014). 
 Hairy-related (her) genes are the highly evolutionarily conserved zebrafish counterparts of the 
Hairy and Enhancer-of-split type genes in Drosophila, and of the Hes/Hey genes in mammals (Muller et 
al., 1996). Her4 is an ortholog of mammalian HES5, and represents one of over 20 members of the 
hairy/enhancer of split gene superfamily of transcription factors found in the zebrafish genome, not 
including duplicate variants of an individual gene (Davis and Turner, 2001). The her4 gene is comprised 
of five tandem duplicate repeats on linkage group 23 of the zebrafish genome. All variants of her4 have 
nearly identical transcripts with minor sequence polymorphisms in the 3’ untranslated region (UTR) and 
are translated into identical peptides. Her4 is a basic-helix-loop-helix-orange (bHLH-O) transcriptional 
repressor that is directly regulated by the Notch-Delta signaling pathway (Takke et al., 1999). Her4 is 
expressed throughout the developing nervous system and hypoblast where it has been shown to be 
necessary for primary neuron and hypochord development, as well as maintaining cyclic gene 
expression during somitogenesis (Takke et al., 1999, Pasini et al., 2004). In the developing CNS, Her4 is 
required for establishing peripheral outgrowth of subsets of sensory neurons in the trigeminal ganglia as 
well as regulating the number of neurog1 and deltaB-positive otic neurons during inner ear 
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development (So et al., 2009, Radosevic et al., 2014). In the adult zebrafish CNS, subsets of Her4 and 
GFAP-GFP positive glia in the optic tectum act as proliferating neural precursors (Jung et al., 2012). In 
addition, her4-expressing radial glia in the adult zebrafish CNS have been shown to proliferate and 
generate neuroblasts in response to brain lesions resulting in efficient rege neration of neurons without 
glial scarring (Kroehne et al., 2011, Skaggs et al., 2014). In previous studies of adult retinal regeneration, 
her4 has primarily been used as a marker for active Notch-Delta signaling in response to acute damage 
(Conner et al., 2014). However, her4 has not been studied in the context of chronic damage, and the 
fate of her4-expressing cells during retinal regeneration has not been determined. 
 In this study, we investigated the role of her4 during regeneration of photoreceptor cells in a 
chronic, rod-specific degeneration background and in an acute light damage model. We generated a 
transgenic zebrafish line that expresses the photoconvertible protein Kaede in her4-positive cells. We 
showed that the her4:Kaede reporter is expressed in a spatiotemporal pattern that faithfully 
recapitulates endogenous her4 expression in the retina. Due to the ability of Kaede to be irreversibly 
photoconverted, it is a useful tool to not only track Kaede expressing cells, but to establish a timeframe 
for cellular migration. Lineage tracing analysis using adult her4:Kaede; XOPS:mCFP zebrafish revealed 
that her4 is expressed in subsets of slowly proliferating Müller glia cells in the INL which give rise to 
progenitor cells that feed into the rod lineage, and that the entire process from her4 expression to rod 
neurogenesis takes place in under three days. We demonstrated that her4 expressing stem cells in the 
CMZ contribute to the lineage of Müller glia and all retinal neurons except rod photoreceptors. We 
established that her4 is also upregulated in response to acute light damage that results in rod and cone 
photoreceptor degeneration, and that the magnitude of the her4 response in the regenerating retina 
correlates with the amount of damage. Our results suggest that her4 and Notch-Delta signaling may play 
a role in a pathway that replenishes depleted progenitor cell populations by maintaining appropriate 
numbers of retinal stem cells. 
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2.2 Materials and Methods 
2.2.1 Zebrafish 
 All zebrafish (Danio rerio) strains were bred, raised, and maintained in accordance with 
established animal care protocols for zebrafish husbandry (Westerfield, 1995). Adult fish, embryos, and 
larvae were housed at 28°C, on a 14 hr light: 10 hr dark cycle. Embryos were staged as previously 
described (Kimmel et al., 1995). The Tg(XRho:gap43-mCFP)q13 transgenic line, hereafter called 
XOPS:mCFP, has been previously described (Morris et al., 2005, Morris et al., 2011). The 
Tg(gfap:GFP)mi2001 line, hereafter called gfap:GFP has been previously described (Bernardos and 
Raymond, 2006) and was obtained from the Zebrafish International Resource Center (ZIRC, Eugene, OR). 
The Tg(UAS:myc-Notch1a-intra)Kca3 and Tg(hsp70i:Gal4)Kca4 lines were obtained from ZIRC and have 
been previously described (Scheer and Campos-Ortega, 1999). The Tg(her4:Kaede) line was generated 
using Tol2-mediated transgenesis (Kwan et al., 2007). Briefly, an expression clone was assembled using 
site-specific recombination cloning with multisite Gateway technology (Life Technologies, Carlsbad, CA). 
The construct contains 3.4 kb of the her4.3 promoter cloned upstream of the photoconvertible Kaede 
reporter, and a separate transgenesis marker consisting of the cardiac myosin light chain promoter 
(cmlc) cloned upstream of GFP (Ando et al., 2002). The expression clone DNA and Tol2 transposase RNA 
were injected into 1-cell stage zebrafish embryos at 30 and 25 ng/μl respectively. The injected embryos 
were screened for GFP expression and raised to adulthood, then outcrossed to identify germline 
transmitting F0 animals that were used to establish the her4:Kaede colony. All animal procedures were 
carried out in accordance with guidelines established by the University of Kentucky Institutional Animal 
Care and Use Committee (IUCAC). 
2.2.2 Morpholino and mRNA microinjections 
 A translation blocking antisense synthetic morpholino oligonucleotide (tbMO) was designed to 
target sequence immediately upstream of the her4 start site. Another morpholino designed to block 
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pre-mRNA splicing (sbMO) of the single her4 intron (which results in a non-sense mutation after the 1st 
exon) was also used to assess off target effects of either morpholino. Both morpholinos produced 
similar phenotypes, however even at low doses, injection of the tbMO resulted in unusually high 
mortality rates by 24 hpf. The tbMO was injected at 1 ng/embryo and the working concentration for the 
sbMO was 10 ng/embryo. A standard control MO, targeting a mutant variant of the human β-globin 
gene was used as dosage matched injection controls. All morpholinos were synthesized by GeneTools, 
LLC (Philomath, OR). A her4 cDNA amplicon was generated from forward and reverse primers that 
contained 5’ restriction sites and cloned into pGEM-TE. Capped mRNA was synthesized using the 
mMessage T7 kit (Ambion, Austin, TX) according to manufacturer’s instructions and purified by phenol-
chloroform extraction and ethanol precipitation. The morpholinos, mRNA (at 1.5 ng/embryo), or a 
combination of the morpholino and mRNA were injected at a volume of 4.18 nl/embryo in buffered 
solution with 0.025% dextran red (as an injection indicator) into the yolk of 1-cell stage zebrafish. All 
morpholino and oligo sequences are listed in (Table 2.1). 
2.2.3 Whole mount in situ hybridization (WISH), fluorescent in situ hybridization (FISH)  
 WISH, FISH, and two color FISH were performed as previously described (Forbes-Osborne et al., 
2013, Pillai-Kastoori et al., 2014). Antisense RNA probes were prepared by in vitro transcription of 
linearized plasmids containing a portion of the coding sequence of the gene of interest using T7 
polymerase and digoxigenin (DIG) or fluorescein (FITC) labeling mix (Roche Applied Science, Indianapolis, 
IN). The her4 and kaede containing plasmids were prepared by cloning PCR products into the pGEM-T-
easy vector (Promega, Madison, WI). The sequences of all PCR primers used in this study are presented 
in (Table 2.1). Images were obtained on an inverted fluorescent microscope (Eclipse Ti-U; Nikon 
Instruments), and were exported into Adobe Photoshop for figure preparation.  
2.2.4 Immunohistochemistry and TUNEL assay 
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 Immunohistochemistry was performed on retinal cryosections as previously described (Fadool, 
2003, Pillai-Kastoori et al., 2014, Wen et al., 2014). Enucleated adult eyes or whole embryos were 
collected at the indicated time points and fixed overnight in 4% PFA at 4°C. The samples were 
cryoprotected in 10% sucrose in PBS for at least 3 hours and in 30% sucrose overnight at 4°C. Samples 
were mounted in OCT Medium (Ted Pella, Redding, CA) and frozen on dry ice. 10 µm sections were cut 
on a cryostat (Leica CM 1850 or CM 1800, Leica Biosystems, Buffalo Grove, IL), mounted on gelatin-
coated slides, and dried overnight at room temperature. Before immunolabeling, sections were 
rehydrated and postfixed in 1% PFA for 10 minutes at room temperature. After 2 washes in PBS, and 2 
washes in PBST, sections were blocked in PBST containing 1% BSA for at least 30 minutes at room 
temperature. Slides were incubated with primary antibody in PBST/BSA with 5% Normal Goat serum, 
overnight at 4°C in a humidified chamber. The following day, slides were washed 3 times in PBST, and  
incubated with secondary antibody in PBST/BSA for 1 hour at room temperature in the dark. Slides were 
washed 2 times with PBST, counterstained with DAPI (4’, 6-diamidino-2-phenylindole, 1:10,000 dilution; 
Sigma-Aldrich) in PBS, and mounted in 40% glycerol  in PBS. The following primary antibodies and 
dilutions were used: 4C12 (mouse, 1:100) generously provided by J. Fadool (Florida State University, 
Tallahassee, FL), which labels rod photoreceptor cell bodies; 1D1 (mouse, 1:100, J. Fadool, FSU, 
Tallahassee, FL), which recognizes Rhodopsin; Zpr-1 (mouse, 1:20, ZIRC), which labels red-green double 
cones; Zrf-1 (mouse, 1:5000, ZIRC), which labels Müller glia; HuC/D (mouse, 1:20, Invitrogen, Grand 
Island, NY), which recognizes retinal ganglion cells and amacrine cells; PKCα (rabbit, 1:100, Santa Cruz 
Biotechnology, Santa Cruz, CA), which recognizes bipolar cells, Prox1 (rabbit, 1:2000, Millipore, Billerica, 
MA), which recognizes horizontal cells; Nr2e3 (rabbit, 1:100), generously provided by J. Nathans (Johns 
Hopkins, Baltimore, MD), which labels rod photoreceptor progenitor/precursor cells; anti -PCNA (mouse, 
1:100, Santa Cruz Biotechnology, Dallas, TX), which labels proliferating cells; anti -BrdU (mouse, 1:500, 
Sigma, St. Louis, MO), which marks cells in S phase of the cell cycle; and anti-Kaede (rabbit, 1:500, MBL, 
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Nagoya, Japan), which labels Kaede expressing cells. Alexa fluor-conjugated secondary antibodies 
(Invitrogen, Grand Island, NY) and Cy-conjugated secondary antibodies (Jackson ImmunoResearch, West 
Grove, PA) were all used at a dilution of 1:200. Sections were counterstained with DAPI (1:10,000, 
Sigma, St. Louis, MO) to visualize cell nuclei. Terminal deoxynucleotide transferase (TdT) -mediated dUTP 
nick end labeling (TUNEL) was performed on retinal cryosections using the ApopTag Fluorescein Direct In 
Situ Apoptosis Detection Kit (Millipore, Billerica, MA) according to the manufacturer’s instructions.  
2.2.5 BrdU exposure 
 Adult zebrafish were exposed to 0.5 % BrdU (Sigma, St. Louis, MO) in fish water overn ight (16 
hours) or continuously for 5 days. BrdU exposure took place in the dark, and the solution was refreshed 
daily. Eyes of 3 animals were dissected immediately following BrdU exposure for the indicated time, and 
retinal cryosections were prepared for anti-BrdU immunohistochemistry. 
2.2.6 Reverse transcriptase PCR (RT-PCR) and real-time quantitative RT-PCR (qRT-PCR) 
 Total RNA was extracted from whole embryos or the eyes of adult XOPS:mCFP and her4:Kaede 
zebrafish using TRIzol reagent (Invitrogen, Grand Island, NY) and first-strand cDNA synthesis was 
performed using the GoScript Reverse Transcriptase System (Promega, Madison, WI). RT-PCR reactions 
were then performed using primers designed to amplify her4 and atp5h (housekeeping control) cDNA 
transcripts. Quantitative real-time PCR was performed using FastStart Essential DNA Green Master Mix 
(Roche, Indianapolis, IN) on a Light Cycler 96 Real-Time PCR System (Roche, Indianapolis, IN). For all 
experiments, three biological replicates and three technical replicates were analyzed and the gene 
expression change was determined using a relative standard curve quantification method with atp5h 
expression as the normalization control. 
2.2.7 Photoconversion 
 Albino her4:Kaede; XOPS:mCFP zebrafish were briefly anesthetized with Tricaine (Sigma, St. 
Louis, MO) and mounted on a coverslip in a pool of dilute Tricaine in fish water. The right eye of each 
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animal was exposed to intense UV light for one minute using the DAPI filter on an inverted fluorescent 
microscope (Eclipse Ti-U; Nikon Instruments) with the neutral density filter at the lowest setting and at 
100x total magnification. The left eye of each animal served as non-UV irradiated control. Following 
photoconversion, the fish were placed in fresh fish water for recovery and the eyes of three animals 
were dissected for cryosectioning at 24 hour increments from 0-7 days post photoconversion. A 
minimum of three animals were photoconverted and imaged for each time point.  
2.2.8 Acute light damage 
 Acute light damage was performed as described previously (Vihtelic and Hyde, 2000). Adult 
albino her4:Kaede fish were dark adapted for 14 days in complete darkness, then immediately exposed 
to 18,000 lux light from four 250 W halogen bulbs centered around the tank. A bubbler, cooling fan, and 
water recirculation system were used to keep the temperature under 32°C. Eyes were dissected and 
retinal cryosections prepared at the indicated time points during and after light treatment and were 
processed for IHC. Eyes from three fish were analyzed for each time point.  
2.2.9 Heat shock and DAPT treatment 
 24 hpf Tg(hsp70i:Gal4)Kca4 and Tg(UAS:myc-Notch1a-intra)Kca3 (hereafter called hsp70:Gal4 
and UAS:NICD, respectively) compound heterozygote embryos and single transgenic controls were heat 
shocked twice for 30 minutes at 39°C and processed for WISH at 48 hpf. Pharmacological inhibition of 
Notch-Delta signaling in embryonic zebrafish was performed using N-[N-(3,5-difluorophenacetyl)-L-
alanyl]-S-phenylglycine t-butyl ester (DAPT), a γ-secretase inhibitor that prevents proteolytic cleavage of 
the Notch intracellular domain from the lumen of the cell membrane (Yang et al., 2008). Wild type 
embryos were dechorionated and transferred to pre-warmed embryo medium containing 100 μM DAPT 
in 1% DMSO. Time-matched siblings in embryo medium with 1% DMSO served as carrier controls. 
Embryos were continuously treated from 10 until 48 hpf and then processed for RT-PCR and WISH. 
2.2.10 Dual luciferase assays 
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 HEK293 cells were transfected with varying amounts of the pcDNA3.1 mammalian expression 
vector (Invitrogen) containing the zebrafish notch1a intracellular domain (NICD) cDNA or her4 cDNA, the 
pGL3 Firefly Luciferase reporter vector (Promega) containing a 3.4 kb her4 promoter fragment driving 
expression of the luciferase gene, the pRL-TK vector (Promega) containing the Renilla luciferase gene 
driven by a ubiquitous tyrosine kinase promoter (to control for transfection efficiency), and balancing 
levels of pGEM3Z (Invitrogen) using Fugene 6 (Promega) transfecting reagent according to the 
manufacturer’s instructions. The total mass of DNA and molar ratios of pGL3 and pRL-TK were held 
constant across transfections, which were repeated a minimum of 3 times. Dose response curves were 
generated using NICD at 0:100, 1:20, 1:10, and 1:5 molar ratios to the her4 reporter. Firefly and Renilla 
luciferase activity were measured at 24-36 hours post transfection using the DualGlo Luciferase Assay 
System (Promega). Data was analyzed as follows: Firefly luciferase (FFluc) was baselined against 
untransfected control (UTC) samples (= FFLuc – UTC) and normalized using the Renilla luciferase (RLuc). 
The Relative Luciferase Activity (RLA) was calculated as (FFLuc-UTC)/(RLuc). 
2.2.11 Quantification and statistical analysis 
 Statistical analysis was performed using a Student’s t-test with Microsoft Excel or GraphPad 
Prism software. For comparing the number of her4-positive sections and the total number of her4-
expressing cells in the CMZ and INL, optic-nerve containing and optic-nerve adjacent sections of 6 wild 
type and 6 XOPS:mCFP animals were examined. For all graphs, data are represented as the mean ± the 
standard deviation (s.d.). 
 
2.3 Results 
2.3.1 Her4 is downstream of the Notch-Delta signaling pathway  
 To verify that her4 is downstream of the Notch-Delta signaling pathway, the expression levels of 
her4 were assessed following manipulation of the Notch pathway in zebrafish embryos. Both 
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pharmacological knock-down and genetic up-regulation of Notch-Delta signaling experiments were 
performed, followed by semi-quantitative RT-PCR. 
 Pharmacological inhibition of Notch-Delta signaling in whole zebrafish embryos was 
accomplished by use of DAPT, a γ-secretase inhibitor that prevents proteolytic cleavage of the Notch 
intracellular domain from the lumen of the cell membrane (Yang et al., 2008). Zebrafish embryos were 
treated with DAPT at a concentration of 100 μM from 10 to 48 hpf. To upregulate the Notch pathway, 
expression of a constitutively active form of the NICD was induced in 24 hpf embryos by heat-shocking 
compound heterozygote hsp70:Gal4; UAS:NICD embryos (with single transgenic siblings used as 
controls). In both cases, her4 expression was assessed by RT-PCR at 48 hpf. 
After treatment with DAPT, there was a noticeable reduction in her4 expression as compared to 
the DMSO carrier control (Figure 2.1A). In addition, the heat shocked compound heterozygote 
hsp70:Gal4; UAS:NICD embryos showed significantly more her4 expression when compared to the single 
transgenic sibling control embryos which do not ectopically express the NICD and do not have 
constitutively active Notch signaling (Figure 2.1B). These data indicate that expression levels of her4 can 
be influenced by manipulation of the Notch-Delta signaling pathway, and that her4 is positively 
regulated by Notch signaling. 
 
 
Figure 2.1: Semi-quantitative RT-PCR for her4. A) Her4 cDNA 
from embryos treated with the γ-secretase inhibitor (DAPT) 
which knocks down the Notch-Delta signaling pathway (and 
DMSO carrier controls) treated from 10-48 hpf shows a 
decrease in her4 expression when Notch signaling is 
disrupted. B) NICD was induced in 24 hpf embryos by heat-
shocking compound heterozygote hsp70:Gal4; UAS:NICD 
embryos which resulted in ectopic Notch-Delta signaling 
(with single transgenic siblings used as controls) shows an 
increase in her4 expression. 
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2.3.2 Morpholino mediated knock down of her4 phenocopies loss of Notch-Delta signaling in the 
zebrafish retina 
2.3.2.1 Comparison of her4-tb morphant and Notch pathway defect retinal phenotypes 
  In order to determine if her4 plays a role in retinal development, expression of her4 was 
manipulated by anti-sense synthetic morpholino oligonucleotide mediated knockdown technology 
(Nasevicius and Ekker, 2000). A morpholino designed to block translation (tbMO) of her4 mRNA (Table 
2.1) was injected into 1-cell stage zebrafish embryos at various concentrations to determine a usable 
dosage. It was immediately apparent that the mortality rate of the morphant embryos was incredibly 
high. At 10 ng/embryo, 100% of the morphants died before 24 hpf, and at a concentration of 5 ng, 
97.4±2.4% of the embryos did not survive to 24 hpf. The dosage was further reduced to 3, 2, and 1 
ng/embryo with 97.2±2.2%, 96.5±2.0%, and 94±1.5% mortality rates respectively (as compared to 
control morpholino injected at the same concentration). Co-injection of the apoptosis blocking p53 
morpholino did not alleviate the toxicity of the her4 tbMO at any dose, and the lowest dosage (1 
ng/embryo) was selected as the working concentration. Surviving embryos were collected at 36, 48, and 
72 hpf (Figure 2.2). At each time point, there are apparent gross morphological defects as compared to 
the control morphant embryos. The her4 morphant embryos all displayed either anophthalmia or 
microphthalmia, pynknotic cells in the brain, altered and/or missing somites, twisted body axis, heart 
edema, missing or reduced pigmentation, and small body size. None of the embryos injected with the 
tbMO survived past 72 hpf, precluding analysis at later time points.  
 Many of the gross morphological defects observed in the surviving embryos were reminiscent of 
the defects observed when Notch-Delta signaling is disrupted, including eye defects. To determine if 
knock down of her4 produced a similar retinal phenotype as defective Notch signaling, I compared the 
morphants to embryos that had been treated with DAPT to pharmacologically inhibit the Notch 
pathway, as well as homozygous mind bomb (mib) zebrafish embryos. Mind bomb zebrafish have an  
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Figure 2.2: The her4-tbMO morphant phenotype. The her4 translation blocking morpholino results in 
high mortality and the surviving morphants display severe developmental defects, including 
anopthalmia or micropthalmia, picnotic cells in the brain, altered and/or missing somites, twisted body 
axis, heart edema, missing or reduced pigmentation, and small body size. Scale, 500 µm.  
 
embryonic lethal recessive mutation in an E3-RING type ubiquitin ligase that results in complete 
abrogation of Notch Delta signaling through improper cycling of Delta ligands (Schier et al., 1996, Itoh et 
al., 2003). Morphants, DAPT-treated embryos, and homozygous mib mutants were collected at 72 hpf, 
and cryosectioned. Immunohistochemistry was performed to visualize ganglion cells, the first retinal cell 
type to differentiate from retinal progenitor cells in the retina (Figure 2.3). When compared to the 
control morpholino injected embryos, the her4-tbMO embryos had micropthalmia, and the retina was 
poorly laminated with no discernable boundaries or transition zones between the ONL, INL, and GCL, 
similar to what was observed in the mib-/- and DAPT treated retinas. In addition, immunostaining for GCs 
revealed a highly expanded number and inflated domain of ganglion cells when compared to controls.  
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Figure 2.3: Notch-Delta signaling disruption and the her4 morphant GC phenotype. Comparison of the 
first retinal neurons that differentiate in the zebrafish retina (ganglion cells) in her4 morphant and 
Notch-Delta knockdown embryos shows that the her4 morphant retina phenocopies disruption of Notch 
signaling. A-A’) IHC to visualize ganglion cells in 72 hpf her4-tbMO morphant retinas show an increased 
number and expanded domain of GCs as compared to ctrl -MO injected controls. B-B’) Mind bomb (Mib) 
heterozygous and homozygous retinas. C-C’) DAPT treated and DMSO ctrl retinas. ONL, outer nuclear 
layer; INL, inner nuclear layer; GCL, ganglion cell layer; L, lens. Scale, 50 µm.  
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Figure 2.4: Notch-Delta signaling disruption and the her4 morphant cone phenotype. Comparison of 
late born retinal neurons (cone PRCs) in her4 morphant and Notch-Delta knockdown embryos show that 
the her4 morphant retina phenocopies disruption of Notch-Delta signaling. A-A’) IHC to visualize cone 
PRCs in 72 hpf her4-tbMO morphant retinas show an decreased number and reduced domain of cones 
as compared to ctrl-MO injected controls. B-B’) Mind bomb (Mib) heterozygous and homozygous 
retinas. C-C’) DAPT treated and DMSO ctrl retinas. ONL, outer nuclear layer; INL, inner nuclear layer; 
GCL, ganglion cell layer; L, lens. Scale = 50 µm. 
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When ganglion cells in the her4 morphant retinas were compared to either mib-/- or DAPT treated 
retinas where Notch signaling had been disrupted, highly similar phenotypes were observed. 
Immunostaining to visualize cone photoreceptors (later born retinal neurons) yielded similar re sults in 
the morphant, mib-/-, and DAPT treated retinas (Figure 2.4). Here, however, unlike the greatly expanded 
number of ganglion cells, the morphant, mib-/-, and DAPT treated retinas had very few cone 
photoreceptors compared to their respective controls. These data suggest that loss of her4 phenocopies 
disruption of the Notch-Delta signaling pathway in the retina. Additionally, the increase in the number 
and expanded domain of the first retinal cell type to differentiate (ganglion cells) happens at the 
expense of later born retinal neurons (such as cone PRCs) because of a prematurely depleted progenitor 
cell pool. These data indicate that Notch-Delta signaling, and the downstream effector her4, keep 
subsets of retinal progenitor cells in the cell cycle, and are required for proper retinal neurogenesis. 
2.3.2.2 The her4 splice blocking morpholino results in lower mortality 
 To verify that the phenotypes observed in the her4-tbMO morphant retina were not artifacts of 
off target mRNA knockdown, a second morpholino was designed to block splicing of her4 pre-mRNA 
(her4-sbMO) and used to determine if it would generate the same phenotypes as previously observed 
(Table 2.1). In addition, use of a second morpholino that targets the same gene would lend insight into a 
possible explanation as to why injection of the her4-tbMO (even at relatively low concentrations) 
resulted in unusually high mortality rates by 24 hpf even though most DAPT treated and mib-/- embryos 
(in which the entire Notch pathway is disrupted) readily survive at least 72 hpf. 
 A dose response curve was generated to determine the optimal concentration of the sbMO to 
inject per embryo. In stark contrast to the mortality observed with the tbMO, mortality at 24 hpf was 
very low across a range of doses (compared to control morpholino injected at the same concentrations): 
at 10, 5, and 2.5 ng of her4-sbMO/embryo, the mortality rates were 5.5±3.0%, 6.0±3.5%, and 4.8±4.4% 
respectively. Effectiveness of her4 knock down was assessed by RT-PCR to compare the relative 
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abundance of spliced versus non-spliced her4 mRNA transcript in the her4-sbMO and control-MO 
injected embryos (Figure 2.S1). Injection of 10 ng/embryo of the her4-sbMO efficiently prevented 
splicing of zygotic her4 pre-mRNA through 2 days post injection, but spliced her4 mRNA could be 
detected starting at 3 days post injection. In addition, most of the morphants (injected at the highest 
dose of 10 ng her4-sbMO/embryo) looked largely phenotypically normal besides varying degrees of 
microphthalmia and slight vertebrae curvature (Figure 2.5). 
 
Figure 2.5: The her4-sbMO morphant phenotype. Injection of 10 ng/embryo of the her4 splice blocking 
morpholino resulted in minimal mortality rates (as compared to the tb-MO) and a milder overall 
phenotype in most of the morphant embryos. ~30% displayed moderate to severe ocular phenotypes, 
including micropthalmia and misshapen eye. Scale, 500 µm. 
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Figure 2.6: Retinal cells in the 72 hpf her4 morphant retina. The her4 morphant retina at 72 hpf displays 
an excess of early born retinal neurons (ganglion cells) at the expense of later born retinal cell types, and 
the morphant phenotype can be rescued by co-injection of 1.5 ng/embryo of her4 mRNA. A-A’’) IHC to 
visualize ganglion cells. B-B’’) Amacrine cells. C-C’’) Horizontal cells. D-D’’) Bipolar cells. E-E’’) Rod 
photoreceptor cells. F-F’’) Cone photoreceptor cells. G-G’’) Müller glia. Scale, 50 µm. 
 
 All retinal cell types were visualized in the morphant embryos by immunohistochemistry at 72 
hpf. Slightly over 30% of the embryos displayed moderate to severe retinal phenotypes such as 
misshapen eye, poor lamination, and microphthalmia (Figure 2.6), in contrast to nearly 100% of the 
surviving tbMO morphants observed at the same time point. Similar to what was observed in the tbMO 
morphants, there was an increase in the number and an expanded domain of RGCs and a reduction or 
nearly complete depletion in the number of any other type of retinal cell type. To rule out off -target 
effects as a cause of the observed morphant phenotypes, in vitro transcribed her4 mRNA was co-
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injected with the sbMO. Co-injection of capped her4 mRNA rescued the morphant phenotype in 93.3% 
of sbMO injected embryos demonstrating that the observed morphant phenotypes were due to 
knockdown of her4. Injection of 1.5 ng of her4 mRNA without morpholino resulted in no obvious 
changes in retinal morphology or rod, cone, and ganglion cell numbers (Figure 2.S2), however injection 
of any higher doses of her4 mRNA resulted in severe developmental defects and high mortality. 
2.3.3 Her4 expression in the adult zebrafish retina 
 Previously, we found by microarray analysis that her4 was upregulated in the adult XOPS:mCFP 
retina, which undergoes chronic rod-specific degeneration and regeneration (Morris et al., 2011). To 
validate the microarray data, we performed quantitative RT-PCR (qRT-PCR) on mRNA prepared from 
wild type and XOPS:mCFP retinas using primers designed to amplify all five her4 tandem duplicate 
repeat variants (her4.1-her4.5) (Table S1). We found that her4 was upregulated over 3.5 fold in the 
XOPS:mCFP retina compared to wild type (3.5±1.08, p<.05) (Figure 2.7A), confirming our previous 
results. To further investigate the possible roles of her4, we determined the expression pattern of her4 
in wild type and XOPS:mCFP retinas by fluorescent in situ hybridization (FISH) with antisense probes that 
were designed to recognize all her4 variants. To validate our her4 in situ probes we performed FISH in 
the developing retina and found that the resulting expression pattern confirmed previous studies 
(Figure 2.S3A). From 48 hours post fertilization (hpf) to 5 days post fertilization (dpf), her4 expression 
shifted from the central retina to the ciliary marginal zone (CMZ) where expression persists into 
adulthood (Figure 2.7B). Treatment with the Notch signaling inhibitor DAPT caused a decrease in her4 
expression (Figure 2.S3B), whereas overexpression of the Notch intracellular domain (NICD) resulted in 
an increase in her4 expression (Figure 2.S3C), confirming that her4 is a target of Notch signaling in the 
zebrafish retina. 
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Figure 2.7: Her4 is expressed in proliferative regions of the adult retina and is upregulated in the 
XOPS:mCFP background. A) qRT-PCR revealed a ~3.5 fold increase in her4 expression in the XOPS:mCFP 
retina. B) Fluorescent in situ hybridization (FISH) for her4 expression in the adult wild type and 
XOPS:mCFP central and peripheral retina demonstrated increased her4 expression in the XOPS:mCFP 
CMZ and INL. C) Percentage of retinal sections that contained her4-expressing cells at the CMZ (n=6 
animals per group, >200 sections analyzed). D) Mean number of her4-expressing cells per CMZ. E) 
Percentage of sections that contained at least 1 her4-expressing cell in the INL. F) Mean her4-expressing 
cells per INL (n=6 animals per group, >200 INL sections analyzed). L, lens; GCL, ganglion cell layer; INL, 
inner nuclear layer; ONL, outer nuclear layer; CMZ, ciliary marginal zone; hpf, hours post fertilization; 
dpf, days post fertilization; scale bar, 50 µm; * P<0.05; ** P<0.001. 
 
 In the adult wild type retina, her4 was primarily expressed in the peripheral most areas of the 
CMZ (51.5±4.5% of all sections observed) (Figure 2.7B,C). Occasionally, her4 expressing cells were also 
58 
 
detected in the inner nuclear layer (INL) of the central wild type retina (3.1±1.8% of all INL sections 
observed) (Figure 2.7B,E). In the wild type background, not only were the majority of sections negative 
for her4 expression in the INL, but the mean number of her4 positive cells per her4 expressing INL was 
low (1.37±0.66). In contrast, in a background of chronic, rod-specific degeneration and regeneration 
(XOPS:mCFP) her4 expression was significantly elevated. The percentage of XOPS:mCFP retinal sections 
containing her4-positive cells in the CMZ was nearly double that of the wild type retina (92.05±2.7%), 
and the total number of her4-expressing cells in the CMZ was also increased in the XOPS:mCFP 
background (WT retina: mean 7.64±0.95; XOPS:mCFP retina 10.08±1.0) (Figure 2.7C,D). These results 
were unexpected because only rod photoreceptors are degenerating/regenerating in the XOPS:mCFP 
retina, and the CMZ is not thought to produce new rods. In addition to an increase in her4 expressing 
cells in the CMZ, we also observed an increase in her4-positive cells in the INL of XOPS:mCFP adult 
retinas compared to wild type (92.6±6.4% vs. 3.19±1.8% of sections analyzed) (Figure. 2.7E). The her4 
positive cells in the INL of the XOPS:mCFP retinas were widely scattered across the central retina, and 
the total number of her4 expressing cells per section was highly variable, ranging from zero to as many 
as eleven positive cells per section (Figure 2.7F). Interestingly, her4 expression was never detected in 
the outer nuclear layer (ONL) of the central retina, where rod progenitor cells reside in either wild type 
or XOPS:mCFP adults. Taken together, these results show that expression of her4 is significantly 
increased in both the INL of the central retina and the peripheral CMZ in response to selective rod 
photoreceptor degeneration. 
2.3.4 Her4 is expressed in slowly proliferating subsets of Müller glia in the INL and more rapidly 
proliferating cells in the CMZ. 
 Previous studies have shown that Notch-Delta signaling regulates the proliferative response of 
Müller glia to acute retinal damage. Therefore, we investigated whether the her4 expressing cells in the 
INL of the XOPS:mCFP retinas were proliferating Müller glia. We performed FISH and immunolabeling 
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experiments on adult gfap:GFP; XOPS:mCFP and gfap:GFP siblings that were exposed to BrdU for either 
16 hours or 5 days. The gfap:GFP line expresses the GFP reporter specifically in glial cells of the zebrafish 
nervous system, including Müller glia in the retina (Bernardos and Raymond, 2006). In the INL of both 
the single transgenic gfap:GFP and double transgenic gfap:GFP; XOPS:mCFP retina, all her4 FISH signal 
co-localized with the GFP reporter, indicating that her4 expression in the INL is restricted to BrdU-
positive Müller cells (Figure 2.8A). In previous studies, we found that there is an increased number of 
proliferating rod progenitor cells in the ONL of the XOPS:mCFP when compared to the wild type retina 
(Morris et al., 2008b), but we did not detect a significant increase in BrdU positive cells in the INL of 
XOPS:mCFP retinas at 15 dpf, nor did we detect an increase in PCNA positive cells in the INL of 
XOPS:mCFP adults (Morris et al., 2005, Morris et al., 2008b). However, when we repeated these 
experiments with a greater number of samples we found a small but significant increase in the number 
of BrdU positive cells in the INL of the XOPS:mCFP central retina, and this increase over wild type was 
even larger when fish were exposed to BrdU for five days (Figure 2.8B). To determine the proportion of 
BrdU-positive cells in the INL that also expressed her4, we performed FISH for her4 combined with 
immunohistochemistry for BrdU. After 16 hours of BrdU exposure, approximately 75% of her4 
expressing cells in the INL of both the wild type and XOPS:mCFP retina had incorporated the BrdU label, 
whereas after 5 days of BrdU exposure, this proportion reached nearly 100%. This suggests that her4 is 
expressed in slowly proliferating subsets of Müller glia in the INL. Interestingly, after both short and long 
exposures to BrdU, the total number of her4/BrdU positive cells was significantly higher in the 
XOPS:mCFP INL than the wild type INL (Figure 2.8C). This result suggests that chronic rod photoreceptor 
degeneration induces a small but significant increase in the number of slowly proliferating Müller glia in 
the inner retina. 
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Figure 2.8: Her4 is expressed in slowly proliferating subsets of Müller glia in the INL and rapidly 
proliferating cells in the CMZ. A) Her4 FISH with anti-GFP and anti-BrdU immunohistochemistry (IHC) in 
retinal sections from XOPS:mCFP; gfap:GFP zebrafish revealed that her4 is expressed in proliferating 
Müller cells in the INL. B) Total number of BrdU-positive cells in the INL following either 16 hour or 5 day 
BrdU exposure in wild type and XOPS:mCFP zebrafish. There was a significant increase in the number of 
BrdU-positive cells in the INL with the longer BrdU exposure, and an increase of BrdU-positive cells in 
the XOPS:mCFP INL compared to WT (n=3 animals per group, >60 INL sections per group observed). C) 
Percentage of sections that contained n her4+ BrdU+ cells in the INL; insets show mean number of her4+ 
BrdU+ cells per INL section (left) and the percentage of her4+ cells that were also BrdU+ (right). D) Her4 
FISH with anti-GFP and anti-BrdU IHC in retinal sections from XOPS:mCFP; gfap:GFP. Nearly all her4-
expressing cells in the CMZ were BrdU+. E) There was a small but significant increase in the number of 
her4+ BrdU+ cells in the CMZ of the XOPS:mCFP retina (top). All of the her4+ cells in the CMZ were also 
BrdU+ after 16 hours of BrdU exposure in both WT and XOPS:mCFP retinas (bottom; n=6 animals, >120 
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sections analyzed). GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; CMZ, 
ciliary marginal zone; scale bar, 50 µm; * P<0.05; ** P<0.001. 
 
 As described above, we detected the expression of her4 in the CMZ of wild type adult retinas 
and this expression was significantly increased in the CMZ of the XOPS:mCFP line. In both the wild type 
and XOPS:mCFP retinas, 99% of her4-expressing cells in the CMZ had incorporated BrdU after the 16-hr 
exposure (Figure 2.8D,E). This result suggests that the population of cells at the her4-expressing cells in 
the CMZ proliferate more rapidly than the her4-expressing cells in the INL. 
2.3.5 Generation of the her4:Kaede transgenic zebrafish line. 
 The identification of a subset of proliferating her4-expressing Müller glia in the XOPS:mCFP 
retina suggests that these cells may function to replenish the pool of more rapidly dividing rod 
progenitor cells in the ONL. To determine whether her4-expressing cells contribute to the rod 
photoreceptor lineage, we generated a transgenic line that expresses the photoconvertible Kaede 
reporter driven by a her4 promoter. A 3.4 kb region containing a segment of the 3’ UTR of her4.2 and 
the presumptive promoter of her4.3 (Figure 2.9A) has been used previously to generate reporter lines 
indicating active Notch-Delta signaling (Yeo et al., 2007). This fragment contains five Suppressor of 
Hairless [Su(H)] consensus binding sites, 64 E-box and 2 N-box sequences. To verify that this her4 
promoter segment is responsive to Notch signaling, we carried out in vitro reporter assays using 
Notch1a intracellular domain (NICD) cDNA and a luciferase reporter driven by the 3.4 kb her4 promoter. 
Co-transfection of the NICD expression vector and the luciferase reporter into HEK293 cells significantly 
increased luciferase activity, demonstrating that the 3.4 kb her4 promoter segment is sufficient to 
respond to Notch signaling (Figure 2.S4A). When a her4 expression vector was co-transfected with the 
her4 luciferase reporter, there was a dose-dependent decrease in luciferase activity, suggesting that 
her4 negatively regulates its own expression (Figure 2.S4B). 
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Figure 2.9: Her4:Kaede zebrafish express the kaede transgene in a spatiotemporal pattern that 
recapitulates endogenous her4 expression. A) Schematic representation of the her4 locus. The 3.4 kb 
fragment between her4.2 and her4.3 contains 5 Suppressor of Hairless [Su(H)] consensus binding sites 
that are necessary for Notch-Delta signaling. B) Schematic of the her4:Kaede expression construct. C) 
Two-color FISH shows co-localization of kaede and endogenous her4 transcript during development (red 
fluorescence in the lens is non-specific). D) Two-color FISH in the adult XOPS:mCFP retina shows co-
localization of kaede and her4 transcripts in the CMZ (top row) and INL of the central retina (bottom 
row). L, lens; GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; CMZ, ciliary 
marginal zone; hpf, hours post fertilization; dpf, days post fertilization; scale bar, 50 µm.  
 
 An expression construct was assembled containing the 3.4 kb her4 promoter upstream of the 
Kaede fluorescent reporter (Figure 2.9B). The her4:Kaede line was generated using Tol2-mediated 
transgenesis (Kwan et al., 2007). To determine if the kaede transgene demonstrated the same 
spatiotemporal expression pattern in the retina as endogenous her4, two-color FISH was performed 
using DIG-labeled and FITC-labeled riboprobes to detect her4 and kaede mRNA respectively. In the 
developing retina of the her4:Kaede embryo, expression of the transgene overlapped with expression of 
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endogenous her4 at 48, 72, and 96 hpf, and both transcripts could only be detected in the CMZ by 5 dpf 
(Figure 2.9C). In adult her4:Kaede; XOPS:mCFP retinas, expression of the kaede transgene co-localized 
with endogenous her4 in all her4-positive cells in the INL and the majority of her4-positive cells in the 
CMZ (Figure 2.9D). These data demonstrate that expression of the her4:Kaede transgene faithfully 
recapitulates expression of endogenous her4 in both the developing and regenerating retina. 
 The Kaede reporter is a highly stable 116 kDa homotetrameric protein that has a relatively long 
biological half-life compared to other fluorescent reporters (Chudakov et al., 2010). Following irradiation 
with ultraviolet light, the green fluorescing chromophore undergoes a β-elimination reaction that results 
in an irreversible photoconversion to red fluorescence (Ando et al., 2002) (Figure 2.S9). We tested the 
feasibility of photoconverting Kaede in living tissues to establish a UV treatment paradigm and to 
confirm that the her4:Kaede transgenic zebrafish would be useful for lineage tracing studies. Her4:Kaede 
embryos were briefly anesthetized at 48 hpf and exposed to low intensity UV light for 1 minute. Before 
photoconversion, green-emitting-Kaede (gKaede) could be observed in the retina and throughout the 
CNS in the GFP channel only (Figure 2.S5A,B). Following the short UV pulse, photoconversion into red-
emitting-Kaede (rKaede) could readily be detected along with a reduction of green-emitting-Kaede 
(gKaede) (Figure 2.S5C,D). The animals were allowed to recover and were observed intermittently for 3 
weeks following the photoconversion procedure. Fluorescence of both gKaede and rKaede persisted for 
the entire observation period (data not shown). We then tested the photoconversion paradigm on 
juvenile (4-6 week old) zebrafish eyes to determine if rKaede fluorescence could be detected in the 
mature retina for a minimum of 1 week post photoconversion. We found that the rKaede signal was 
easily detectable in the central retina, and that within the 7 day window, a significant amount of new 
gKaede expression originating from the CMZ could be observed (Figure 2.S5E). These data not only 
indicate that the Kaede reporter is suitable for lineage tracing studies, but also confirm that her4-
expressing cells in the CMZ proliferate to generate new retinal cells in the growing eye. 
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2.3.6 Her4-expressing Müller cells in the INL of the XOPS:mCFP retina contribute to the rod photoreceptor 
cell lineage. 
 To determine the fate of her4-expressing Müller glia in the XOPS:mCFP retina, we conducted 
lineage tracing analyses. The entire right eye of albino XOPS:mCFP; her4:Kaede adults was briefly 
exposed to intense UV light, with the left eye serving as a non-UV treated control. Eyes were dissected 
at various time points post photoconversion, and retinal sections were processed for 
immunohistochemistry. Lineage tracing analysis was restricted to the central retina to avoid Kaede -
expressing cells derived from the CMZ. Because the XOPS:mCFP reporter is expressed in rods prior to 
degeneration, it was not possible to distinguish green fluorescing Kaede (gKaede) from mCFP 
fluorescence in the ONL in the non-photoconverted eye. We therefore immunolabeled retinal sections 
with a rod-specific antibody to distinguish gKaede-expressing non-rod cells from mCFP-expressing rods. 
 In the non-UV treated control eyes, all her4-expressing cells in the retina displayed green 
fluorescence, with no detectable red signal (Figure 2.10A). In contrast, when observed immediately 
after UV treatment, the UV-exposed eye displayed complete green to red photoconversion of all Kaede-
expressing cells in the retina (Figure 2.10B). At 0 days post photoconversion (0d post PC), cells in the 
ONL that expressed the photoconverted rKaede reporter co-localized with markers for rod 
photoreceptors, indicating that cells that once expressed her4 contribute to the rod lineage (Figure 
2.10B’’’). In the INL, rKaede expressing cells with morphological characteristics of Müller glia were 
observed, as well as smaller round cells located in the vicinity of the presumptive rKaede-positive Müller 
glia. This pattern suggests that at the time of UV treatment, the lineage of her4 expressing cells was 
comprised of various cells in different stages of the rod replenishing pathway.  
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Figure 2.4: Her4-expressing cells in the INL contribute to the rod photoreceptor lineage. Column 1, 
non-photoconverted Kaede (gKaede) and mCFP fluorescence; column 2, photoconverted Kaede 
(rKaede); column 3, immunolabeling for rod photoreceptors in the ONL with 4C12 antibody; column 4, 
merge of rKaede and 4C12. A-A’’’) The non-photoconverted retina (no PC) shows gKaede fluorescence in 
the INL, and no rKaede fluorescence. B-B’’’) The photoconverted retina immediately after UV treatment 
(0d post PC) shows only rKaede fluorescence in the INL (arrows), and co-localization of rKaede and 4C12 
in the ONL (arrowheads). C-C’’’) At 1d post PC, new gKaede expressing cells can already be detected in 
the INL (arrows) along with persistent rKaede in the INL and ONL. D-D’’’) At 2d post PC, very little rKaede 
remains in the INL, but in the ONL rKaede persists in rod precursors. E-E’’’) By 3d post PC, only gKaede 
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can be detected in the INL (arrows). 3 animals and 30 sections were observed per time point. INL, inner 
nuclear layer; ONL, outer nuclear layer; CMZ, ciliary marginal zone; scale bar, 50 µm. 
 
 By 1d post PC, a large reduction in the number of rKaede-positive, elongated cells was observed 
in the INL, with an increase in the number of the smaller rounded cells in both the INL and ONL that 
retained rKaede signal. This same pattern was observed in the UV-treated eyes of at least three animals 
analyzed and in all sections examined. In addition, at 1d post PC, gKaede signal could already be 
detected in the INL of the same sections, indicating that her4 continued to be expressed in these cells 
after the UV treatment (Figure 2.10C). At 2d post PC, the majority of sections observed contained no 
rKaede reporter expression in the INL. The few INL sections that were rKaede positive contained no 
elongated rKaede positive cells (Figure 2.10D). By 3d post PC, only gKaede positive cells were found in 
the INL. However, numerous small rKaede positive cells were observed in the ONL (Figure 2.10E). These 
data suggest that the cycle of her4 expression to rod neurogenesis is completed in under 3 days.  
 In order to determine the identity of her4 expressing cells in the INL of the XOPS:mCFP central 
retina, we performed immunohistochemistry with cell -type specific antibodies on retinal sections from 
XOPS:mCFP; her4:Kaede adults. Elongated rKaede-positive cells in the INL co-localized with markers for 
Müller glia, although only a small subset of Müller glial cells expressed the Kaede reporter (Figure 
2.11A). The elongated cells in the INL as well as the smaller rounded cells in the INL and ONL were also 
PCNA positive, indicating that subsets of Müller cells as well as their descendants were proliferating 
(Figure 2.11B). Furthermore, some of the small, rounded rKaede-positive cells in the INL and all of the 
cells in the ONL that retained rKaede fluorescence co-localized with Nr2e3, a marker for rod progenitor 
cells and post-mitotic rod precursors (Figure 2.11C). These data confirm that subpopulations of her4  
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Figure 2.11: The her4-expressing lineage in the XOPS:mCFP retina includes proliferating Müller glia 
and photoreceptor progenitors. A-A’’) Photoconverted Kaede (rKaede) co-localizes with Zrf-1, a marker 
for Müller glia. B-B’’) rKaede+ elongated cells and small rounded cells co-localize with PCNA. C-C’) 
Subsets of Nr2e3-positive cells in the INL and ONL of XOPS:mCFP retinas co-localize with the rKaede 
reporter. INL, inner nuclear layer; ONL, outer nuclear layer; scale bar, 50 µm. 
 
expressing Müller glia cells proliferate in the INL and give rise to rod progenitor cells, which migrate to 
the ONL and differentiate into rods. 
2.3.7 Her4 expressing cells in the CMZ differentiate into retinal neurons and Müller glia, but not rods.  
 To determine the fate of the her4 expressing cells in the CMZ, immunolabeling experiments 
were performed on her4:Kaede and her4:Kaede; XOPS:mCFP adult retinal sections. To rule out 
confounding mCFP fluorescence, double labeling was performed with anti -Kaede antibodies as well as 
markers for the various retinal cell types. Following the double labeling experiments, only the peripheral 
most areas of the central retina adjacent to the CMZ were analyzed to ensure that the Kaede positive 
cells we observed were derived from the CMZ. 
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Figure 2.12: Her4-expressing cells in the CMZ generate any retinal cell type except rod photoreceptors. 
A-A’’) Kaede and amacrine cell marker (HuC/D) co-localization in the INL. B-B’’) Kaede and ganglion cell 
marker (HuC/D) co-localization in the GCL. C-C’’) Kaede and bipolar cell marker (PKCα) co-localization. D-
D’’) Kaede and horizontal cell marker (Prox-1) co-localization. E-E’’) Kaede and red-green cone 
photoreceptor marker (Zpr-1) co-localization. F-F’’) Kaede and Müller glia marker (Zrf-1) co-localization. 
G-H’’) Kaede does not co-localize with a marker for rod photoreceptors (4C12) in the WT retina (G-G’’) 
or XOPS:mCFP retina (H-H’’). GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; 
OS, photoreceptor outer segments; CMZ, cil iary marginal zone; scale bar, 50 µm. 
 
In the peripheral retina adjacent to the CMZ, we observed co-localization of the Kaede reporter 
with markers for Müller glia, amacrine, bipolar, and horizontal cells in the INL, as well as ganglion cells in 
the GCL (Figure 2.12). Interestingly, although Kaede expression was detected in each of these cell types, 
not all of the cells in the peripheral retina were Kaede-positive. In addition, the intensity of Kaede 
fluorescence decreased with increasing distance from the CMZ. Markers for cone photoreceptors in the 
ONL also co-localized with Kaede, but the number of these double labeled cells detected in the ONL was 
small compared to the number of Kaede-positive INL and GCL neurons, suggesting that perhaps the 
turnover rate of Kaede is higher in cones, which are highly metabolically active (Figure 2.12E). 
Previous studies have suggested that rod photoreceptors are not generated from the CMZ of 
teleost fish (Johns and Fernald, 1981, Johns, 1982, Otteson et al., 2001). However, as described above, 
we observed a significant increase in the number of her4-expressing cells in the CMZ of the XOPS:mCFP 
retina, in which only rod photoreceptors degenerate. We therefore asked whether her4-positive cells in 
the CMZ could also produce rod photoreceptors. We immunolabeled retinal sections with a rod-specific 
antibody and searched for rods in the peripheral retina that co-localized with the CMZ-derived 
her4:Kaede reporter. In agreement with previous studies, we did not detect Kaede expression in rods 
adjacent to the CMZ in any wild type sections (Figure 2.12G). In addition, in XOPS:mCFP retinas we only 
detected one Kaede-positive rod adjacent to the CMZ in a single section (out of 160 sections examined). 
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These data suggest that the stem cells at the peripheral most CMZ that transiently express her4 have the 
capacity to generate any retinal cell type except rods, even in the XOPS:mCFP background where the 
her4-expressing cell population in the CMZ is expanded. 
2.3.8 Her4 is upregulated in the retina following acute light damage. 
 Because there was a small but significant increase of her4-expressing Müller glia in a background 
of chronic rod degeneration, we wanted to determine whether more significant damage would result in 
more her4 expression. Therefore, we examined her4:Kaede expression following acute light damage, 
which results in both rod and cone photoreceptor degeneration (Vihtelic and Hyde, 2000). In contrast to 
the slow, chronic rod degeneration observed in the XOPS:mCFP retina, intense light damage causes 
synchronized photoreceptor cell death, reactive gliosis, and proliferation followed by migration and 
differentiation into new photoreceptor cells. Adult her4:Kaede albino zebrafish were dark adapted for 
14 days and then exposed to 18,000 lux light for 7 days. Immunohistochemistry was performed on 
retinal sections to confirm that the light damage resulted in rod and cone degeneration (Figure 2.S6). 
TUNEL and PCNA labeling confirmed that the light treatment resulted in photoreceptor apoptosis and an 
ensuing proliferative response (Figure 2.S7). An antibody to the Kaede reporter was used to characterize 
the extent and timing of her4 expression. Before the onset of light damage the Kaede reporter was not 
detected in the central retina (Figure 2.13A). In contrast, after 4 and 7 days of light damage (4d and 7d 
LD), numerous Kaede positive cells were observed in the INL and ONL of the central retina (Figure 
2.13B,C). Double labeling experiments with PCNA revealed that the Kaede positive cells were 
proliferating (Figure 2.13H). After 2 days of recovery post light damage (2d PLD), there were very few 
Kaede-positive cells in the INL and only a diffuse Kaede signal in the ONL (Figure 2.13D). At 4 and 21d 
PLD, Kaede was not detected anywhere in the central retina (Figure 2.13E,F). QRT-PCR confirmed that 
her4 was upregulated over 10-fold at 4d LD (Figure 2.13G). Interestingly, by 7d LD, the magnitude of  
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Figure 2.7: Her4 expression is upregulated in the light damaged retina. A) Kaede signal is not detected 
in the central retina before light damage onset (0d LD). B) Kaede signal is abundant in the central retina 
after 4 days of light damage (4d LD) and the morphology of the ONL is highly disrupted. C) At 7d LD 
Kaede signal is still highly expressed, the localization is more diffuse in the ONL. D) Few Kaede positive 
cells were observed at 2 days post light damage (2d post LD). E-F’’) No Kaede fluorescence was observed 
in the central retina at 4d or 21d post LD. G. qRT-PCR confirms that her4 is upregulated ~11 fold at 4d LD 
and decreases to ~5 fold over 0d LD at 7d LD. H) Kaede and PCNA double labeling shows that Kaede 
expressing cells are proliferating in the acute light damaged retina. INL, inner nuclear layer; ONL, outer 
nuclear layer; scale bar, 50 µm; * P<0.05; ** P< .001. 
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her4 expression change decreased to 5-fold over 0d LD, and this correlated with an increase in rod and 
cone labeling in the ONL, even though the light treatment was ongoing (Figure 2.S6). These results 
suggest that after four days of intense light exposure, the zebrafish retina may adapt such that 
regeneration can proceed and further light damage is minimized. Taken together, these results 
demonstrate that the extent of her4 expression in the retina depends upon the amount of damage the 
retina receives. 
 
2.4 Discussion  
Morpholino mediated knockdown of her4 during embryonic retinal development resulted in a 
vast increase in the number and domain of ganglion cells within the retina, which came at the expense 
of later born retinal cell types. The pre-mature depletion of retinal progenitor cells indicates that her4 
plays a role in keeping subsets of these RPCs in the cell cycle and influences cell fate decision by causing 
the cells that express her4 to ignore spatiotemporally regulated extrinsic cues that push non her4-
expressing cells towards a particular cell fate in distinct regions of the retina at appropriate times.  
 Interestingly, injection of the splice blocking morpholino at a relatively high dose (10 
ng/embryo) resulted in the same retinal phenotypes as injection of low dose (1 ng/embryo) translation 
blocking morpholino, but only in 1/3 of the embryos. The remaining embryos exhibited a range of retinal 
phenotypes; some of the morphants exhibited moderate to mild retinal lamination defects and 
comparatively less excess ganglion cells and more later born retinal cell types as compared to tbMO 
injected embryos. To address this discrepancy in the relative effectiveness of her4 knockdown between 
the tbMO and the sbMO, RT-PCR experiments were performed on 2, 4, and 48 hpf WT zebrafish 
embryos to assess the maternal contribution of mature her4 mRNA to the ovum (Figure 2.S8). The 
maternal to zygotic transition of control of the transcriptome in the zebrafish embryo occurs shortly 
after 4 hpf (Lee et al., 2014). RT-PCR experiments showed that there is abundant maternal deposition of 
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mature (spliced) her4 mRNA at 2 and 4 hpf, with an expected increase in spliced her4 transcript 
observed at 48 hpf. Because the tbMO blocks translation of any her4 transcript (pre-mRNA or mature 
mRNA), no maternal effect could be observed when using it to knock down her4 expression. With the 
splice blocking morpholino, any maternally deposited mRNA would escape knockdown and be 
translated into Her4. This would result in Her4 dosage being dependent entirely upon levels of mature 
her4 mRNA in each ovum, regardless of how much her4-sbMO was injected. 
 The most striking result when knocking down her4, however, is that knockdown of only 1 of the 
26 total hes/hey/her transcription factors results in a retina that phenocopies disruption of the entire 
Notch-Delta signaling pathway. This result was unexpected because many of the bHLH-O transcription 
factors expressed during zebrafish development that are known targets of Notch signaling are also 
expressed in the primordial eye field and later in retinal progenitor cells, and would presumably confer 
some redundancy in the pathway. It is unknown whether knockdown of any of the other bHLH-O 
transcription factors could yield a similar phenotype as knockdown of her4 alone. It is possible that 
there is a minimum dosage of expression hes/her/hey factors in the developing retina required to 
repress neurogenesis, and that her4 is simply the most highly expressed bHLH-O gene in this particular 
tissue. 
 Due to its Notch-dependent expression in most tissues, the bHLH-O transcriptional regulator 
her4 has been studied in the context of neurogenesis and differentiation of various components of the 
CNS during development (Takke et al., 1999, So et al., 2009, Forbes-Osborne et al., 2013, Radosevic et 
al., 2014). In addition, her4 expression has been used as an indicator of active Notch-Delta signaling 
during regeneration of CNS tissues (Conner et al., 2014, Skaggs et al., 2014). Previous microarray data 
indicated that her4 was upregulated in the adult XOPS:mCFP retina, in addition to other components of 
the Notch pathway, including notch1a and deltaB (Morris et al., 2011). We therefore hypothesized that 
her4 plays a role in the regeneration of rod photoreceptors downstream of Notch-Delta signaling. In this 
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study, we provide support for this hypothesis by characterizing and tracking the lineage of her4-
expressing cells in the XOPS:mCFP retina. Although we showed that expression of her4 decreases when 
Notch signaling is knocked down, and increases when components of the pathway are upregulated, it is 
unclear if Notch signaling activates all variants of her4, or what variants of the gene are being expressed 
in the retina. It is possible that only one or a few of the her4 variants are expressed in the retina 
downstream of Notch and other duplicates could be expressed in non-retinal tissues downstream of 
other pathways. 
In the undamaged adult retina, her4 was primarily expressed in proliferating cells in the 
peripheral CMZ. In contrast, in the XOPS:mCFP retina, we observed her4 expression in a small number of 
slowly proliferating Müller glia cells in the INL. This result is consistent with previous work showing that 
in response to acute retinal damage, Müller cells in the INL proliferate to produce neuronal progenitors 
(Bernardos et al., 2007, Thummel et al., 2008, Montgomery et al., 2010, Gorsuch and Hyde, 2014) . 
However, whereas acute damage induces proliferation of a large number of Müller glia, in the 
XOPS:mCFP line only a very small subset of Müller cells scattered throughout the INL expressed her4 and 
were BrdU-positive. Significantly more of these her4-expressing INL cells incorporated BrdU after 
exposure to BrdU for five days (compared to an overnight exposure), demonstrating that her4 is 
expressed in slowly proliferating Müller glia as opposed to the more rapidly proliferating rod progenitor 
cells at the base of the ONL. Furthermore, even though the rods are continually degenerating in the 
XOPS:mCFP line and there is a significant increase of rod progenitor proliferation at the base of the ONL, 
we did not detect expression of her4 in the rod progenitor cells. Taken together, these data suggest that 
the role of the her4-positive proliferating Müller glia may be to replenish the rod progenitor pool as it 
gets depleted by continual rod photoreceptor regeneration. 
Lineage tracing analysis using our her4:Kaede transgenic line crossed onto the XOPS:mCFP 
background revealed that the slowly proliferating her4-positive Müller cells in the INL give rise to Nr2e3-
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expressing progenitor cells. These progenitor cells then migrate to the base of the ONL where they 
differentiate into rod precursor cells and then rods. In contrast to the more rapid response resulting in 
neurogenesis following acute damage (Thummel et al., 2008, Thomas et al., 2012), we found the cycle of 
her4 expression to rod neurogenesis can take up to three days. As early as one day post-
photoconversion, we observed new non-photoconverted Kaede in presumptive Müller glia in INL, 
demonstrating that the chronic rod degeneration and regeneration experienced in the XOPS-mCFP 
retina elicits a continual, albeit low-level, response in the INL. These data support the hypothesis that 
her4 upregulation in small subsets of Müller cells is associated with the need to restock the rod 
progenitor pool as those progenitors are continually depleted. It is possible that ONL rod progenitors 
have an intrinsic limit with regard to how many times they can divide to produce rod precursors, and 
therefore INL derived stem cells must replenish ONL progenitor numbers. The her4:Kaede transgenic 
line was also used to compare the her4 response in the XOPS:mCFP chronic damage model to the acute 
light damaged retina. We found that her4 was upregulated over 10 fold after 4 days of intense light 
treatment. Similarly, IHC experiments revealed that Müller cells in the INL that expressed the Kaede 
reporter were responsible for contributing to the proliferative response. These experiments show that 
the magnitude of the her4 response is correlated with the amount of damage to the retina. 
In addition to upregulation of her4 in the INL of the XOPS:mCFP retina, her4 was also 
upregulated in the CMZ. This result was surprising because unlike other retinal neurons, rod 
photoreceptors are not derived from the CMZ but from populations of stem cells that reside in the INL 
of the central retina (Raymond et al., 2006, Morris et al., 2008a, Morris et al., 2008b). Increased mitotic 
activity, however, has been reported in the CMZ of the retina following acute damage, even though the 
cells generated do not directly contribute to the population of regenerated neurons (Negishi et al., 
1982, Hitchcock and Raymond, 1992). We used the her4:Kaede transgenic line to determine what cell 
types her4-expressing stem cells in the CMZ have the capacity to generate. We found that cells in the 
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peripheral retina that retained the Kaede reporter included all retinal cell types except for rod 
photoreceptors. Although we cannot rule out that rods can be generated from the CMZ on the basis of 
lack of co-localization of rod markers with Kaede in the peripheral retina, these results are consistent 
with previous observations. Why we observe a significantly expanded number of her4-expressing cells in 
the CMZ of the XOPS:mCFP retina even though they do not contribute to rod neurogenesis remains 
unclear. It has been shown that acute photoreceptor damage results in release of cytokines such as 
ciliary neurotrophic factor (CNTF) and tumor necrosis factor alpha (TNFα), resulting in increased 
expression of stat3 and ascl1a and Müller glia proliferation in the INL of the central retina (Kassen et al., 
2007, Kassen et al., 2009, Nelson et al., 2012, Nelson et al., 2013). It is possible that soluble factors 
released by apoptotic rods in the ONL diffuse to the CMZ as well as the INL of the central retina, and the 
stem cell niche of the CMZ is stimulated to increase her4 expression, but is still restricted as to what cell 
types it can produce. In addition, the specific signals that stimulate the small number of Müller glia in 
the INL of the XOPS:mCFP retina to express her4 and contribute to the rod lineage remain to be 
elucidated. Possible mechanisms include juxtacrine signaling that stimulates Notch activity, gradients of 
extrinsic factors generated by dying photoreceptors, intrinsic cues that sensitize subsets of Müller cells 
to rod degeneration, or some combination of the above. 
In summary, our results demonstrate that her4 is a primary effector of the Notch-Delta signaling 
pathway during embryonic retinal development, and acts downstream of Notch signaling to repress pro-
differentiation genes in subsets of retinal progenitor cells in a specific spatiotemporal pattern. In the 
adult retina, her4 is expressed in slowly proliferating subsets of Müller cells in the INL of the central 
retina as well as in proliferating cells of the peripheral CMZ. Previous studies concluded that there was 
no observable difference in the number of Müller glia in the chronic rod degeneration line (Morris et al., 
2008b), and that there must be a large amount of synchronized rod cell death to initiate Müller glia 
proliferation in the INL (Montgomery et al., 2010). Here, we demonstrate that there is a small but 
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significant increase in the number of slowly proliferating subsets of Müller cells in the INL of the chronic 
rod degenerating XOPS:mCFP retina, as well as an increase in her4 expression in the CMZ. Why her4 
expression was increased in the XOPS:mCFP CMZ even though the CMZ did not generate rods, as well as 
why this proliferative zone is restricted from rod neurogenesis remains unclear. In addition, the 
her4:Kaede transgenic zebrafish proved to be a useful tool for lineage tracing analyses due to temporal 
labeling via photoconversion and the robust nature of the Kaede reporter. In the future, the her4:Kaede 
line could be used to not only track descendants of proliferating glia in the retina, but throughout the 
CNS. 
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Chapter 2 Tables 
Table 2.1: Chapter 2 oligo sequences and application: 
Oligo name Oligo sequence Use 
her4 forward CCTGACGGAGAACTGAACACAAGACACACA RT-PCR 
her4 reverse TTTCTCAATGGTACGGCGGGTGCTCTGGGC RT-PCR 
atp5h forward TGCCATCTCAGCAAAACTTG RT-PCR, qPCR 
atp5h reverse CACAGGCTCAGGAACAGTCA RT-PCR, qPCR 
her4 coding forward AAGCTTCCTGACGGAGAACTGAACACAAGACACACA cDNA plasmid 
her4 coding reverse GAATTCTTTCTCAATGGTACGGCGGGTGCTCTGGGC cDNA plasmid 
her4 probe forward TGACAAACAAGCTGAGAAAGCCCA probe 
her4 probe reverse AGCAGTGTGGTCATCCTTTACATGC probe 
kaede probe forward ATGAGTCTGATTAAACCAGAAATGAAGATCA probe 
kaede probe reverse TTACTTGACGTTGTCCGGCAATCCA probe 
her4 forward GAGCGAATCAACAGCAGCATCG qPCR 
her4 reverse CAGCCGCACTGCTTTTCTGAGA qPCR 
her4.3 P forward CTGTGTGAGCAGTCATGTTTGATCTCAATG cloning 
her4.3 P reverse TTCAGGATCAGATCTGAGCTGTGCTAAACT cloning 
her4-tbMO ATTGCTGTGTGTCTTGTGTTCAGTT morpholino 
her4-sbMO TGATCAATATTTACCTTGTTTGTCA morpholino 
std-Ctrl-MO CCTCTTACCTCAGTTACAATTTATA morpholino 
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Chapter 2 Supplemental Figures 
 
Figure 2.S1: RT-PCR to assess effectiveness of the her4-sbMO. Injection of the her4 splice blocking 
morpholino results in loss of the spliced her4 mRNA transcript up to 3 days post injection. 
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Figure 2.S2: Overexpression of her4 mRNA results in no apparent retinal phenotype. IHC comparing 
the expression of late born retinal neurons (rods and cone PRCs) to the first retinal cell type to 
differentiate (ganglion cells) show no difference between the retinas of 72 hpf embryos injected with 
1.5 ng/embryo of her4 mRNA and uninjected controls. 
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Figure 2.S3: Her4 expression during retinal development is downstream of Notch-Delta signaling. A) 
Fluorescent in situ hybridization (FISH) for her4 expression in the developing retina at 48 hpf, 72 hpf, 
and 5 dpf. B) Whole mount in situ hybridization (WISH) performed on 48 hpf embryos show a decrease 
in her4 expression in embryos treated with the γ-secretase inhibitor DAPT compared to vehicle controls 
(1% DMSO). C) Single transgenic hsp70:Gal4 and double transgenic hsp70:Gal4; UAS:NICD 48 hpf 
embryos were heat shocked at 24 hpf and processed for WISH at 48 hpf. The double transgenic embryos 
displayed higher levels of her4 expression upon ectopic expression of the NICD. A, anterior; P, posterior; 
V, ventral; D, dorsal; L, lens; scale bar, 50 µm. 
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Figure 2.S4: The 3.4 kb her4.3 promoter is responsive to Notch signaling. A) Dual luciferase assays were 
performed in HEK293 cells transfected with the pGL3-her4 firefly luciferase reporter, the pRL-TK Renilla 
luciferase transfection control reporter, and varying amounts of the pCDNA3-NICD expression vector 
with balancing amounts of pGEM3Z. There is a dose dependent increase in luciferase activity with 
increasing amounts of NICD. B) Dual luciferase assays in HEK293 cells using pGL3-her4 firefly luciferase 
reporter, the pRL-TK Renilla luciferase transfection control reporter, and varying amounts of the 
pCDNA3-her4 expression vector show that with increasing amounts of her4 expression there is a dosage 
dependent decrease in relative luciferase activity. * P<0.05, ** P<0.001. 
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Figure 2.S5: Her4:Kaede zebrafish express the Kaede reporter which can be stably photoconverted in 
living tissues. A) Non-photoconverted (gKaede) fluorescence in the brain and retina (arrowheads) and 
cmlc-EGFP transgenesis reporter in the heart (arrow) in the GFP channel. B) No photoconverted Kaede 
(rKaede) can be detected in the red channel before UV treatment. C-D) Following brief UV exposure, 
there is a decrease of gKaede (C) and an increase of rKaede fluorescence (D). E) Cryosection of a mature 
retina 1 week after UV treatment reveals rKaede fluorescence in the central retina and the contribution 
of new gKaede-positive cells from the CMZ. L, lens; GCL, ganglion cell layer; INL, inner nuclear layer; 
ONL, outer nuclear layer; CMZ, ciliary marginal zone; hpf, hours post fertilization; scale bar, 50 µm.  
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Figure 2.S6: Acute light damage results in degeneration of rod and cone photoreceptors. 
Immunohistochemistry on retinal cryosections of light damaged her4:Kaede albino zebrafish confirm 
degeneration of rod and cone photoreceptors at 4 and 7 days post light onset (LD). OS, outer segments; 
ONL, outer nuclear layer; INL, inner nuclear layer; scale bar, 50 µm. 
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Figure 2.S7: Acute light damage results in apoptosis of photoreceptors and increased cell proliferation 
in the INL and ONL. A-C) TUNEL labeling confirms that there are apoptotic cells in the ONL at 4 and 7 
days post light damage onset (LD). D-F) PCNA labeling confirms that there is a robust proliferative 
response from cells in the INL and ONL following light induced retinal damage. ONL, outer nuclear layer; 
INL, inner nuclear layer; scale bar, 50 µm. 
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Figure 2.S8: Her4 maternal effect. RT-PCR from cDNAs generated from wild type embryos show 
significant maternal deposition of spliced her4 mRNA at 2 and 4 hpf (before the maternal to zygotic 
transition of transcription), and an increase of her4 mRNA at 48 hpf indicating zygotic transcription of 
her4. 
 
 
 
 
 
 
 
 
 
 
 
 
87 
 
 
 
Figure 2.S9: The photoconvertible Kaede reporter protein. The Kaede fluorescent reporter is a 116 kDa 
homotetrameric protein that fluoresces green when exposed to blue light. Following exposure to UV 
light, the chromophore undergoes an irreversible β-elimination reaction at the amide linkage and the 
resulting chromophore fluoresces red when exposed to green light, with no green fluorescence when 
exposed to blue light. 
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CHAPTER 3: Her9 acts downstream of Retinoic Acid (RA) signaling during retinal 
vasculogenesis 
 
Keywords: Her9, HES1, Retinoic Acid, Vasculogenesis, Zebrafish, Retina 
3.1 Abstract 
 A previous study demonstrated that hairy-related 9 or hairy/enhancer of split-related 9 (her9), a 
basic-helix-loop-helix-orange (bHLH-O) transcriptional repressor that is the zebrafish homolog of the 
human HES1 gene, is among the group of genes that are upregulated in a background of chronic rod 
photoreceptor specific degeneration and regeneration in the zebrafish retina (Morris et al., 2011). Here 
we show that her9 acts downstream of the retinoic acid (RA) signaling pathway during retinal 
development, and is expressed in the retina independently of Notch-Delta signaling unlike its 
mammalian homolog HES1. Knockdown of her9 expression during embryonic ocular development 
resulted in a decrease in retinal vasculature, and overexpression resulted in ectopic retinal vasculature. 
In addition, the vasculature defect phenotype was only observed when a translation blocking 
morpholino was injected, and not when a splice-blocking morpholino was used. RT-PCR analysis showed 
that there is significant maternal deposition of spliced her9 mRNA in the developing embryo, and that 
the amount of maternally deposited her9 mRNA is sufficient to result in normal retinal vasculature. 
 
3.2 Introduction 
3.2.1 Vasculogenesis in the zebrafish 
 The vasculature network in vertebrates is a highly specialized organ that is required for proper 
function of a number of key physiological tasks including transport of oxygen and removal of carbon 
dioxide, nutrient disbursement, regulation of osmotic pressure, transport of waste products and debris, 
immune system response, and remediation of infection. Formation of the vascular network is an 
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essential step in embryonic development, and is generally considered to take place primarily through 
two often complimentary mechanisms, vasculogenesis and angiogenesis (Patel-Hett and D'Amore, 
2011). Both vasculogenesis, the de novo formation of vessels from endothelial precursor cells, and 
angiogenesis, the growth of new vessels from pre-existing vasculature by sprouting, are complex and 
highly regulated processes that are mediated by the precise coordination of multiple signaling pathways 
and transcription factors. 
The zebrafish has recently emerged as an excellent vertebrate model for studying the various 
paradigms of blood and lymphatic vascular development. Due to their relatively small size, external and 
rapid development, optical transparency of the embryos, high fecundity, and availability of various 
vasculature-specific transgenic and mutant lines, the zebrafish has become a useful model for studying 
the formation of vasculature in vertebrates. The zebrafish have a closed circulatory system, and the 
anatomical and molecular features in the developing blood vessels are highly similar to those in humans 
and other higher vertebrates (Isogai et al., 2001). Because of their high fecundity, small size, and fast 
generation time, zebrafish have been utilized in large-scale forward-genetic screens in which mutations 
in novel genes that regulate vasculature development have been identified (Gore et al., 2012). In 
addition, because of their small size, the zebrafish embryos and larvae receive a sufficient amount of 
oxygen for the first few days post fertilization by passive diffusion alone, al lowing for organogenesis and 
tissue development (including the retina) to proceed for a limited time in the absence of a functional 
cardiovascular system. This unique trait allows for the study of numerous vasculature defects in a 
vertebrate model system that wouldn’t be feasible in other established vertebrate models. When 
passive diffusion alone cannot supply adequate levels of oxygen for organogenesis and tissue 
development to occur before embryonic lethality (such as in mouse or chick models), the study  of blood 
or lymphatic vessel development could not be conducted. 
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Similar to other vertebrates, endothelial vasculature tissues and hematopoietic cells in zebrafish 
embryos arise in close association with each other, and are generally considered to be deri ved from 
common precursor cells. In mammalian embryos, endothelial and hematopoietic precursor cells develop 
and differentiate in extraembryonic yolk sac areas, and in zebrafish, they develop in the intermediate 
cell mass (derived from the ventral mesoderm) after gastrulation (Detrich et al., 1995). Early 
hematopoietic and endothelial cells in zebrafish and mammals express a common set of genes and are 
controlled largely by the same regulatory networks. Early expression of stem cell leukemia (scl) and fetal 
liver kinase/vascular endothelial growth factor receptor 2 (flk1/vegfr2) in the ventral mesoderm have 
been shown to be required for endothelial and hematopoietic stem cell development in mouse and 
zebrafish (Kabrun et al., 1997). Additionally, forward genetic screens have identified numerous genes 
that are involved in retinal vasculogenesis and retinal development, and misexpression or nonsense 
mutations in these genes results in microphthalmia, small or missing lens, and reduced or missing retinal 
vasculature. 
 Some endothelial precursor cells become lineage restricted during mid-gastrula stages in the 
developing zebrafish, and they begin to express endothelial-specific genes during somitogenesis 
(Kimmel et al., 1990). Cells located near the animal pole of the early gastrula give rise to ectodermal 
fates, whereas cells located near the blastoderm margin give rise to mesodermal and endodermal fates, 
including vasculature endothelium in the retina. After angioblasts have been specified from the ventral 
mesoderm, they migrate to the embryonic midline directly above the endoderm to form the primordial 
axial vessels, the dorsal aorta, and the posterior cardinal vein which constitute the two major trunk axial 
vessels. These cells are positioned dorsal to the endodermal layer and ventral to the hypochord 
(Fouquet et al., 1997). Vasculogenesis of the axial vessels in the zebrafish resembles de novo assembly 
of vessels in other developing vertebrates with few minor differences in timing of diffe rentiation of the 
dorsal aorta and posterior cardinal vein angioblasts. In all vertebrates, paired axial vessel primordia 
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eventually contact each other and establish a closed circulatory network. The zebrafish has a relatively 
simple embryonic circulatory network that develops extremely rapidly compared to other vertebrates, 
however, and only contains a single dorsal aorta and posterior cardinal endothelium. In other 
vertebrates, persistent expression of bone morphogenetic protein (BMP) inhibitors from the midline 
notochord is required for the initial separation of the bilateral dorsal aorta, and it has been suggested 
that early absence of these BMP inhibitors during zebrafish development permits formation of a single 
tube at early stages (Bressan et al., 2009). 
 After the first axial vessels form by vasculogenesis to produce the dorsal aorta, cardinal vein, 
and primitive cranial vasculature, an early fate decision results in either arterial or venous identity of the 
forming vessel (Roman et al., 2002). Acquisition of arterial-venous (A-V) identity has been thought to be 
directed by physiological parameters such as blood flow, dissolved gas levels, and regional blood 
pressure differences that appear shortly after blood circulation begins. Recent studies, however, have 
demonstrated that the endothelial cells lining arteries and veins are functionally and molecularly 
distinct, and are regulated by pre-defined genetic programs and signaling networks (Swift and 
Weinstein, 2009, Patel-Hett and D'Amore, 2011). Studies performed using zebrafish have uncovered the 
functional roles of upstream signaling pathways and factors that result in acquisition of A-V identity. A 
signaling cascade consisting of sequential Hh, Vegf, and Notch-Delta signaling is required for arterial fate 
determination (Lawson et al., 2001), and disruption of the Notch pathway results in ectopic expansion of 
normally venous-restricted markers into arterial domains. Additional zebrafish studies have shown that 
Hh and Vegf signaling act upstream of Notch during arterial differentiation, and embryos lacking either 
sonic hedgehog (shh) or vegfa fail to express markers for arterial cell fate within their blood vessels, and 
show a similar expansion of venous-restricted markers (Lawson et al., 2002). 
3.2.2 Vasculogenesis in the vertebrate retina 
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 The zebrafish retina is considered to be particularly sensitive to the effects of reduced or 
ectopic expression of transcription factors that are downstream of multiple signaling pathways , partially 
due to the extremely rapid development of such a complex structure as the eye itself. Thus, visualization 
of retinal vasculature and of the eye itself allows for relatively rapid identification of genes involved in 
vasculogenesis, as well as small molecule screens that identify compounds that also affect this process 
(Lawson and Weinstein, 2002a). The retina is one of the most metabolically active tissues found in the 
body and has a higher rate of oxygen consumption than any other area of the CNS, including the brain 
(Wangsa-Wirawan and Linsenmeier, 2003). Proper nourishment of the eye and retina by vascular 
networks is critical for maintaining vision and visual acuity. Severe forms of vision loss and blindness in 
humans, including diabetic retinopathy and age relate macular degeneration (AMD) are linked with 
vascular abnormalities (Fruttiger, 2007). 
Similar to the major axial vessels in the trunk, the cranial vasculature is initially established by de 
novo vasculogenesis, followed by sprouting of the more complex cranial vasculature network by 
angiogenesis (Lee et al., 2009). Close examination of vasculogenesis and angiogenesis in the retina 
reveals a highly conserved sequence of events that take place in most vertebrates, with the major 
difference being the rate of ocular development with respect to the rest of the CNS among the various 
classes in the phyla (Isogai et al., 2001).  
In mammals, the mature retina is nourished by two independent circulatory systems, the 
choroidal and retinal vasculature networks. The choroidal vessels in the non-neural RPE are responsible 
for around 80% of blood flow to the retina and nourish the highly metabolically active photoreceptor 
cells in the ONL. The central retinal artery that emanates from the optic disc carries the remaining blood 
flow that nourishes cells in the INL and GCL. The retinal vessels form intraretinal capillaries that interface 
with cells at the inner and outer plexiform layers (Provis, 2001). During initial mammalian eye 
development before the inner retinal vasculature appears, oxygen is provided to the retina and lens by 
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choroidal and hyaloid vessels. The hyaloid vasculature is complex of transient intraocular vessels from 
the optic disc that extend through the choroid fissure and partially envelop the anterior portion of the 
lens. The hyaloid vessels undergo progressive regression by apoptosis as the retinal vasculature network 
develops by angiogenesis in a synchronous fashion (Gariano and Gardner, 2005). Failure of the hyaloid 
vessels to regress results in ocular pathologies such as persistent foetal vasculature, which in turn leads 
to intraocular hemorrhages, retinal detachment, and vision loss. It has also been observed that failure of 
the hyaloid vessels to regress coincides with incomplete retinal vascularization, suggesting that the same 
regulatory pathways and signaling networks are responsible for simultaneously controlling hyaloid  
vessel regression and formation of the retinal vasculature network (Zhu et al., 1999). 
During zebrafish retinal vasculature development, the optic artery branches out from the 
primitive internal carotid artery around 24 hpf and enters the eye ventrally through the optic fissure and 
forms the hyaloid artery. They hyaloid artery extends to the lens basket and forms a single loop and 
then exits the optic fissure as the hyaloid vein by 30 hpf (Alvarez et al., 2007). Endothelial cells between 
the lens and retina give rise to the first hyaloid vessels at 60 hpf and are tightly connected to the lens. As 
development continues, the vessels progressively branch and start to lose contact with the lens and 
adhere to the inner limiting membrane of the juvenile retina by 30 days post fertilization. Unlike 
mammals, the zebrafish hyaloid vessels do not regress, but simply detach from the lens and contribute 
to the maturing retinal vasculature network (Alvarez et al., 2007). 
The retinal vasculature in the zebrafish inner limiting membrane is not organized in any defined 
pattern, and the majority of adult retinas have 6-7 retinal vessels branching from the central artery 
emerging from the optic stalk; moreover, the exact number of branches can vary from the left and right 
eye of the same animal. The main branches extend radially from the central artery and branch into 
capillary networks before connecting to a circumferential vein in the ciliary marginal zone of the retina. 
Unlike the human retina, the zebrafish do not possess an avascular cone rich region in the central retina 
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(fovea of the macula). The zebrafish retinal vasculature extends throughout the inner limiting 
membrane and nourishes all GCL and INL neurons. The choroidal vasculature adjacent to the non-neural 
RPE of the zebrafish, similar to the choroidal vasculature in mammals, is primarily responsible for 
nourishment of the highly metabolically active photoreceptors. 
Throughout the life of the zebrafish, the vasculature network is expanded and refined as the eye 
grows. In addition, the retinal blood supply is associated with a Müller glial scaffold in the retina whose 
end feet make direct contact with blood vessels in the inner limiting membrane and have processes that 
extend the entire thickness of the retina. Transgenic gfap:GFP zebrafish which express GFP in glial cells, 
and kdrl:mCherry or fli1:EGFP transgenic lines (which express fluorescent reporters in vasculature 
endothelial cells) show co-localization of reporter signal in the inner limiting membrane as well as the 
RPE, suggesting that it is the Müller glia cells associating with capillaries that are responsible for 
disbursement of oxygen and other nutrients throughout the thickness of the retina (Gore et al., 2012). 
3.2.3 The retinoic acid signaling pathway 
 Retinoic acid (RA) is a vitamin-A derived small lipophilic molecule that acts as a morphogen. RA 
is a ligand for members of the nuclear RA receptor (RAR) superfamily, and binding of RA to a RAR results 
in activation of target genes. Vitamin-A (retinol) has long been known to be involved in the visual cycle; 
its derivative 11-cis retinal undergoes photoisomerization when struck by a photon of light which 
triggers initiation of the visual phototransduction pathway (Larhammar et al., 2009, Yau and Hardie, 
2009, Fain et al., 2010). It was discovered from work in avian and rodent models that deficiency of 
vitamin-A as well as abnormal embryonic exposure to its metabolite retinoic acid, resulted in a wide 
range of developmental defects (Wilson et al., 1953, Clagett-Dame and Knutson, 2011).  
After the potent teratogenic effects of RA were observed, possible functions of RA during 
embryonic development were inferred by global or local exposure of RA at multiple developmental 
stages and body/tissue locations in a wide range of species, including amphibians, reptiles, chicks, 
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rodents and higher mammals (Avantaggiato et al., 1996). Eventually the genes and enzymatic pathways 
that regulate RA synthesis in maternally deposited retinoids as well as the highly regulated process of RA 
catabolism were more fully characterized with the advent of modern molecular techniques. It has been 
shown that most elements of the RA signaling pathway (metabolic/catabolic pathways, expre ssion 
patterns, and affected tissues) are highly conserved across most vertebrates (Avantaggiato et al., 1996, 
Rhinn and Dolle, 2012). 
Retinoic acid binds to retinoic acid receptors (RARs), which are members of the highly conserved 
nuclear receptor superfamily that includes RARα, RARβ and RARγ. When bound to the RA ligand, RARs 
act in heterodimeric combinations with retinoid X receptors (RXRα, RXRβ and RXRγ). RXRs themselves 
cannot bind RA and act mainly as scaffolding proteins to facilitate binding of the RAR-RXR heterodimer 
complex to DNA (Chawla et al., 2001). There is a large degree of functional redundancy with the various 
permutations of RAR/RXR heterodimers, and developmental abnormalities usually only occur when two 
receptors are inactivated in combination or if there abnormal levels of the RA ligand (Mark et al., 2009). 
After the RA ligand and RAR/RXR receptors come into contact, the heterodimer-ligand complex 
translocates to the nucleus where it binds to retinoic-acid-response-elements (RAREs) in the promoters 
of target genes. The core RARE DNA motif consists of repeats of the he xameric sequence 5′-
(A/G)G(G/T)TCA-3′. Tight genetic regulation of RA signaling is accomplished by the ability of the 
RAR/RXR heterodimer to bind to RAREs in the absence of the RA ligand and repress expression of target 
genes. It is only in the presence of RA that a conformational change in the complex leads to the release 
of co-repressors and recruitment of co-activator transcription factors which then result in expression of 
target genes (Rhinn and Dolle, 2012). Some of the known co-activators include chromatin remodeling 
genes which decompact the chromatin and allowing for the assembly of the transcription pre -initiation 
complex. 
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The morphogen-like gradients resulting from retinoic acid production in specific areas and cell 
types plays a role in numerous developmental pathways; the establishment of signaling boundaries due 
to RA metabolism allows the RA signaling pathway to finely control the differentiation and patterning of 
stem and progenitor cell populations throughout the developing embryo. RA signaling and the effects of 
inappropriate levels of RA have been well documented in hindbrain development, where disruption of 
the pathway leads to numerous developmental defects (Kiecker and Lumsden, 2005). During forebrain 
development, RA signaling is required for proper anterior-posterior patterning and cell survival of the 
telencephalon. In addition, RA signaling mediates crosstalk between Hh, Wnt, and FGF to establish 
morphology and cell types (Halilagic et al., 2003). In some cases, excess RA in the developing zebrafish 
optic primordia causes a duplication of the retina along the dorsoventral axis (Hyatt and Dowling, 1997). 
3.2.4 Hairy-related 9 (her9) during embryonic development 
 Hairy-related 9 or hairy/enhancer of split-related 9 (her9), is a basic-helix-loop-helix-orange 
(bHLH-O) transcriptional repressor that is the zebrafish ortholog of the human HES1 gene (see chapter 1 
for an overview of the structure and function of the bHLH-O class of transcription factors). Unlike the 
mouse and chicken orthologs (Hes1 and c-hairy 1 respectively), the zebrafish ortholog her9 is not 
expressed cyclically in the presomitic mesoderm, but rather in the ectodermal tissues during early 
embryonic development (Leve et al., 2001). In addition, expression of her9 in all observed tissues does 
not appear to be sensitive to manipulation of the Notch-Delta signaling pathway, whereas the human, 
mouse, and chicken homologs are commonly used as indicators of active notch-delta signaling (Kitagawa 
et al., 2013). 
The pro-neural domains in a developing embryo which give rise to primary motor, inter-, and 
Rohon-Beard neurons are established at the beginning of neurogenesis along the anteroposterior axis in 
the dorsal ectoderm. Here, pro-neural and inter-proneural domains are established by expression of 
numerous bHLH and bHLH-O genes, including her9. In these domains, her9 has been shown to be 
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downstream of Bmp signaling, and morpholino based knockdown of her9 results in ectopic expression of 
pro-neural genes and a greatly expanded pro-neural domain at the expense of inter-pro-neural domains 
(Bae et al., 2005). These data indicated that her9 and BMP signaling have distinct roles in neurogenesis 
from the Notch pathway, and her9 functions as a prepattern gene in the early developing 
neuroectoderm. 
To further add to the complexity of her9 regulation in the developing zebrafish embryo, her9 has 
also been implicated in floor plate development in midline precursor cells derived from the dorsal 
organizer during gastrulation. Expression of her9 has been shown to regulate notochord development 
and promote floor plate specification, and similar to expression in other tissues, her9 expression in early 
floor plate cells does not require Notch signaling (Latimer et al., 2005). Here, her9 expression is 
dependent upon midline-Nodal signaling and acts downstream of the Nodal signaling pathway to inhibit 
notochord development. 
Recent studies have also demonstrated that her9 represses a neurogenic fate downstream of 
tbx1 and retinoic acid signaling during inner ear development (Radosevic et al., 2011). In the developing 
cranial otic placode, her9 expression defines the posterolateral non-neurogenic field downstream of 
tbx1, and both genes are responsive to RA signaling. In addition, opposing RA and Hh signaling position 
the boundary between the neurogenic and non-neurogenic domains, however manipulation of Hh 
signaling alone does not influence her9 expression in this tissue. In the retina, it has also been shown 
that an interconnected core transcriptional network consisting of sex determining region Y-box 2 (sox2), 
T-cell leukemia homeobox-1 (tlx), GLI family zinc finger 3 (gli3), and her9 transcription factors are 
responsible for restriction of retina-specific homeobox gene 2 (rx2) expression to the peripheral ciliary 
marginal zone where the rx2-positive cells behave a stem cells for both the neuro-retina and the non-
neural RPE (Reinhardt et al., 2015). Although her9 appears to be involved in a wide variety of neurogenic 
processes, the role that her9 plays during retinal development, and in particular retinal vasculogenesis 
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remains poorly defined. In this study, we wanted to determine if her9 expression was involved in retinal 
vasculogenesis and to place retinal expression of her9 within the context of a gene regulatory network. 
We were able to demonstrate that expression of her9 in the retina is regulated by RA signaling, and that 
the spatiotemporal expression pattern of her9 coincides with retinal vasculogenesis. In addition, 
knockdown of her9 or RA signaling results in decreased retinal vasculature, while overexpression results 
in ectopic vascular development. 
 
3.3 Results 
3.3.1 Her9 expression in the wild type and XOPS:mCFP retina 
 A previous microarray analyses has demonstrated that hairy-related 9 (her9) is 
upregulated in the mature retinas of transgenic XOPS:mCFP zebrafish that experience constitutive rod 
photoreceptor degeneration and regeneration (Morris et al., 2011). These results were verified by semi-
quantitative RT-PCR and quantitative PCR (Figure 3.1), and showed that her9 expression in the retina of 
XOPS:mCFP zebrafish is increased roughly 4-fold as compared to controls. To further understand the 
possible role(s) of her9, and to place her9 within the context of a retina specific gene regulatory 
network, it was necessary to establish which signaling pathway influenced retinal her9 expression. In 
order to address this question, the normal expression pattern of her9 in the retina had to be examined. 
The spatiotemporal expression pattern of her9 in the wild type developing retina and in the 
adult XOPS:mCFP regenerating zebrafish retinas were determined by in situ hybridization using DIG-
labeled RNA probes specifically designed to detect her9 transcript (table 3.1). At 24 hpf, her9 was 
expressed throughout the developing wild type retina, including the lens (Figure 3.2A). From 30-36 hpf, 
however, her9 expression appeared to largely cease in the central retina and be restricted more towards 
the ciliary marginal zone, with some expression remaining in posterior regions of the central retina 
(from a dorsal view) (Figure 3.2B,C). By 42 hpf, retinal expression of her9 appeared to be restricted  
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primarily to the CMZ, with persistent expression in the posterior retina (again, from the dorsal view of a 
whole-mount in situ hybridization image). When viewed laterally, and with the eye dissected away from 
the rest of the head, it is clear that at 42 hpf that her9 is expressed at the peripheral most CMZ-lens 
transition area and in the choroid fissure (Figure 3.2C,D). This result was surprising because the bHLH-O 
genes (including the mammalian ortholog of her9, HES1) have not been previously implicated in retinal 
vasculature development, and as previously mentioned, these are exactly the same spatiotemporal 
patterns in the developing zebrafish retina where the hyaloid artery and lens basket vasculature are 
forming. By 48 hpf, her9 expression could not be detected anywhere in the retina, and at any later time 
point beyond 48 hpf, only traces of her9 expression could be observed in the hindbrain of the wild type 
retina (data not shown). 
In the mature zebrafish retina, expression of her9 visualized by colorimetric in situ hybridization 
in adult retinal sections could not be detected in the central retina of the wild type zebrafish or in the 
CMZ (Figure 3.3A,B). In the adult transgenic XOPS:mCFP retina, however, expression of her9 could be 
observed adjacent to the RPE, possibly where choroidal vasculature cells are present (although it must 
be noted that depending on the probe used, background coloration sometimes develops in the RPE 
Figure 3.1: Expression levels of her9 in adult wild 
type and XOPS:mCFP retinas. A) Semi-quantitative 
RT-PCR demonstrates that her9 expression is 
increased in the adult XOPS:mCFP retina. B) qRT-PCR 
revealed a ~4 fold increase in expression in the adult 
XOPS:mCFP retina compared to wild type controls. In 
both experiments, atp5h was used as the house-
keeping control. 
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Figure 3.2: Expression of her9 in the developing zebrafish retina. A-D) Whole mount in situ 
hybridization used to visualize the spatiotemporal pattern of her9 expression shows that from 24 hpf to 
42 hpf her9 expression gets restricted to the peripheral retina adjacent to the lens (dorsal view). E-F) 
Lateral view of the retina reveals that besides expression in the peripheral most CMZ, her9 is also 
expressed in the choroid fissure. L, lens; GCL, ganglion cell layer; PR, peripheral retina; CMZ, ciliary 
marginal zone; CF, choroid fissure; A, anterior; P, posterior; scale bar, 50 µm. 
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Figure 3.3: Expression of her9 in the adult retina. Her9 expression cannot be detected by colorimetric in 
situ hybridization in the adult wild type embryo, but can be detected in the choroid and CMZ of the 
adult XOPS:mCFP retina. A-B) Colorimetric ISH on adult wild type sections reveal that her9 is either not 
expressed in the central retina, choroid, and CMZ, or that expression levels are too low to detect by this 
method in the wild type background. C-D) Her9 is expressed in some cells in the choroid and CMZ of the 
XOPS:mCFP retina, but not in the central retina. GCL, ganglion cell layer; INL, inner nuclear layer; ONL, 
outer nuclear layer; CMZ, ciliary marginal zone; RPE, retinal pigmented epithelium; scale bar, 50 µm. 
 
even if the gene is not expressed there; during WISH experiments, however, the coloration patterns 
detected when using the her9 probe is consistent with what is observed when individual or small groups 
of cells contain a specific transcript) (Figure 3.3C). In addition, a small number of cells in the CMZ of the 
adult XOPS:mCFP retina also expressed her9 (Figure 3.3D). Interestingly, in the mature XOPS:mCFP 
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retina, expression of her9 resembled expression of her4 in the CMZ of the chronic rod 
degeneration/regeneration line. Her9, unlike her4 (which is a known downstream effector of Notch-
Delta signaling), was not expressed in the central neural-retina of the adult wild type or XOPS:mCFP 
retina, but rather adjacent to the RPE in the choroid. 
3.3.2 Her9 is expressed in retinal vasculature endothelium during embryonic retinal development 
To address whether expression of her9 coincides with markers for retinal vasculature, 
fluorescent in situ hybridization (FISH) experiments were conducted in a transgenic line of zebrafish that 
express EGFP specifically in vasculature endothelial cells (fli1:EGFP). At 36 hpf, expression of her9 was 
largely restricted to the ciliary marginal zone and the choroid fissure of the retina and overlapped with 
fli1 signal, especially in the choroid fissure where the hyaloid artery was forming (Figure 3.4A-D). By 42 
hpf, expression of her9 in the retina could only be detected in the peripheral areas of the retina around 
the lens basket vasculature, and in the choroid fissure (Figure 3.4E-F). These data suggest that because 
of the spatiotemporally overlapping expression of her9 and fli1,that the her9 transcription factor might 
be playing a role in specifying precursor cells to differentiate into vascular endothelial cells, or is 
expressed in already differentiating vascular endothelial cells to preclude a neuronal fate in the retina.  
3.3.3 Her9 is expressed downstream of RA signaling in the developing zebrafish retina  
 In situ hybridization and quantitative RT-PCR experiments were performed on 36 hpf embryos to 
determine whether her9 expression in the retina is affected by manipulation of the RA signaling 
pathway. 24 hpf embryos (that already had an established primordial retina and lens) were 
dechorionated and treated with either 1 µM retinoic acid with 0.3% DMSO, 100 µM of the RA signaling 
inhibitor diethylaminobenzaldehyde (DEAB) in 0.3% DMSO, or 0.3% DMSO alone as the carrier control 
until 36 hpf when they were processed for WISH, or heads removed and processed for qPCR. The 
expression pattern of her9 observed in the retina of the control group was typical of her9 expression in 
embryos raised in fish water, with expression at the peripheral CMZ adjacent to the lens and expression  
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Figure 3.4: Her9 is expressed in retinal vasculature in the developing retina. Fluorescent in situ 
hybridization (FISH) and anti-GFP immunohistochemistry (IHC) reveal her9 is expressed in retinal 
vasculature. A-H) FISH and IHC double labeling experiments in 36 and 42 hpf retinal sections of fli1:EGFP 
embryos shows co-localization of her9 transcript and the reporter for vascular endothelial cells in the 
peripheral CMZ and choroid fissure in the embryonic retina during development of the retinal 
vasculature network. CF, choroid fissure; L, lens; scale bar, 50 µm. 
 
in the choroid fissure (Figure 3.5A). Compared to the control group, the DEAB treated embryos 
displayed reduced her9 expression in the retina (Figure 3.5B). In contrast, in the RA treated embryos 
there was a large increase in the amount of her9 expression as well as an expanded domain of 
expression in the RA treated embryos when compared to either the control group or the DEAB treated 
embryos (Figure 3.5C). QRT-PCR experiments corroborated these findings, with the RA treated heads 
having a 2-fold increase in her9 expression and the DEAB treated heads having a 3-fold decrease in her9 
expression when compared to the control group (Figure 3.6). The her9 expression changes observed 
with treatment of both DEAB and RA were consistent and significant across all biological replicates. 
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Figure 3.5: Expression of her9 in the retina is downstream of retinoic acid signaling. A) WISH showing 
her9 expression in 36 hpf embryos treated from 24-36 hpf with the DMSO vehicle control. B) WISH 
showing her9 expression is decreased at 36 hpf when the embryo is treated from 24-36 hpf with the RA 
signaling inhibitor, DEAB. C) Expression of her9 at 36 hpf is increased when RA is added to the embryo 
medium from 24-36 hpf. L, lens; CF, choroid fissure. 
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Figure 3.6: Her9 qPCR following RA and DEAB treatments. Quantitative RT-PCR shows her9 expression 
in the whole heads of 36 hpf zebrafish embryos following drug treatments from 24-36 hpf shows that 
compared to DMSO controls, her9 expression in the heads of 36 hpf zebrafish increases when RA 
signaling increases, and decreases when RA signaling is inhibited by DEAB. N=20 heads per biological 
replicate, 3 biological replicates per drug treatment. Error bars = standard deviation, *=P<0.05. 
 
3.3.4 RA signaling influences vasculogenesis in the embryonic zebrafish retina.  
 Fluorescent in situ hybridization (FISH), and anti-GFP immunohistochemistry (IHC) experiments 
were performed on retinal sections of fli1:EGFP embryos that were treated with RA, DEAB, or DMSO to 
visualize the change in her9 expression in sections, as well as to determine if there were any retinal 
vasculature defects when RA signaling is pharmacologically manipulated. As with the WISH experiments, 
there was an obvious decrease in her9 expression when RA signaling was inhibited, and an increase in 
the RA treated retina compared to controls (Figure 3.7). IHC to visualize vascular endothelial cells 
revealed a decrease in retinal vasculature in the DEAB treated group, and a striking increase in the 
number of ectopic blood vessels in the RA treated retinas (Figure 3.7). Interestingly, the ectopic 
vasculature was expanded throughout the central retina, not just in the choroid. QPCR experiments 
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were performed on cDNA pools made from RNA from the heads of the drug treated embryos to quantify 
the expression levels of vascular endothelial growth factor receptor 2 (vegfr2), a marker for vasculature 
endothelium. In agreement with the IHC data, vegfr2 expression increased in the RA treated group, and 
decreased in the DEAB treated embryos when compared to controls (Figure 3.8). The expression of 
vegfr2 was consistent across all biological replicates. 
 
Figure 3.7: Retinal vasculature following RA and DEAB treatment. Fluorescent in situ hybridization 
(FISH) and anti-GFP immunohistochemistry (IHC) in the fli1:EGFP background reveals that along with 
her9 expression, retinal vasculature development is directly affected by transient manipulation of the RA 
signaling pathway. A-A’’’) FISH and IHC on embryos treated with DMSO control from 24-36 hpf. B-B’’’) 
FISH and IHC on embryos treated with the RA signaling inhibitor DEAB show a decrease in her9 
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expression and a decrease in retinal vasculature. C-C’’’) FISH and IHC on embryos treated with RA show 
increased her9 expression and ectopic retinal vasculature. L, lens; CF, choroid fissure; Scale bar, 50 µm. 
 
 
Figure 3.8: Vegfr2 qPCR following RA and DEAB treatments. Quantitative RT-PCR shows vegfr2 
expression in the whole heads of 36 hpf zebrafish embryos following drug treatments from 24-36 hpf. 
Quantitative RT-PCR shows vegfr2 expression in the whole heads of 36 hpf zebrafish embryos following 
drug treatments from 24-36 hpf demonstrating that compared to DMSO controls, vegfr2 expression in 
the heads of 36 hpf zebrafish increases when RA signaling increases, and decreases when RA signaling is 
inhibited by DEAB. These data correlate with the observed changes in retinal vasculature during the 
drug treatments. N=20 heads per biological replicate, 3 biological replicates per drug treatment. Error 
bars = standard deviation, *=P<0.05. 
 
3.3.5 Morpholino mediated knockdown of her9 results in reduced retinal vasculature, and overexpression 
results in ectopic blood vessels in the retina 
 To assess the contribution of her9 to retinal and/or retinal vasculature development, a 
morpholino mediated knockdown strategy was used to knockdown expression of her9 in the developing 
zebrafish embryo (Nasevicius and Ekker, 2000). A morpholino designed to block translation (tbMO) of 
her9 mRNA (Table 3.1) was injected into 1-cell stage fli1:EGFP zebrafish embryos at various 
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concentrations to determine a usable dosage. At 3 ng/embryo, survivability of the her9 morphants was 
similar to the control-MO (cMO) injected embryos at the same dosage, however there was a range of 
morphant phenotype severity by 48 hpf (Figure 3.9A-D). Upon close examination ~30% of the embryos 
had mild, ~40% moderate, and ~30% severe morphant phenotypes, and the moderate category was 
selected for further analysis. When compared to the cMO injected embryos, the her9 morphant retinas 
had significantly less retinal vasculature at the same time point (Figure 3.9C’’). 
 
Figure 3.9: Knockdown of her9 using the her9-tbMO. A) Control embryos injected at the 1-cell stage 
with 3 ng/embryo of the std-ctrl morpholino. B-D) Injection of 3 ng/embryo of the her9 translation 
blocking morpholino results in a range of morphant phenotype severity. A’-A’’) Fli1:EGFP signal in the 
normal looking zebrafish control-MO retina. C-C’’) Fli1:EGFP signal in the her9 morphants ranked as 
“moderate” severity shows highly abnormal retinal vasculature phenotypes. L, lens; Scale bar, 50 µm. 
 
 To assess the specificity of the her9-tbMO, in vitro transcribed her9 mRNA (missing the her9-
tbMO binding site was co-injected at 1.5 ng/embryo with the tbMO into fli1:EGFP embryos. Addition of 
the capped her9 mRNA rescued the morphant phenotype (data not shown). Interestingly, however, 
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when injected alone, the addition of 1.5 ng/embryo of her9 mRNA resulted in ectopic and expanded 
retinal vasculature domains when compared to uninjected control fli1:EGFP embryos (Figure 3.10). 
 
Figure 3.10: Overexpression of her9. Injection of 1.5 ng of capped her9 mRNA results in ectopic 
expression of vascular endothelium and expanded vasculature domains in the retina. UIC, uninjected 
control; L, lens; Scale bar, 50 µm. 
 
To further verify that the observed vasculature defect phenotype observed in the her9-tbMO 
morphant retina, a second morpholino was used to block splicing of her9 pre-mRNA (her9-sbMO) (Table 
3.1). Unlike the tbMO, however, injection of even high doses (10 ng/embryo of the sbMO) did not result 
in any obvious retinal defects by 48 hpf (Figure 3.11A). RT-PCR analysis was used to confirm that the 
her9-sbMO was capable of blocking splicing of her9 pre-mRNA (Figure 3.11B). RT-PCR analysis at 2, 4, 
and 48 hpf revealed the presence of significant amounts maternal deposition of spliced her9 mRNA 
before the onset of zygotic transcription which occurs slightly after 4 hpf (Figure 3.11C). This could 
explain the lack of any observable retinal vasculature defect phenotype when the sbMO was used. 
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Figure 3.11: The her9-sbMO morphant does not have a retinal phenotype. A) Unlike the her9-tbMO, 
injection of high doses (10 ng/embryo of the sbMO) did not result in any obvious retinal defects by 48 
hpf B) RT-PCR analysis was used to confirm that the her9-sbMO was capable of blocking splicing of her9 
pre-mRNA C). RT-PCR analysis at 2, 4, and 48 hpf shows significant maternal deposition of spliced her9 
mRNA before the onset of zygotic transcription which occurs slightly after 4 hpf. L, lens; Scale bar, 50 
µm. 
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3.4 Discussion 
 A previous microarray and subsequent validation by qPCR showed that there was around a 4-
fold increase in expression of her9 in the mature XOPS:mCFP retina, which constitutively undergoes rod-
specific degeneration and regeneration. These data suggested that her9 might play a role in 
photoreceptor regeneration or maintenance of photoreceptor progenitor cell pools similar to what was 
observed with her4 (HES5 in mammals) (Wilson et al., 2016). Additionally, because HES1 (the 
mammalian homolog of her9) is commonly used for a read-out of activated Notch-Delta signaling in 
mammals, we thought it could be possible that Notch signaling influences her9 expression in the retina, 
though it is known to be downstream of other regulatory pathways (Bmp, Nodal, Hh, RA) in other 
tissues during development. However, our results show that in fact retinal expression of her9 is not 
dependent upon the Notch pathway, but RA signaling. 
 In the adult wild type retina, her9 expression could not be detected anywhere in the central 
retina or CMZ by colorimetric in situ hybridization. There are her9 expressing cells, however, in the 
XOPS:mCFP CMZ as well as in discrete pockets of cells in the choroid. It is possible that the her9-
expressing cells belong to the choroidal vasculature network which may be expanded in the XOPS:mCFP 
eye due to the high metabolic needs of constant rod photoreceptor turnover; however, further studies 
are needed to determine if this is the case. The purpose of the small populations of her9-expressing cells 
in the CMZ of the XOPS:mCFP retina also remains unclear. 
 In the developing retina, the spatiotemporal expression pattern of her9 overlapped with 
location and development of the hyaloid artery in the choroid fissure and the lens basket vasculature 
adjacent to the CMZ. FISH experiments performed in the fli1:EGFP zebrafish showed that expression of 
her9 near the CMZ and in the choroid fissure co-localized with the EGFP reporter, indicating that her9 is 
expressed in retinal vasculature tissue. This unexpected result suggested that her9 could be playing a 
role in development of the retinal vasculature network. The gene regulatory network for retinal 
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vasculogenesis in the zebrafish has been partially described, and this novel finding could place her9 
within that network. 
 In order to determine what signaling pathway(s) regulate her9 expression in the retina, drugs 
were used to transiently knockdown candidate pathways during retinal development. Pharmacological 
inhibition of Notch-Delta, Hh, and Fgf signaling pathways from 24-36 hpf (after the eye field and lens 
primordia have already been established) did not result in altered her9 expression in the retina (data not 
shown). In contrast, her9 expression in the retina was sensitive to RA signaling. Addition of RA resulted 
in increase of her9 expression and an expansion of the expression domains in the developing retina, and 
inhibition of RA signaling resulted in a decrease of her9 expression. In addition, transient RA treatment 
or inhibition resulted not only in up- or down-regulation of her9, but greatly affected the retinal 
vasculature network. These data indicated that not only was her9 regulated by RA signaling in the retina, 
but also that exposure to retinoic acid or a drug that inhibits RA signaling during a transient window 
when the retinal vasculature develops in the zebrafish is enough to modulate her9 expression and 
influence vasculogenesis. 
 Morpholino mediated knockdown of her9 using a translation blocking morpholino (her9-tbMO) 
resulted in a decrease of vasculature endothelial cells in the retina compared to control embryos. 
Surprisingly, co-injection of in vitro transcribed capped her9 mRNA not only rescued the morphant 
phenotype, but injection of her9 mRNA alone resulted in excess retinal vasculature. These data indicate 
that her9, even independent of RA modulation, plays a role in development of the retinal vasculature 
network. In contrast to the retinal phenotype observed when using a relatively low concentration of the 
tbMO, injection of a splice blocking morpholino (sbMO), even at a high dose , failed to yield any 
appreciable retinal phenotype. Subsequent RT-PCR analysis showed that although the sbMO did indeed 
block splicing of her9 pre-mRNA, there was significant maternal deposition of mature her9 mRNA that 
can be seen before the transition to zygotic transcription. Along with the fact that her9 expression 
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completely subsides in the retina by 48 hpf, these data suggest that the amount of maternally deposited 
her9 mRNA is adequate to generate a phenotypically normal retina, even in the absence of zygotically 
produced mature her9 mRNA. 
 Taken together, these data demonstrate a novel role for her9 during zebrafish CNS 
development. The ability of her9 to regulate development of the retinal vasculature network 
downstream of RA signaling has not been previously shown, and adds another known role for this bHLH-
O transcription factor. In addition the possibility that manipulation of her9 could lead to changes blood 
vessel development in the retina of a patient experiencing one of the several ocular diseases that lead to 
retinopathy and vision loss is an exciting prospect that warrants further investigation. 
3.5 Materials and methods 
3.5.1 Zebrafish  
 All zebrafish (Danio rerio) strains were bred, raised, and maintained in accordance with 
established animal care protocols for zebrafish husbandry (Westerfield, 1995). Adult fish, embryos, and 
larvae were housed at 28°C, on a 14 hr light: 10 hr dark cycle. Embryos were staged as previously 
described (Kimmel et al., 1995). The Tg(XRho:gap43-mCFP)q13 transgenic line, hereafter called 
XOPS:mCFP, has been previously described (Morris et al., 2005, Morris et al., 2011). The 
Tg(fli1a:EGFP)y1Tg, hereafter called fli1:EGFP has been previously described (Lawson and Weinstein, 
2002b). All animal procedures were carried out in accordance with guidelines established by the 
University of Kentucky Institutional Animal Care and Use Committee (IUCAC). 
3.5.2 Drug treatments 
 24 hpf wild type or fli1:EGFP embryos were manually dechorionated and treated in 6-well plates 
with pre-warmed 1 µM retinoic acid with 0.3% DMSO in embryo medium, 100 µM of the RA signaling 
inhibitor diethylaminobenzaldehyde (DEAB) in 0.3% DMSO in embryo medium, or 0.3% DMSO alone as 
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the carrier control in complete darkness until 36 hpf when they were processed for WISH, or heads 
removed and processed for qPCR. 
3.5.3 RNA isolation 
 RNA was isolated from whole embryos at indicated developmental time points. Embryos and 
larvae were euthanized by rapid cooling as previously described (Wilson et al., 2009). RNA was extracted 
from pools of embryos using TRIzol Reagent (Life Technologies, Invitrogen), following the 
manufacturer’s protocol, then treated with RNAse-Free DNAse I (Roche, Indianapolis, IN) to remove 
genomic DNA. 
3.5.4 Morpholino and mRNA microinjections 
 A translation blocking antisense synthetic morpholino oligonucleotide (tbMO) was designed to 
target sequence immediately upstream of the her9 start site (table 3.1). Another morpholino designed 
block pre-mRNA splicing (sbMO) of the first her9 intron was also used to assess off target effects of 
either morpholino (table 3.1). The tbMO was injected at a concentration of 3 ng/embryo, and the sbMO 
was injected at a concentration of 10 ng/embryo. A standard control MO, targeting a targeting a mutant 
variant of the human β-globin gene (Table 3.1) was used as dosage matched injection controls. All 
morpholinos were synthesized by GeneTools, LLC (Philomath, OR). A her9 cDNA amplicon was generated 
from forward and reverse primers that contained 5’ restriction sites (Table 3.1) and cloned into pGEM-
TE. Capped mRNA was synthesized using the mMessage T7 kit (Ambion, Austin, TX) according to 
manufacturer’s instructions and purified by phenol-chloroform extraction and ethanol precipitation. The 
morpholinos, mRNA (at 1.5 ng/embryo), or a combination of the morpholino and mRNA were injected at 
a volume of 4.18 nl/embryo in buffered solution with 0.025% dextran red (as an injection indicator) into 
the yolk of 1-cell stage zebrafish. 
3.5.5 Reverse transcriptase PCR (RTPCR) 
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 Following embryo collection and RNA extraction at 36 hpf, approximately 500-1000 ng of RNA 
derived from the heads of the embryos only was reverse transcribed into cDNA (GoScript Reverse 
Transcriptase System, Promega, Madison, WI) according to the manufacturer’s instructions. PCR 
reactions were then performed using primers designed to amplify her4 and atp5h (housekeeping 
control) cDNA transcripts (Table 3.1). 
3.5.6 Immunohistochemistry 
 Whole embryos were collected at 72 hpf and fixed overnight in 4% PFA at 4°C. Fixed embryos 
were cryoprotected in 10% sucrose in PBS for at least 3 hours and in 30% sucrose overnight at 4°C. 
Samples were mounted in OCT Medium (Ted Pella, Redding, CA) and frozen on dry ice. 10 µm sections 
were cut on a cryostat (Leica CM 1850 or CM 1800, Leica Biosystems, Buffalo Grove, IL), mounted on 
gelatin-coated slides, and dried overnight at room temperature. Before immunolabeling, sections were 
rehydrated and postfixed in 1% PFA for 10 minutes at room temperature. After 2 washes in PBS, and 2 
washes in PBST, sections were blocked in PBST containing 1% BSA for at least 30 minutes at room 
temperature. Slides were incubated with anti-GFP (rabbit, 1:1000, Millipore, Billerica, MA) primary 
antibody in PBST/BSA with 5% Normal Goat serum, overnight at 4°C in a humidified chamber. The 
following day, slides were washed 3 times in PBST, and incubated with secondary antibody  (Alexa fluor-
conjugated secondary antibodies (Invitrogen, Grand Island, NY) and Cy-conjugated secondary antibodies 
(Jackson ImmunoResearch, West Grove, PA) were all used at a dilution of 1:200) in PBST/BSA for 1 hour 
at room temperature in the dark. Slides were washed 2 times with PBST, counterstained with DAPI (4’, 
6-diamidino-2-phenylindole, 1:10,000 dilution; Sigma-Aldrich) in PBS, and mounted in 40% glycerol in 
PBS. Images were obtained on an inverted fluorescent microscope (Eclipse Ti -U; Nikon Instruments. 
3.5.7 Whole mount in situ hybridization (WISH) and fluorescent in situ hybridization (FISH)  
 WISH, FISH, and two color FISH were performed as previously described (Forbes-Osborne et al., 
2013, Pillai-Kastoori et al., 2014). Antisense RNA probes were prepared by in vitro transcription of 
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linearized plasmids containing a portion of the coding sequence of the gene of interest using T7 
polymerase and digoxigenin (DIG) or fluorescein (FITC) labeling mix (Roche Applied Science, Indianapolis, 
IN). The her9 containing plasmids were prepared by cloning PCR products into the pGEM-T-easy vector 
(Promega, Madison, WI). The sequences of all PCR primers used in this study are presented in (Table 
3.1). Images were obtained on an inverted fluorescent microscope (Eclipse Ti -U; Nikon Instruments), 
and were exported into Adobe Photoshop for figure preparation. 
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Chapter 3 Tables 
Table 3.1: Chapter 3 oligo sequences and application: 
oligo name oligo sequence use 
her9 forward CCTGACGGAGAACTGAACACAAGACACACA RT-PCR/ISH 
her9 reverse TTTCTCAATGGTACGGCGGGTGCTCTGGGC RT-PCR/ISH 
atp5h forward TGCCATCTCAGCAAAACTTG RT-PCR/qPCR 
atp5h reverse CACAGGCTCAGGAACAGTCA RT-PCR/qPCR 
her9 coding forward AAGCTTCCTGACGGAGAACTGAACACAAGACACACA cDNA plasmid 
her9 coding reverse GAATTCTTTCTCAATGGTACGGCGGGTGCTCTGGGC cDNA plasmid 
her9 forward CTCAGCAAGTACCGCGCAGGAT qPCR 
her9 reverse TCCCATACAACCGGACAGGTGG qPCR 
vegfr2 forward ACTATTGATGAGAGGCAAGGGCC qPCR 
vegfr2 reverse AAAGGGTGCTGGAACTCCATACG qPCR 
her9-tbMO CTCCATATTATCGGCTGGCATGATC morpholino 
her9-sbMO GTGATTTTTACCTTTCTATGCTCGC morpholino 
std-Ctrl-MO CCTCTTACCTCAGTTACAATTTATA morpholino 
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Chapter 4: Generation and validation of zebrafish her9 mutant lines using clustered regularly 
interspaced short palindromic repeats (CRISPR/Cas9 nuclease) technology  
 
KEYWORDS: Her9, HES1, CRISPR, Cas9, Zebrafish, Retina 
4.1 Abstract 
 Previous morpholino-mediated knockdown studies have indicated that the zebrafish her9 gene 
plays a role in development of the retinal vasculature. However, her9 mutant lines are not available to 
the research community. Until recently, the only wide-spread reverse genetic tools that could be used in 
the zebrafish with varying degrees of success have been anti -sense synthetic morpholino 
oligonucleotide technology. Although morpholinos allow for relatively rapid study of gene function, they 
only transiently knock down gene expression during early development do not cause permanent genetic 
lesions, which may prove to be insufficient in the study of many genes. Recently, new reverse genetic 
approaches have been developed in which the gene of interest is knocked out rather than transiently 
knocked down by inducing targeted genetic lesions, allowing not only for study of gene function during 
embryonic development, but throughout the life of the zebrafish. Here, we discuss using the 
CRISPR/Cas9 genome editing technology to generate various mutant her9 zebrafish lines, validate the 
mutant lines result in a predicted non-functional gene product, and describe preliminary 
characterization of the early her9 mutant phenotype. 
 
4.2 Introduction 
4.2.1 Forward and reverse genetic approaches in the zebrafish 
 Classical forward genetic screens have long been used with great success in Drosophila, 
however, finding mutations in vertebrates is a much slower process. One of the advantages to using the 
zebrafish as a model organism is that the zebrafish has remarkably high fecundity for a vertebrate. In 
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addition, due to the rapid external development of the optically transparent embryo, mutations are 
relatively easy to identify. One of the great benefits of a forward genetic screen is that it results in an 
unbiased mutagenesis approach that can uncover functions of novel genes (or previously undescribed 
cis-regulatory elements). Numerous mutant lines in which previously unknown genes have been 
discovered have already been made available to the zebrafish research community by use of l arge scale 
forward genetic screens (Driever et al., 1996). 
 With the relatively recent advance of automated DNA sequencing, large volumes of genomic 
sequence data have been rapidly generated from numerous types of organisms. These data sets contain 
sequences of genes with known functions in specific organisms that yield specific phenotypic traits, but 
unknown functions in other species. In addition, much of this large scale sequence data contain 
sequences with no known biological role. Although targeted genome editing by homologous 
recombination to generate a wide variety of knockout and knock-in lines has been extensively used in 
several different vertebrates, it requires the ability to readily culture embryonic stem (ES) cells (Babinet 
et al., 1989, Baribault and Kemler, 1989), something that has proven to be difficult to accomplish 
efficiently in zebrafish (Fan and Collodi, 2006). New targeted genome editing techniques that have been 
developed now allow for reverse genetic approaches to elucidate the biological function of sequences of 
interest in the zebrafish. 
 Since the early last decade, injection of synthetic antisense morpholino oligonucleotides into 1-
cell stage zebrafish embryos has given researchers a quick, inexpensive, and high-throughput method of 
targeted gene knockdown, without tissue specific effects as observed with RNA-based interference 
methods (Nasevicius and Ekker, 2000). Unlike a mutant, however, morpholino mediated approach to 
study gene function only results in transient knockdown of the target gene during early development; 
the morpholino concentrations in each cell gets too diluted to be effective as the animal grows and 
more cell division takes place. This results in morpholino based knockdown approaches being 
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insufficient for the study of specific genes that function late in embryonic development or in the adult 
zebrafish. In addition, maternal effect (if a splice blocking morpholino is used) as well as off target 
effects have been shown to result in a morphant phenotype that does resemble the knockout 
phenotype of the same gene (Kok et al., 2015). 
 Zinc finger nucleases (ZFNs) were the first artificial restriction enzymes that allowed for the 
custom nuclease-targeted genome engineering approach to be used in the zebrafish. ZFNs have a 
modular architecture composed of multiple three-base recognition motifs consisting of about 30 amino 
acid residues that are assembled together that make up the zinc finger DNA-binding domain. The non-
specific cleavage domain is from the FokI restriction endonuclease that non-specifically cuts DNA when 
dimerized to another FokI domain. When assembled (which is a non-intuitive and rather laborious 
process), the zinc finger domain binds to a target sequence in the zebrafish genome which is then cut by 
the FokI domain after a second ZFN (targeted to the complimentary strand) also binds and the two FokI 
domains dimerize. After the cleavage of the DNA at the target site, error prone  double stranded break 
(DSB) repair pathways introduce random alterations in the DNA sequence. ZFN technology has not 
proven to be extremely useful for many research labs due to difficulty of product ion, high costs, and low 
efficacy in editing the zebrafish genome due to poor target recognition and off target cutting (Blackburn 
et al., 2013). 
 Transcription activator-like effector nucleases (TALENs) were built upon a DNA binding system 
from a group of bacterial plant pathogens and improved the custom nuclease technology by greatly 
expanding targeting flexibility, cutting efficiency, and target specificity. Importantly, TALEN technology is 
open source and relatively easy to produce, providing zebrafish laboratories with affordable genome 
editing tools that can be made rapidly at low cost. TALENs are made up of repeat module s of 
approximately 34 amino acids organized into TAL effector arrays. A two amino acid sequence within 
each repeat module forms the variable di-residue (RVD), and unlike the 3 base recognition ability of a 
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zinc finger, RVDs exhibit one-one base pairing, resulting in much higher target sequence flexibility 
(Bogdanove and Voytas, 2011). Like ZFNs, TALENs utilize FokI homodimers to introduce DSBs in their 
targets.  
4.2.2 The CRISPR/Cas9 system  
 The newest method of targeted genome editing which has exploded in popularity within the last 
2-3 years is the clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-
associated systems (Cas) (commonly referred to as CRISPR/Cas systems) which are derived from bacteria 
and archaea and constitute a form of adaptive immunity in these microbes (Wiedenheft et al., 2012). 
The CRISPR system relies on the incorporation of exogenous plasmid DNA and phage sequence into 
spacer regions of the bacterial genome flanked by short palindromic repeats which are cleaved and 
transcribed into CRISPR RNAs (crRNAs). The crRNAs contain sequences that are complimentary to the 
target sequence on the invading phage, and when the crRNAs form a complex with Cas DNA nucleases 
and the target DNA sequence, DSBs are generated. There are three categories of CRISPR/Cas systems 
found in bacteria and archaea (Wiedenheft et al., 2012). 
The type II CRISPR system is the most useful for genome editing because it involves a 
transactivating CRISPR RNA (tracrRNA) and crRNA that readily assemble into a complex with the Cas9 
endonuclease (Deltcheva et al., 2011). The crRNA contains a spacer sequence that determines the target 
DNA sequence and binds on either strand next to a NGG-trinucleotide protospacer adjacent motif (PAM) 
that is required for recognition of the target sequence. Cas9 then cuts both strands of DNA within the 
target sequence resulting in DSBs and subsequent error prone DSB repair (Jinek et al., 2012). 
Similar to the type II CRISPR system found in nature, the CRISPR/Cas9 genome editing method 
only requires a dual-RNA structure consisting of a tracrRNA and crRNA duplex (hereafter referred to as 
guide-RNA or gRNA) that has been designed to target a gene of interest as well as Cas9 mRNA to be 
synthesized. After injection of the gRNA and Cas9 mRNA into an embryo, the sequence in the gRNA that 
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is complimentary to the target site recognizes the target sequence adjacent to the PAM site. After 
binding, the gRNA associates with Cas9 which results in DSB usually 4-6 bp upstream of the PAM site 
(Jinek et al., 2012). 
The CRISPR/Cas9 genome editing system has been show to work with very high efficiency and 
good specificity in a wide variety of organisms, including zebrafish, at a very low cost and rapid 
development rate. In addition, the system has quickly matured to where libraries of zebrafish specific 
donor plasmids and zebrafish codon optimized Cas9 plasmids are available to the research community.  
Compared to other techniques available, the Cas9/gRNA system is considerably easier to develop and 
implement. Unlike the comparatively complicated assembly of the TAL effector array in the TALEN 
system, in which a more sophisticated recombination based cloning method must be used to make the 
expression construct, the only synthesis involved is of specific gRNA ol igo pairs of ~100 nucleotides 
(which are then easily ligated into existing donor vectors) and a Cas9 expression plasmid. Many groups 
have been very successful at creating a variety of genetic lesions using this system (Jao et al., 2013, Ni et 
al., 2014, Hisano et al., 2015). 
In this study, I designed two gRNAs that target her9 in order to make stable her9 mutant lines 
that would result in loss of gene product in order to study the function of her9 in the developing retina 
as well as the adult. In addition, I developed a CRISPR/Cas9 based method to knock-in a mCherry 
reporter to the endogenous her9 locus (which would also result in loss of her9 gene function). 
 
4.3 Results 
4.3.1 Design and generation of CRISPR/Cas9 constructs 
 In order to use the CRISPR/Cas9 targeted genomic editing system to knockout her9, I designed 
two single-stranded guide RNAs (gRNAs) that were complimentary to specific sequences within the her9 
coding region hereafter referred to as her9 CRISPR 1 and her9 CRISPR 2 (Figure 4.1). Her9 CRISPR 1 was  
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Figure 4.1: CRISPR targets in the her9 genomic locus. The her9 locus contains 3 exons spanning 1786 bp 
on linkage group 23. The first CRISPR target site is 54 bp 3’ of the translation start site, and 46 bp 
upstream of the beginning of the bHLH domain. The second CRISPR target site is just after the end of the 
Orange domain in exon 3. 
 
designed to target a region of exon 1 ~50 bp 3’ of the start codon and before the basic DNA binding 
domain in the bHLH motif. CRISPR 2 was designed to target a site near the middle of the coding region, 
just after the Orange domain. CRISPR gRNAs were synthesized by direct in vitro transcription (IVT) from 
a restriction digest fragment produced from a donor vector that contained the synthetic oligos. 
Zebrafish codon optimized and nuclear localized cas9 mRNA was also made by IVT. 
 To verify that the cas9 mRNA was effective (as well as to demonstrate that we could make gRNA 
properly), we first tested the efficiency of CRISPR/Cas9 targeted gene editing in our hands by creating 
mosaic “sandy” zebrafish by targeting the tyrosinase gene, which encodes an enzyme required for 
melanin synthesis and normal pigment formation (Jao et al., 2013). Injection of 50 pg/embryo of the 
tyrosinase gRNA and 150 pg/embryo of nls-zCas9-nls mRNA resulted in a range of “sandy” zebrafish with 
various degrees of pigment loss in a mosaic fashion, and genomic lesions in the tyrosinase allele were 
also verified by high resolution melting analysis (HRMA) and sequencing (data not shown).  
4.3.2 Injection of her9 gRNA and Cas9 results in her9 gene disruption in F0 embryos 
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 CRISPR/Cas9 mutagenesis of her9 should result in different mixtures of mutant and wildtype 
alleles in the mosaic F0 embryos regardless of whether the gRNAs are injected together or 
independently. The small amplicons generated during single embryo F0 HRMA analysis will contain wild 
type and various different mutant sequences that were amplified from different cells, resulting in 
heteroduplex DNA which will melt at a lower temperature than wild type homoduplex DNA due to 
improper base pairing. Whenever heteroduplex DNA was detected in F0 embryos by HRMA, pools of the 
PCR product from that single embryo (using the same HRMA primers) were ligated into a sequencing 
vector and sequencing was performed on a minimum of 10 colonies. Because half of the HRMA 
amplicons are expected to be wild type from heteroduplex DNA (and these were not F1 heterozygote 
embryos but F0 mosiacs, so the ratio will be much lower than 50% mutant to wild type amplicons) 
sequencing multiple samples from the same single embryo increased the chances of detecti ng mutant 
variants of her9 from sequencing). 
 
Figure 4.2: HRMA analysis in CRISPR injected F0 embryos. A-A’) PCR products (HRMA amplicons) from 
whole embryo genomic DNA extracts of CRISPR 1 gDNA + nls-zCas9-nls mRNA injected embryos show a 
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variety of melting curves due to mosaicism compared to uninjected controls. B-B’) HRMA showing 
melting curves generated when using CRISPR 2 + nls-zCas9-nls mRNA compared to uninjected controls. 
C) Genetic lesions in the her9 CRISPR 1 target site recovered from F0 mosaic embryos. D) Only 1 genetic 
lesion was recovered from CRISPR 2 F0 mosaic embryos (10 sequencing reactions total).  
 
Injection of 50 pg/embryo of the her9 gRNA and 150 pg/embryo of nls-zCas9-nls mRNA into 1-
cell stage fli1:EGFP embryos (which express the EGFP reporter in vasculature endothelial cells) resulted 
mosaic expression of numerous her9 alleles that harbored various genetic lesions when using CRISPR 1 
(as demonstrated by HRMA analysis and sequencing), but few mutations were observed when CRISPR 2 
was injected (Figure 4.2A-D). In addition, retinal vasculature defects were observed in the F0 mosiac 
embryos injected with CRISPR 1, but only a small percentage of the F0 CRISPR 2 injected embryos had 
any phenotypic abnormalities at all at 24 hpf (Figure 4.3A-B), and the few (~5% compared to uninjected 
controls) CRISPR 2 embryos observed that were delayed could be attributable to the injection/rearing 
process itself rather than mosaic knockout of her9. By 48 hpf, the CRISPR 1 F0 embryos still had ocular 
defects like micropthalmia and coloboma as well as decreased retinal vasculature and the CRISPR 2 
embryos looked phenotypically normal (Figure 4.3C-D). In addition to the retinal vasculature phenotype 
observed in the CRISPR 1 F0 embryos, ~15-20% had defective vascular networks in the tail that looked 
like bulbs of expanded vasculature tissue at 48 hpf (Figure 4.4). Blood cells could be easily observed 
pooling up in the bulb region, however, blood was still flowing through the tail region and the moving 
cells were either bumping off of or flowing around the anterior portion of the pooled blood cells. This 
defect was not observed in any of the CRISPR 2 F0 embryos. 
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Figure 4.3: Retinal phenotypes observed in F0 mosaic embryos. A-A’’) Brightfield images of uninjected 
control (UIC) and her9 CRISPR injected embryos at 24 hpf show ocular defects in the CRISPR injected 
embryos. B-B’’) Fli1 reporter shows abnormal retinal vasculature in the CRISPR 1 F0 but not in the 
CRISPR 2 F0 compared to the UIC. C-C’’) The 48 hpf CRISPR 1 F0 eye is microphthalmic and has 
coloboma, while the CRISPR 2 F0 eye is only slightly smaller than the UIC eye. D-D’’) Fli1 signal shows 
that the CRISPR 1 F0 eye has abnormal retinal vasculature at 48 hpf while vasculature in the CRISPR 2 
eye closely resembles the vasculature in the UIC eye. 
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Figure 4.4: Vasculature defects in the her9 CRISPR F0. The 48 hpf her9 CRISPR 1 F0 displays defective 
tail vasculature in ~15% of the F0 embryos observed. The circulatory system was still functional, but 
bulbs of expanded vasculature endothelial cells held pools of blood cell near the tail.  
 
When considering the contrast in the observed F0 mosaic phenotypes between the two 
CRISPRs, these data suggest that CRISPR 1 was more effective at creating genetic lesions in the her9 
allele than CRISPR 2. This could simply be due to the higher binding affinity of gRNA 1 to the target 
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sequence than gRNA 2. Due to this, for the remainder of the study, only her9 CRISPR 1 was used for 
mutagenesis of the her9 gene. 
4.3.4 Identification of F0 founder zebrafish that transmit mutant her9 alleles in the germline 
 To determine if CRISPR/Cas9 generated genetic lesions in her9 were heritable, putative F0 
founders were screened to not only determine if they were transmitting a mutant her9 allele in their 
germline, but to also characterize the type of mutant allele being transmitted. Since these were mosaic 
fish, a single F0 could be transmitting several different types of mutant her9 alleles (or only wild type). 
 Putative F0 founders were outcrossed to fli1:EGFP fish (to maintain this useful reporter in the 
mutant background), and single embryos were then used for HRMA analysis. It has been reported that 
the CRISPR/Cas9 mutagenesis approach typically yields 1-10% germline transmittance of targeted 
mutant alleles (Blackburn et al., 2013). Unlike the HRMA analysis in F0 mosaics, the majority of the 
embryos were expected to be wild type and have a similar melting curve as control groups  (all 
homoduplex DNA), and when heteroduplex amplicons were detected in single embryos, likely the other 
mutant embryos in that group would share the same melting curve as they would likely be sharing the 
same mutation. Although the majority of the putative F0 founders screened did not transmit any mutant 
variants of her9 in the germline (36/46 total F0s screened at ~100 embryos from each potential 
founder), 10 F0 fish were recovered that transmitted a her9 mutation in the germline. Nine of the 
founders transmitted 1 mutant her9 allele, and 1 founder was found by HRMA to transmit 2 different 
mutant her9 alleles in the germline (Figure 4.5). 
 After identifying a founder by HRMA, the genomic DNA of the F1 embryo used for the HRMA 
experiments was used as a template for PCR. The PCR amplicons were ligated into sequencing vectors 
and a minimum of 6 clones were sequenced from each HRMA positive embryo to identify the wild type 
and mutant her9 sequences from each HRMA positive F1. Interestingly, the first 7 germline transmitting 
mutant her9 sequences recovered were all deletions in multiples of 3 (ranging from 6-36 nucleotides) 
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Figure 4.5: HRMA identifies mutant her9 alleles transmitted in the germline to F1 embryos. A-B) 
Normalized melting peaks (A) and difference plot (B) of the her9 CRISPR 1 HRMA amplicon from 
individual F1 embryos shows the wild type her9 curve (blue arrow) and a single her9 mutant allele 
passed in the germline from the F0 founder to several F1 embryos. C-D) Normalized melting peaks (A) 
and difference plot (B) of her9 CRISPR 1 HRMA amplicon from individual F1 embryos shows a grouping 
of the wild type allele (blue arrow), however this F0 transmits two mutant her9 alleles in the germline 
(red arrows). 
 
 
 
Figure 4.6: Sequence of the target site of CRISPR 1 F1 her9 carrying mutants. A) The first seven 
germline transmitted her9 mutant alleles recovered were all in-frame deletions that would lead to a 
slightly truncated protein, but not affect any of the functional domains and likely result in functional 
her9 gene product. B) The next three mutant her9 alleles recovered that were transmitted in the 
germline produce early frameshift deletion and truncated proteins. 
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(Figure 4.6). This early result raised the concern that the frame-shifting mutations in her9 might result in 
haploinsufficiency (and would therefore not be recovered) given that there is a less than 0.05% chance 
that the first seven germline transmitting mutants identified would all have in-frame deletions. 
However, the next three mutations uncovered were a 1 bp deletion, a 1 bp insertion, and a 10 bp 
insertion in three different F0 fish that resulted in early frameshift mutations of the her9 gene (Figure 
4.6).  
4.3.5 Identification of germline transmitting F1 and F2 her9 mutant zebrafish 
The frameshift mutant F0 founders were then repeatedly outcrossed to the fli1:EGFP line and 
the resulting F1 embryos were raised to adulthood. Tail clips were performed on individual F1 fish and 
genomic DNA was extracted for genotyping. The 1 bp deletion mutation in the her9 gene (progeny of 
the F532.4 F0 founder) can be identified by restriction fragment length polymorphism (RFLP) analysis 
due to a BsaJI restriction site being introduced into the gene by the 1 bp deletion mutation. Fortunately, 
the F532.4 F0 founder not only had the highest fecundity of the 3 out-of-frame her9 mutation carrying 
fish, but also the highest germline transmission rate. Seven heterozygous her9 mutant F1 fish were 
recovered that harbored the 1 bp deletion and were used to generate ~100 F2 fish from both incrosses 
and outcrosses of F1s (as of this writing, only 1 heterozygous F1 fish carrying the 1 bp insertion mutation 
has been recovered; numerous F2 fish from that line have been generated, but not screened). The 
remainder of this chapter will focus on the 1 bp deletion line. 
Another benefit of using RFLP rather than the more expensive HRMA analysis method to screen 
for mutants, is that although HRMA analysis is very good at distinguishing between homo- and hetero-
duplex amplicons, this method is not very sensitive when distinguishing between homoduplex (1 bp 
deletion) mutant and homoduplex (wild type) amplicons of the same length. Although the sequences 
between the two PCR products are different at one nucleotide, their respective melting curves are much 
closer than that of heteroduplex DNA. On the other hand, RFLP analysis, when possible, is the far better 
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choice when screening F2 embryos or adults resulting from heterozygous F1 (Figure 4.7A). As shown in 
figure 4.7B, when F2 embryos resulting from F1 incrosses were screened by HRMA alone, the majority of 
the time the homozygous mutant and homozygous wild type embryos grouped together due to highly 
similar melting curves, while only the heterozygous carriers with heteroduplex amplicons grouped 
differently (Figure 4.7B). 
 
Figure 4.7: RFLP and HRMA analysis to identify 1 bp deletion her9 mutant F1 and F2 fish. A) 556 bp 
PCR amplicons generated from genomic DNA template of F1 and F2 zebrafish digested with BasJI. The 
her9 homozygous wild type, homozygous mutant and heterozygous fish are all easily distinguishable 
from each other by RFLP analysis. B) Heterozygous fish are easily identified by HRMA due to the 
heteroduplex DNA, but the homozygous wild type and homozygous mutant fish grouped very closely 
together when performing HRMA analysis on F2 larvae and were nearly indistinguishable.  
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4.3.6 Her9 is required for survival past larval stages in the zebrafish 
 Due to the presence of maternal pre-spliced her9 mRNA deposited into the ovum, which 
masked the effect of the her9 splice-blocking morpholinos during embryonic development (discussed in 
chapter 3), I wanted to generate homozygous her9 mutant lines that I could then incross to observe the 
true phenotype of complete loss of her9 during early embryonic development. In particular, I was 
curious if the maternal zygotic mutant phenotype would recapitulate the various vasculature defect 
phenotypes that were observed in embryos that were injected with the her9 translation blocking 
morpholino. 
 To address this question and to generate to her9 homozygous mutant lines, F1 or F2 
heterozygote her9 mutant zebrafish (at the time only heterozygote F2 mutants had been recovered, or 
homozygous mutants would have been used) were repeatedly incrossed to various members of 
different families and the resulting offspring were grown to a stage where they could be safely tail -
clipped and genotyped by the RFLP screening procedure mentioned previously. Some of the individual 
zebrafish were adults when screened, but most were juveniles (3-6 weeks old). Surprisingly, after 
screening a total of 74 zebrafish derived from heterozygous incrosses, zero homozygous mutants were 
recovered, and instead the population of F2 juveniles and adults contained 46 heterozygous carriers, 
and 25 homozygous wild type fish. Assuming the her9 mutant allele would follow the simple 1:2:1 
Mendelian ratio for a heterozygous incross, I would have expected around ~18 homozygous wild type, 
~37 heterozygous, and ~18 homozygous mutants; and this obviously wasn’t the case  (χ² < p=0.0001). 
However, numerous homozygous mutant embryos were previously detected during the screening of 
initial F1 heterozygous incrosses conducted at 2-3 dpf. These results suggested that her9 homozygous 
mutant offspring were dying some time between 3 dpf and the juvenile stage. 
 During the normal rearing process of the zebrafish offspring, there is usually some degree of 
death at 24 hpf (primarily due to improper fertilization of the egg). In general, if an embryo survives past 
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24 hpf and into later larval stages, the survival rate is reasonably high (Westerfield, 1995). It has been 
observed, however, that some mortality occurs in all wild type strains around 13-14 dpf due to complete 
exhaustion of the yolk and starvation, usually of the larval zebrafish with the slowest grow rate. 
Whereas the offspring of her9 heterozygous mutant incrosses experienced approximately normal rates 
of survival at 24 hpf I noticed that there seemed to be unusually high mortality around ~10-14 dpf as 
compared to other lines our lab commonly uses. 
 To determine at what stage the her9 homozygous mutant larvae were dying, multiple her9 
heterozygous incrosses were set up using different families of het carriers. At 24 hpf, there were 132 
surviving embryos that all looked phenotypically normal. By 5 dpf, there were 116 surviving larvae 
(consistent with normal rearing of other lines). From this point on, the larvae were separated into 
groups of 10 in 6 well plates with embryo medium refreshed daily (and normal feeding routines). Any 
larvae that looked phenotypically abnormal (no swim bladder, misshapen body/head, small body size, 
etc.) or displayed abnormal behavior (laying on their side at the bottom of the plate, not responding to 
touch stimuli, etc.) were removed and processed for gDNA extraction/genotyping. Using these criteria, 
40 out of 116 total progeny (34.5%) of her9 heterozygous incrosses were classified as phenotypically 
abnormal. The abnormal larvae collected at 5 dpf had a curved body, excess yolk, heart edema, and 
were microphthalmic compared to normal looking larvae collected at the same time point (Figure 4.8A-
B). In addition, the abnormal looking larvae had severe vasculature defects including abnormal 
intersegmental vessel formation and incomplete connections of vasculature throughout the trunk 
(Figure 4.8B’-C’’). All larvae with abnormal phenotypic or behavioral characteristics were found to be 
her9 homozygous mutants, whereas the normal looking larvae collected at the same tie point were 
either homozygous wild type or heterozygous. The heads were dissected from the first batch of larvae 
that displayed the aforementioned abnormal characteristics at 5 dpf (after imaging and cataloging), then 
sectioned to closely visualize the retina (with the rest of the body processed for gDNA extraction), and  
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Figure 4.8: The her9 mutant phenotype. A) 5 dpf wild type zebrafish larvae. A’-A’’) Fli1 signal 
(vasculature endothelial cell reporter) showing normal intersegmental vessels for this stage. B) 
Compared to the wild type control, the 5 dpf her9 mutant larvae displays micropthalmia, increased yolk 
sac size, loss of swim bladder, and body curvature. B’-B’’) Fli1 signal shows severe vasculature defects 
including abnormal intersegmental vessel formation and incomplete connections of vasculature 
throughout the trunk. C-C’’) Retinal sections of the same 5 dpf wild type larvae from A shows normal 
lamination and retinal vasculature for that stage. D-D’’) The 5 dpf her9 retina has poorly laminated and 
has numerous morphological defects, including almost complete absence of retinal vasculature.  
 
processed for IHC along with wild type larvae to serve as controls (Figure 4.8C-D). The retinas of the 
homozygous mutant larvae were poorly laminated and had numerous morphological defects, including 
almost complete absence of retinal vasculature. 
After the initial 5 dpf collection, any abnormal larvae were collected daily and processed for 
genomic DNA until 14 dpf, when all of the remaining larvae were collected for DNA extraction.  Following 
the final collection and DNA extraction, RFLP analysis was conducted on all of the samples to determine 
genotype. Interestingly, abnormal looking larvae were only observed prior to 10 dpf,  with her9 
homozygous mutants accounting for 67% (n=27/40) of the embryos collected before this time point. 
From 10-14 dpf, no abnormal animals were observed, and 100% of the remaining larvae were either 
heterozygous or homozygous wild type (n=76). In summary, from a pool of 116 larvae at 5 dpf, 23% of 
the larvae were homozygous her9 mutants, 57% were heterozygous, and (20%) were homozygous wild 
type. Interestingly, of the 76 embryos collected after 10 dpf (that all looked normal), not a single 
homozygous mutant was found out of the group. These data strongly suggest that homozygous 
mutation of her9 is lethal in zebrafish during the larval stage (between 5 and 10 dpf) . 
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4.4 Discussion 
 As described in Chapter 3 of this dissertation, morpholino mediated knockdown of the zebrafish 
bHLH-O transcription factor her9 (ortholog of the mammalian HES1) resulted in striking retinal 
vasculature defect phenotypes. However, due to the transient nature of gene knockdown with 
morpholinos, it was impossible to study later occurring phenotypes that might result from loss of her9 
gene function. Therefore, we concluded that it would be highly beneficial to study the loss of her9 gene 
function in a genetic knockout zebrafish model. In this study, we demonstrate generation of various 
her9 knockout lines using the recently developed CRISPR/Cas9 genome editing tools.  
HRMA analysis followed by sequencing confirmed various genetic lesions were created in F0 
embryos when injected with gRNA targeting the first exon of her9 along with Cas9 mRNA. In addition, 
various vasculature defect phenotypes could be observed in the F0 mosaic embryos, including loss of 
retinal vasculature and abnormal vasculogenesis in the tail resulting in bulbs of blood vessels in a 
portion of the embryos observed. This early data was a good indication that the loss of her9 might not 
only play a role in development of the retinal vasculature network, but in vasculogenesis throughout the 
body. 
 Numerous F0 embryos were raised to adulthood and screened for germline transmission of 
mutant her9 alleles. Although the first CRISPR mutants generated harbored only in-frame deletions, the 
next three germline transmitted her9 mutant alleles recovered from F0 founders contained indels that 
resulted frameshift mutations, and 2 of the 3 germline transmitting mutations are now being analyzed in 
subsequent generations. 
 Initially, heterozygous her9 mutant zebrafish were incrossed and the resulting embryos were 
raised to adulthood to screen for both heterozygous and homozygous F2 fish. Interestingly, although 
homozygous her9 mutants could be detected in embryos at Mendelian ratios, not a single her9 -/- adult 
fish was ever recovered. Subsequent analysis revealed that all of the homozygous mutant larvae die 
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before 14 dpf and display a wide range of phenotypic abnormalities, including severe vasculature 
defects throughout the body. Similar to what was observed when using a splice blocking morpholino to 
knockdown her9 expression, it is reasonable to assume that the maternally deposited mRNA is sufficient 
to permit survival of her9 -/- embryos at least to the 5 dpf larval stage. However, as the pool of maternal 
wild type her9 is depleted, numerous morphological and vascular defects start to appear that ultimately 
lead to death of the larvae at later stages due to loss of her9 function. 
 Taken together, we have successfully utilized the CRISPR/Cas9 targeted genome editing 
approach to induce genetic lesions in the zebrafish her9 allele resulting in stable germline transmitting 
mutants. In addition, we confirmed previous morpholino data that loss of her9 gene function results in a 
wide range of vascular defects during development, and that maternal deposition of her9 mRNA is 
sufficient for embryonic survival to early larval stages, but additional Her9 is required for further 
development. It is possible that the high mortality observed in the her9 homozygous mutant larvae is 
due to vasculature defects, and that at mid- to late-larval stages, enough oxygen and nutrients are not 
available to tissues because they are not properly vascularized. Although it will be impossible to 
generate maternal zygotic her9 mutant embryos to study early developmental phenotypes due to the 
inability to recover any homozygous her9 mutant adults, there are numerous zygotic phenotypes 
observed in the larval stage that could give much insight into these novel functions of her9. The retinas 
of her9 homozygous mutants were poorly laminated, and had a greatly expanded GCL domain. In 
addition, the retinal vasculature network was largely absent in these larvae, suggesting that her9 not 
only plays a role in proper neurogenesis, but formation of retinal vasculature. It may be possible, that in 
conjunction with translation blocking morpholinos to inhibit any maternal effect, a facsimile of a true 
maternal zygotic her9 homozygous mutant zebrafish could be generated to study both early embryonic 
and late larval defects resulting from loss of her9. 
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4.5 Materials and Methods 
4.5.1 Zebrafish 
 All zebrafish (Danio rerio) strains were bred, raised, and maintained in accordance with 
established animal care protocols for zebrafish husbandry (Westerfield, 1995). Adult fish, embryos, and 
larvae were housed at 28°C, on a 14 hr light: 10 hr dark cycle. Embryos were staged as previously 
described (Kimmel et al., 1995). The Tg(fli1a:EGFP)y1Tg, hereafter called fli1:EGFP has been previously 
described (Lawson and Weinstein, 2002b). All animal procedures were carried out in accordance with 
guidelines established by the University of Kentucky Institutional Animal Care and Use Committee 
(IUCAC). 
4.5.2 Generation of guide RNA oligonucleotides  
 The two target sites for CRISPR/Cas9 based genome editing within the her9 gene were selected 
to be in the first and third exons. First target site was 54 bp 3’ of the translation start site, and 46 bp 
upstream of the beginning of the bHLH domain (Table 4.1). The second target site is immediately after 
the coding region that corresponds to the Orange domain of her9. Single strand DNA oligonucleotides 
used to generate the guide RNA (gRNA) donor vector were designed using the ZiFit online tool 
(http://zifit.partners.org/ZiFiT/), selecting the T7 promoter to generate a 100-115 bp amplicon. Oligos 
were annealed at a concentration of 100 µM (5 minutes at 95-100oC, then slowly cooled to room 
temperature for 5 hours) and ligated into BsaI (NEB: R0535S) digested pDR274 vector (Addgene: 42250). 
Recombinant vectors containing the gRNA insert sequence were digested with DraI (NEB: R0129S) and 
the insert was amplified by PCR using DraI primer. The PCR product was (QIAquick PCR purification kit) 
and in vitro transcribed using Ambion-MEGAscript T7 Transcription Kit (Life Technologies#AM1334) then 
purified by phenol:chloroform extraction followed by ethanol precipitation.  A gRNA targeting the 
tyrosinase gene was used as a positive control for the study. pT7tyrgRNA (Addgene: 46761) plasmid was 
linearized using BamHI (NEB: R3136T) and in vitro transcribed using Ambion-MEGAscript T7 
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Transcription Kit (Life Technologies: AM1334) then purified by phenol:chloroform extraction followed by 
ethanol precipitation. 
4.5.3 Cas9 mRNA 
 The pT3TS-nls-zCas9-nls (Addgene: 46757) expression vector that contains a zebrafish codon 
optimized Cas9 coding sequence flanked by nuclear localization sequence was linearized with XbaI (NEB: 
R0145S) and purified by phenol:chloroform extraction and ethanol precipitation. Capped mRNA was 
generated using Ambion mMESSAGE mMACHINE T3 Transcription Kit (Life Technologies:AM1304) and 
purified by phenol:chloroform extraction and ethanol precipitation. 
4.5.4 Microinjections 
 Cas9 mRNA and gRNA were injected at 150-300 and 50-100 ng/embryo respectively at a volume 
of 4.18 nl/embryo in buffered solution with 0.025% dextran red (as an injection indicator) into the yolk 
of 1-cell stage zebrafish. 
4.5.5 High resolution melting analysis (HRMA) 
 Genomic DNA was isolated from individual 24-72 hpf embryos or from adult tail clips by placing 
the sample in 20 µl Thermopol buffer and incubating at 95oC for 10 minutes, then adding 5 µl of 
proteinase-K (10 mg/ml), incubating again at 55oC for 2 hours followed by a 10 minute 95oC proteinase-K 
denaturation step. HRMA was performed using LightCycler 480 High Resolution Melting Master (Roche) 
according to manufacturer’s instructions on a LightCycler 96 Real-Time PCR System (Roche). Primer 
sequences used for HRMA study are listed in (Table 4.1). 
4.5.6 Restriction fragment length polymorphism (RFLP) analysis 
 The mutant her9 allele carrying a 1 bp deletion could be identified by RFLP analysis due to the 
introduction of a BsaJI (NEB: R0563S) restriction endonuclease site created by the CRISPR mutagenesis 
based deletion. Genomic DNA from whole embryos or from tail clips were amplified by PCR using the 
primers listed in (Table 4.1). 
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Chapter 4 Tables 
Table 4.1: Chapter 4 oligo sequences and application 
oligo name oligo sequence use 
her9 forward CRISPR1 GTGTTTGATCATGCCAGCCGAT HRMA/sequencing 
her9 reverse CRISPR1 CCTTTCTATGCTCGCTGGCATT HRMA/sequencing 
her9 forward CRISPR2 CCACCTGTCCGGTTGTATGGG HRMA/sequencing 
her9 reverse CRISPR2 GAGGCGCCGTTGATGGGTAAC HRMA/sequencing 
her9 C1 forward ATCTATAAATACCGCTGGCGTGTGG RFLP 
her9 C1 reverse TCTCGTTGATTCTCGCTCTGCG RFLP 
CRISPR1 target site GGAGTATGAGATCCACTGGC her9 target 1 
CRISPR1 oligo-1 TAGGAGTATGAGATCCACTGGC her9 C1 oligo-1 
CRISPR1 oligo-2 AAACGCCAGTGGATCTCATACT her9 C1 oligo-2 
CRISPR2 target site GGCAGGCTGAGGGTAGTTCA her9 target 2 
CRISPR2 oligo-1 TAGGCAGGCTGAGGGTAGTTCA her9 C2 oligo-1 
CRISPR2 oligo-2 AAACTGAACTACCCTCAGCCTG her9 C2 oligo-2 
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Chapter 5: Summary and Discussion: Her4 and Her9 bHLH-O transcription factors in the 
developing and regenerating vertebrate retina 
5.1 Summary and Discussion 
 For proper visual function, a myriad of diverse cell types, tissue structures, and refined 
interconnections between numerous neurons and glia must be formed and maintained with near 
precision. The ability to see, or detect photons of light emanating from our environment, is enabled in 
part by the retina, with further processing of visual information taking place in the brain. The retina 
itself is a highly organized multi-layered tissue that results from complex interactions of regulatory 
networks and spatiotemporally controlled gene expression events during development. Because the 
ability to see is a critical function of our own biology, the extrinsic and intrinsic signals as well as the 
gene regulatory networks that control neurogenesis of the retina have been intensely studied. However, 
there are still many questions about how the retina develops, is maintained, and in the case of some 
cold-blooded animals, regenerates following damage. 
 The retina is the external most part of the central nervous system, and as such, is more tractable 
to study and experimental manipulation (including possible treatment) than other parts of the CNS such 
as the brain. The mammalian CNS, including the retina, is unable to repair damage from various types of 
acute trauma or chronic disease. Damage to the mammalian retina results in glial scarring, apoptosis of 
retinal cells, various degrees of vision loss, and in many cases, complete blindness. The zebrafish retina, 
however, undergoes a proliferative response that results not only in new retinal cells of the correct type 
positioned in the proper location, but also functional integration of these cells the existing neural 
networks and full restoration of vision after the retina has been damaged. The long term goal for many 
teams who study zebrafish visual system biology is to understand exactly how and why many cold-
blooded animals such as the zebrafish are capable of retinal regeneration, what gene regulatory 
networks and cell types enable and regulate this phenomenon, and if it is possible to recapitulate or 
142 
 
emulate these processes in human patients with visual system disorders. Our current understanding of 
retinal neurogenesis, including both development and regeneration, are too incomplete to be able to 
design and implement all but the most rudimentary types of therapies for patients suffering from vision 
loss. A greater understanding of the gene regulatory networks and cellular mechanisms that enable 
retinal neurogenesis will enhance future therapeutic efforts to maintain or restore funct ional vision to 
patients suffering from visual impairment or vision loss. 
 In this dissertation, the goals were to determine the functions of the basic-helix-loop-helix-
orange (bHLH-O) transcription factors her4 and her9 during development and regeneration of the 
vertebrate retina using the zebrafish as a model organism (Figure 5.S1). The roles of these two genes in 
retinogenesis have not been previously described in zebrafish, nor have the functions of their 
mammalian orthologs (HES5 and HES1 respectively) during retinal development been elucidated. Her4 
and her9, as well as many of the other bHLH-O paralogs are known to be involved in numerous 
developmental processes including regulation of the segmentation clock during somitogenesis, neural 
tube closure, floor plate development, and establishment of cranial sensory placodes. In most cases, 
genes of this class tend to restrict differentiation of cells from adopting a typically pro-neural fate and 
keep progenitors in the cell cycle so that they can give rise  to later born neurons and glia downstream of 
the Notch-Delta signaling master regulatory pathway. 
 Both her4 and her9 have been shown to be upregulated in a background of chronic, rod-specific 
degeneration and regeneration in the zebrafish retina, and are primarily expressed in proliferative areas 
of the developing as well as the mature retina. Thus, the initial hypothesis was that these genes play a 
role in the maintenance of pools of proliferating stem and progenitor cells that give rise to rod 
photoreceptors. The experiments detailed in Chapter 2 of this dissertation placed her4 directly 
downstream of the Notch-Delta signaling pathway, and the primary function of Notch signaling has been 
widely considered to be repression of cells from differentiating into neurons, and to keep cells in the cell 
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cycle. Consistent with this idea, and perhaps one of the most important insights into the function of her4 
with respect to retinal neurogenesis, is that morpholino mediated knockdown of her4 results in a retina 
that phenocopies disruption of the entire Notch-Delta signaling pathway. This evidence suggests that 
her4 is a primary effector of Notch-Delta signaling during retinal neurogenesis, even though there are 
numerous other genes that are Notch responsive and are also expressed in the retina. 
Why is it that knockdown of this single transcription factor phenocopies Notch pathway defects, 
when there are over 20 Notch-responsive bHLH-O genes expressed in the zebrafish? One possible 
explanation is that the genes directly regulated by her4 in the retina have unknown cis-regulatory 
elements that preclude binding of any other bHLH-O protein besides Her4. Another possibility is that 
there could be heterodimerization partners for Her4 that are only expressed in the retina, and it is 
unique combinations of her gene expression that leads to repression of target genes. A third possibility 
is that there is a minimum threshold of Notch-responsive bHLH-O genes that must be expressed during 
retinal development to see the effects of Notch-Delta signaling, and her4 is simply one of the more 
highly abundantly expressed bHLH-O genes in the retina. To further explore this unexpected result, 
additional experiments would need to be performed. One possible approach would be to try to rescue 
the morphant phenotype with a complimentary bHLH-O gene (Notch-responsive, WRPW tetrapeptide C-
terminal motif). If this other bHLH-O transcription factor was able to rescue the her4 morphant 
phenotype, it would indicate that there is nothing particularly special about her4, and that the observed 
knockdown phenotype is simply due to a decrease in the dosage of bHLH-O factors in the retina. 
Another approach could be to try to knock down expression of every bHLH-O gene that is expressed in 
the retina, independently of her4. If knockdown of any of the other genes phenocopies the her4 
morphant, that would be strong evidence that the function of her4 in the retina is dependent upon 
unique heterodimerization partners. 
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 Additional experiments detailed in Chapter 2 showed that in the adult retina, her4 is primarily 
expressed in the CMZ, and that in a background of rod degeneration/regeneration (XOPS:mCFP), her4 
was upregulated in both the CMZ, and central retina. The expression patterns of her4 here were 
unexpected because in the XOPS:mCFP retina, it is the rod progenitor cells at the base of the outer 
nuclear layer that are rapidly proliferating in response to rod degeneration, and her4 was not expressed 
in these cells. Instead, we found that her4 was upregulated in slowly proliferating subsets of Müller glia 
in the INL of the central retina in addition to the increased her4 expression at the CMZ. Previous studies 
have concluded that there was no significant difference in the number of Müller cells in the  central 
XOPS:mCFP retina compared to wild type controls, and this appeared to be the case, but the number of 
her4-expressing Müller glia that have re-entered the cell cycle is increased in the transgenic background. 
We therefore hypothesized that it is this population of cells that feed into the rod photoreceptor 
lineage, and also suspected that there might be some contribution to the rod lineage from the CMZ as 
well.  
 The transgenic her4:Kaede zebrafish was generated to conduct lineage tracing experiments in 
order to determine the fate of her4 expressing cells in the retina. We demonstrated that expression of 
the transgene recapitulates expression of the endogenous her4 transcript, even though the her4.3 
promoter segment used to drive expression of Kaede only represented one of the five possible her4 
promoters in the her4 loci. Lineage tracing analysis using the her4:Kaede line crossed onto the 
XOPS:mCFP background revealed that the slowly proliferating her4-positive Müller glia in the inner 
nuclear layer give rise to Nr2e3-expressing progenitor cells. These progenitor cells then migrate to the 
base of the outer nuclear layer where they differentiate into rod precursor cells and then rods. In 
contrast to the comparatively more rapid response of Müller cells following acute damage (Thummel et 
al., 2008, Thomas et al., 2012), the cycle of her4 expression to rod neurogenesis can take up to three 
days. As early as one day post photoconversion, new non-photoconverted Kaede in presumptive Müller 
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cells in the inner nuclear layer could already be observed, demonstrating that the chronic rod 
degeneration and regeneration experienced in the XOPS:mCFP retina elicits a continual, albeit low -level, 
response in the inner nuclear layer. These data support the hypothesis that upregulation of her4 in small 
subsets of Müller cells spread throughout the central retina is associated with the need to restock and 
replenish the rod progenitor pool as those progenitors are continually depleted. In addition, acute light 
damage that lead to widespread synchronized rod and cone photoreceptor cell death showed that the 
magnitude of the her4 response is correlated with the amount of damage the retina receives. Similar to 
the XOPS:mCFP retina, it is her4-expressing Müller cells in the inner nuclear layer that mediate the 
proliferative response following injury. 
 As mentioned previously, in addition to upregulation of her4 in the central retina, her4 was also 
upregulated in the CMZ. This result was surprising because unlike other retinal neurons, rod 
photoreceptors are not derived from the CMZ but from populations of stem cells the reside in the INL of 
the central retina (Raymond et al., 2006, Morris et al., 2008a, Morris et al., 2008b). The her4:Kaede line 
was used to determine what cell types the CMZ had the capacity to generate, and consistent with 
previous observations, the lineage of her4-expressing cells from the CMZ includes all retinal cell types 
except for rod photoreceptors. Why there is a significantly expanded number of her4-expressing cells in 
an area of the retina that does not give rise to rod photoreceptors in the XOPS:mCFP background 
remains unclear. It has previously been demonstrated that acute photoreceptor damage results in the 
release of cytokines such as CNTF and TNFα which in turn result in increased expression of stat3 and 
ascl1a and Müller glia proliferation in the INL of the central retina (Kassen et al., 2007, Kassen et al., 
2009, Nelson et al., 2012, Nelson et al., 2013). It is possible that soluble factors released from apoptotic 
rod cells diffuse throughout the retina, and the cells in the stem cell niche at the CMZ are stimulated to 
increase her4 expression but the CMZ itself is still restricted as to what cell types it can produce. In 
addition, the signals that stimulate small numbers of Müller cells in the INL to express her4 and 
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contribute to the rod lineage remain unknown, as well as why only small subset of Müller cells respond 
to these signals. Possible mechanisms include juxtacrine signaling that stimulates Notch activity, 
gradients of extrinsic factors generated by dying photoreceptors, intrinsic cues that sensitize subsets of 
Müller cells to rod degeneration, or some combination of the above.  
 Unlike its paralog her4, her9 is not responsive to Notch-Delta signaling, even though the 
mammalian homolog of her9 (HES1) is commonly used as a readout for activated Notch signaling. Her9 
is a particularly interesting bHLH-O transcription factor because it is an effector of multiple distinct 
signaling pathways and regulatory networks in a tissue dependent manner (as discussed in detail in 
Chapter 3). For example, it is downstream of Bmp signaling and involved in pre-patterning of the early 
neuroectoderm, and downstream of midline Nodal signaling during notochord development (Bae et al., 
2005, Latimer et al., 2005).  
Drug screens to transiently inhibit Notch-Delta, Hh, and Fgf signaling pathways did not result in 
altered her9 expression in the retina. Manipulation of the retinoic acid (RA) signaling pathway, however, 
did change the expression levels and expression domain of her9 in the retina, suggesting that in retinal 
tissue, her9 is downstream of RA signaling. Analysis of the presumptive upstream cis-regulatory 
elements of her9 show that there are three predicted Su(H) binding sites in the promoter region of her9, 
suggesting that it could be a Notch responsive gene. However, these Su(H) sites are also flanked by 
multiple retinoic acid responsive elements (RARs), including several RARs within the coding region of the 
gene as well. It is possible that the RAR elements are blocking activation of her9 by Notch mediated 
signaling, and that this lead to sub-functionalization of this gene in the retina, however, further studies 
must be completed to fully understand the contribution of the cis-regulatory elements that play a role in 
the expression of her9 in the retina. 
Interestingly, the spatiotemporal expression pattern of her9 in the retina coincides with 
development of the retinal vasculature. During early embryonic retinal development, her9, like her4, is 
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expressed throughout the proliferating neuroepithelialial cells of the primordial eye, and expression is 
restricted to the peripheral CMZ as the retina matures. Unlike her4, however, her9 is expressed in the 
choroid fissure and expression of her9 here persists until angiogenesis of the hyaloid artery is 
completed. Fluorescent in situ hybridization of experiments to visualize her9 expression along with 
immunohistochemistry to visualize vasculature endothelial cells showed co-localization of her9 
transcript with retinal vasculature in both the choroid artery and vein, as well as the lens basket 
vasculature. These data suggested that her9 could play a previously undescribed role in vasculogenesis 
downstream of the RA signaling pathway in the retina. 
Morpholino mediated knockdown of her9 using a translation blocking morpholino resulted in a 
decrease of vasculature endothelial cells in the retina compared to controls. The morphant phenotype 
could not only be rescued by co-injection of in vitro transcribed capped her9 mRNA, but injection of her9 
mRNA alone resulted in excess retinal vasculature. These data coincide with the excess of retinal 
vasculature cells when the embryo was transiently exposed to excess RA from 24-36 hpf and a decrease 
in retinal vasculature when RA signaling was inhibited during the same time period, further supporting 
the observations from in situ hybridization and qPCR experiments that her9 appeared to be an effector 
of RA signaling during retinal vasculature development. These exciting results demonstrate that her9 has 
a novel function in development of the retinal vasculature network. 
 To better understand the role of her9 during retinal vasculogenesis, her9 mutants were 
generated using the CRISPR/Cas9 targeted genome editing technique (Varshney et al., 2015). High 
resolution melting analysis (HRMA) followed by sequencing of the her9 allele showed that the 
CRISPR/Cas9 based genome editing efficiently created genomic lesions in the her9 allele, and that these 
mutations were heritable. Interestingly, a variety of vasculature defect phenotypes could be detected 
even in the mosaic F0 embryos that were injected with the her9 CRISPRs, including loss of retinal 
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vasculature and deformed trunk blood vessels that resulted in bulbs of vasculature endothelial cells that 
inhibited normal blood flow in the tail of the developing larvae. 
 When zebrafish heterozygous for a mutant frame-shift allele of her9 were incrossed, and the 
subsequent generation raised to adulthood, her9 -/- zebrafish were never recovered. Subsequent 
analysis showed that the homozygous her9 mutant larvae were dying before 14 dpf and possessed a 
wide range of phenotypic abnormalities, including severe vasculature defects throughout the body such 
as intersegmental vessel defects and severe retinal vasculature and lamination defects. So although it 
will probably be impossible to ever recover homozygous her9 mutant adults that could be used to 
generate maternal zygotic mutant embryos, zygotic phenotypes in homozygous mutants resulting from 
heterozygous incrosses can be studied. 
Similar to what was observed when using splice blocking morpholinos rather than translation 
blocking morpholinos to knockdown her9 expression, it is reasonable to assume that the maternally 
deposited mRNA is sufficient to permit survival of her9 homozygous mutant embryos at least to the 5 
dpf larval stage. However, as the pool of her9 is depleted, and no endogenous her9 is generated to 
replace it, numerous morphological and vascular defects start to appear that may lead to death of the 
larvae at later stages. 
This phenomenon could prove to be a major disadvantage of using genetic knockouts (either 
generated through tilling, TALENs, CRISPRs or otherwise) when studying early developmental 
phenotypes as compared to the morpholino mediated transient knockdown approach. It has already 
been documented that the mutant phenotypes resulting from lesions in numerous zebrafish genes do 
not necessarily recapitulate the morphant phenotypes observed when those same genes are knocked 
down (Kok et al., 2015). Presumably, this is in part due to the significant effects of maternal deposition 
of spliced mRNA within the ovum, and also due to the fact that the zebrafish develops extremely rapidly 
compared to other vertebrate model systems. As with many questions in biology, there is no perfect 
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solution, and best available technique to study the function of a particular gene during early 
development might include both use of knockout lines as well as translation blocking morpholinos if the 
use of maternal zygotic mutants is not feasible. 
The numerous bHLH-O genes expressed in the zebrafish play a wide variety of roles during 
development as well as in various tissues of the adult zebrafish. This dissertation describes some the 
functions of two of these bHLH-O transcription factors (her4 and her9) in the retina. Given that the one 
of the primary functions of the Notch-Delta signaling pathway is to regulate neurogenesis by keeping 
stem- and progenitor cells in the cell cycle, it stands to reason that a downstream effector of the Notch 
pathway would suppress expression of pro-neural genes. Only a few targets of her4 mediated repression 
have been identified in the retina, including neuroD, ath5, ascl1a, and insm1a, and all of these genes 
play a pro-neuronal function during retinal neurogenesis. To better understand the role of her4 during 
retinal development and regeneration, a more complete description of the her4 gene regulatory 
network will have to be elucidated. One of the ways that this can be accomplished would be to generate 
mutant zebrafish lines in which her4 is knocked out. This may prove to be difficult because her4 is 
encoded on five tandem duplicate repeats (all of which produce the same gene product), so every 
iteration of the her4 gene would need to either be independently knocked out or the entire her4.1-
her4.5 allele removed altogether. Fortunately, with new genome editing technologies available in the 
zebrafish, this might be feasible. In addition to completely removing the her4 allele, it would be 
beneficial to have the ability to conditionally knockout the allele in a tissue and temporally dependent 
manner to study the effects of loss of all her4 variants not only during embryonic retinal development 
but also during regeneration. To accomplish this, CRISPR/Cas9 mediated genome editing techniques 
could be used to knock-in LoxP sites that flank the allele, and these transgenic fish could be outcrossed 
to rx2-CRE or rx2-CreERT2 lines to generate conditional knockouts and temporally controlled conditional 
knockouts respectively (Hans et al., 2011). This would enable a more complete understanding of the 
150 
 
contribution of her4 to the processes of retinal development and retinal regeneration independently, 
and would give valuable insight into the gene regulatory networks that control retinal neurogenesis 
downstream of her4. 
A similar approach could be undertaken to differentiate between the roles of her9 during 
development and its role during regeneration. Her9, unlike her4, is not Notch-dependent and is 
regulated by different signal transduction pathways in a tissue dependent manner. The experiments 
outlined in Chapters 3 and 4 of this dissertation provide evidence that her9 plays a role in development 
of not only the retinal vasculature network, but also blood vessels throughout the trunk of the zebrafish. 
This novel finding adds to the known roles of her9 during the segmentation clock during somitogenesis, 
floor plate development, and establishment of non-neural identity during cranial sensory placode 
development. It is interesting that one gene functions in such diverse physiological processes in different 
tissues, and can be activated by numerous signaling pathways. This leads me to beli eve that one of the 
primary functions of her9 in the zebrafish might be to mediate cross-talk between regulatory networks 
during development so that cell- or tissue-specific events take place with proper coordination. Given 
that a her9 homozygous mutant adult zebrafish cannot be recovered (thus precluding the study of 
maternal zygotic mutants), a conditional knockout approach to study the various functions of her9 
would be highly desirable. At this point, it is clear that her9 is involved to some degree in vasculogenesis, 
but why is it upregulated in the retina of zebrafish that experience rod-specific degeneration and 
regeneration remains unknown. It is possible that the function of her9 at the CMZ could be redundant 
with the function of her4, but her9 appears to play no role in rod neurogenesis. Her9 expression in the 
choroid, however, could be indicative of the need for additional vasculature to meet the metabolic 
demand of constant rod photoreceptor turnover. If this were the case, then a conditional knockout of 
her9 in a background of chronic rod degeneration and regeneration could result in a more severe retinal 
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phenotype in the XOPS:mCFP eye, and could possibly lead to secondary loss of other retinal neurons 
besides rod photoreceptors. 
There could be numerous long term implications of this work, including possible roles in gene 
therapy in human patients who have experienced various degrees of retinal degeneration and vision loss 
from ophthalmic disorders. Induction of HES5 (her4 in zebrafish) expression in a diseased human retina, 
for example, could be part of a possible treatment that would induce resident Müller glia to 
dedifferentiate and re-enter the cell cycle resulting in progenitor cells that could be further directed to 
differentiate as replacement neurons. Knockdown of HES1 (her9 in zebrafish) could possibly be used to 
suppress excess vasculogenesis during retinopathy, and overexpression could possibly provide a 
mechanism to generate new vasculature tissue de novo not only in a diseased retina, but throughout 
the body. For these possibilities to become a reality a much more thorough understanding of the exact 
mechanisms of these genes within the context of larger gene regulatory networks would need to be 
realized. In addition, there are numerous other factors and pathways that have yet to be described that 
enable regeneration in the zebrafish but preclude regeneration in mammals. 
Taken together, the projects detailed in this dissertation provide a detailed examination and 
description of novel functions of two bHLH-O transcription factors during development and 
regeneration of the zebrafish retina. This dissertation includes detailed descriptions of the expression 
patterns and knockdown and/or knockdown phenotypes observed with her4 and her9 and shows the 
importance of these genes during embryonic retinal development and regeneration of the mature 
zebrafish retina. It is my hope that these studies could contribute in some way towards a greater 
understanding of development and regeneration of the visual system which could in turn lead to the 
development or deployment of therapies that could meaningfully delay or reverse vision loss resulting 
from a variety of diseases that lead to visual impairment in humans. 
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Figure 5.S1: Her4 and her9 during retinal development and regeneration. The bHLH-O transcription 
factors her4 and her9 are upregulated during zebrafish rod degeneration/regeneration. The her4 
transcription factor plays a role in retinal neuron neurogenesis, while her9 plays a role in development 
of the retinal vasculature network. 
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